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ABSTRACT 
The new field of ‘omics’ has spawned the development of metaproteomics, an approach 
that has the ability to identify and decipher the metabolic functions of a proteome 
derived from a microbial community that is largely uncultivable.  With the development 
and availabilities of high throughput proteomics, high performance liquid 
chromatography coupled to mass spectrometry (MS) has been leading the field for 
metaproteomics.  MS-based metaproteomics has been successful in its’ investigations 
of complex microbial communities from soils to the human body.   
Like the environment, the human body is host to a multitude of microorganisms 
that reside within the skin, oral cavity, vagina, and gastrointestinal tract, referred to as 
the human microbiome.  The human microbiome is made up of trillions of bacteria that 
outnumber human genes by several orders of magnitude.  These microbes are 
essential for human survival with a significant dependence on the microbes to encode 
and carryout metabolic functions that humans have not evolved on their own.  Recently, 
metaproteomics has emerged as the primary technology to understand the metabolic 
functional signature of the human microbiome. 
Using a newly developed integrated approach that combines metagenomics and 
metaproteomics, we attempted to address the following questions: i) do humans share a 
core functional microbiome and ii) how do microbial communities change in response to 
disease.  This resulted in a comprehensive identification and characterization of the 
metaproteome from two healthy human gut microbiomes.  These analyses have 
resulted in an extended application to characterize how Crohn’s disease affects the 
functional signature of the microbiota. 
Contrary to measuring highly complex and representative gut metaproteomes is 
a less complex, controlled human-derived microbial community present in the gut of 
gnotobiotic mice.  This human gut model system enhanced the capability to directly 
monitor fundamental interactions between two dominant phyla, Bacteroides and 
Firmicutes, in gut microbiomes colonized with two or more phylotypes.  These analyses 
revealed membership abundance and functional differences between phylotypes when 
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present in either a binary or 12-member consortia.  This dissertation aims to 
characterize host microbial interactions and develop MS-based methods that can 
provide a better understanding of the human gut microbiota composition and function 
using both approaches.  
	   vii	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Chapter One 
Characterization of human host-microbiome interactions at the molecular level 
with metaproteomics approaches  
Part of the introduction is adapted from the ‘proteomics and metaproteomics’ 
chapter in ‘The Human Microbiome’ book (CABI with editor Dr. Julian Marchesi) 
written by Alison R Erickson (2012 release date). 
1.1: Introduction 
In a natural ecosystem, microbes do not exist in isolation, but rather in populations and 
communities in which competition and cooperation are essential to shaping the 
composition and function of a microbial community. To understand microbial community 
composition, structure, function, and evolution, research has focused on development of 
approaches to advance beyond single pure-culture laboratory experiments to in situ 
analyses of environmental microbial populations and communities, since single 
microbial isolates in lab cultures do not accurately capture the complexities of microbial 
interactions in environmental communities.  An organism cultivated in the laboratory 
may not represent or reflect its true activity and physiology in a natural environment 
where conditions such as resource competition and predation are widespread[1].  In 
addition, estimates suggest that ~90% of the microorganisms inhabiting the 
environment are not cultivable[2,3].  As a result, intensive research efforts have focused 
on improving methodologies for cloning, sequencing, and annotating whole genomes 
from heterogeneous microbial environments.  For many complex environmental 
communities, metagenomics (genomic sequencing and analysis of uncultured microbes 
[4]) has provided insight into the genetic diversity, evolution, and metabolic potential of 
uncultivable microorganisms[5,6,7,8] otherwise not possible with traditional laboratory 
techniques. 
With the emergence of metagenomics, extensive research has focused on 
sequencing and characterization of environmental microbial communities collected from 
extreme ecosystems, such as the Acid Mine Drainage[9] and hydrothermal systems[10], 
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the ocean[11,12], soils[13], and more recently the human body[14].  The human body is 
one example of a unique ecosystem where microbes and the human host live in 
symbiosis (Figure 1.1), in which the microbial cells outnumber human cells by 10-fold.  
Our collective microbial counterpart inhabits multiple body sites (e.g., skin, vagina, oral 
and gastrointestinal tract) and is referred to as the human microbiome.  Although the 
human microbiome is made up of thousands of bacterial species (Figure 1.2), ~20-60% 
of the bacteria inhabiting the human-associated microbiome cannot be 
cultured[15,16,17,18,19].  For example, ~50% of the human oral microbiome is 
estimated to be non-cultivable[20].  However, with the increasing availability and 
quantity of human microbiota-associated metagenomic sequence data[21,22,23,24,25], 
we can begin to study and understand the human microbiome in both healthy and 
disease conditions.  This sequence data has already increased our knowledge of the 
human microbiota gene content and variability and paved the way for systems biology 
(‘omic’) type studies, in particular making metaproteomics, a comprehensive community 
proteome analysis, feasible [26].  These whole community genomic sequences currently 
serve as the foundation for metaproteomics in the human microbiome (Figure 1.3) and 
enable the identification of hundreds to thousands of proteins.  However, the dogma 
that DNA and RNA are equivalent is no longer considered accurate, as suggested by Li 
et al., mandating that the primarily focus cannot only be on DNA, but RNA as a separate 
entity, since its alterations induce changes in the final end product, the proteins[27].  
Although metagenomic sequencing unveils the collective functional ‘potential’ of a 
microbial community, this prediction is not directly related to the ‘actual’ host-microbial 
functional signature where protein information provides a deeper look at the molecular 
activities.  Because metagenomics only captures the complete reportiore of genome 
capacity, it will be the integration of metaproteomics and/or metatranscriptomics with 
metagenomics that can serve as a powerful tool to study and collectively characterize 
the functional and metabolic signatures of the complex human microbiome. 
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Figure 1.1: An interconnected landscape of host genetics, microbiota, and external 
factors such as diet regulate the stability of the unique human ecosystem where 
microbes and the human host live in symbiosis. 
 
 
 
Figure 1.2: Microbial density in the gastrointestinal tract[26]. 
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Figure 1.3: Integration and interconnectivity of metaproteomics with other ‘omic’ 
disciplines, with metagenomics as the primary foundation for all other ‘omics.’  
Metagenomics provides DNA information, metatranscriptomics provides RNA 
information, metaproteomics provide protein-level information, metabolomics provides 
information about small-molecule metabolites, and interactomics provides information 
about all interactions between proteins and other molecules. 
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Metaproteomics
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Interactomics
Human
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1.2: Microbial Community Functional Analysis 
Proteomics, the identification and cataloguing of the entire suite of proteins translated in 
an organelle, organism(s), or tissue, has begun to rise in significance in the ‘post-
genomic era’, since proteomics reveals the final gene products that are inscribed in the 
genome “dictionary.”  It is the proteins, not genes, that are the active enzymatic and 
metabolic players, and their complex network interactions and pathways that are 
responsible for the complexity of humans and their microorganisms’ phenotype[28] in 
the human microbiome.  For example, the specific order and arrangement of genes in 
the genome does not provide any information about the structures and functions of 
protein complexes.  Studies have shown that proteins rarely function on their own, but 
rather usually exist in multi-component complexes and function with remarkable 
specificity[29,30].  Protein-protein interactions and post-translation modifications and 
are also very important and are not revealed by genomes or metagenomes.  Therefore, 
to understand the human microbiome, one has to not only identify and characterize the 
gene content, but identify how its complete suite of proteins actually function in vivo, 
which can not be revealed through metagenomics. 
To enable comprehensive functional analysis, high-throughput sequencing 
approaches (of transcripts and/or peptides) with high accuracy, sensitivity, and 
reproducibility are necessary to study the complex and diverse human microbiota.  
Microbial community functionality can be measured with either metaproteomics or 
metatranscriptomics, which is the sequencing of community mRNA.  Recent 
developments in microbial sequencing technologies from microarrays to RNA-seq have 
yielded a tremendous increase in the throughput, accuracy, and sequence coverage 
(number and length of reads) of microbial transcriptomes and metatranscriptomes.  
Metatranscriptomics has shown to be successful in the analysis of environmental 
communities[31,32,33,34,35,36] and recently was applied to the analysis of the human 
gastrointestinal microbiome[37,38,39,40,41].  In comparison, proteomics has also 
advanced from two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and 
single protein measurement platforms to MS-based proteomics and metaproteomics.  
The first large-scale metaproteome characterizations of microbial communities from a 
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static snapshot in time include the low-diversity Acid Mine Drainage (AMD)[42,43], 
wastewater sludge[44], as well as the more complex ecosystems such as the 
ocean[45,46] and the human gastrointestinal[26,47] and salivary[48,49] microbiome.  
These omics’ studies have demonstrated the experimental capabilities and feasibility of 
applying metatranscriptomics and metaproteomics to complex environmental 
communities, including the human microbiome.  Unlike traditional laboratory techniques, 
both technologies are valuable resources that can be used to characterize the 
functionality of uncultivable microorganisms and how it relates back to the genomic and 
taxonomic diversity in microbial communities derived from complex natural 
environments.  While both ‘omic’ technologies are viable, there are advantages and 
disadvantages to selectively use one over the other to understand microbial 
functionality, as outlined below.    
With respect to metatranscriptomics, there are several challenges when working 
with bacterial RNA.  For example, the half-life is short and fraction of obtainable 
bacterial mRNA is limited.  Compared to eukaryotic mRNA, most bacterial mRNA do not 
have 3’ poly-A tails[50], which complicates isolation and purification from other non-
coding RNA types when bacterial RNA preps consist of ~50-80% of rRNA and 
tRNA[51].  Although several studies have begun to identify methods to remove or 
deplete these contaminating RNA species[52,53,54,55], this comes at the risk of 
potentially altering or disrupting the true composition and nature of the environmental 
community transcriptome.  Similarly, technical challenges exist with for metaproteomics. 
Protein extraction from natural environments can be i) biased for high or low-abundance 
members within a community and ii) inefficient when exposed to complex sample 
matrices such as humic compounds commonly found in soils and sediment.  The 
separation and resolution of thousands of proteins from a consortium of microorganisms 
can prove difficult with liquid chromotraphy (LC) timescales and current MS platforms.  
Additionally, the vast dynamic range and complexity of microorganisms and proteins 
within a consortium (e.g., 10-100 trillion microorganisms inhabiting the human 
gastrointestinal tract) can hinder the ability to comprehensively identify the proteome of 
all members of a microbial community.  While both technologies have their limitations, 
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using either or both metatranscriptomics and metaproteomics, is still highly valuable in 
providing insight into the functional profile and physiological responses of a natural 
microbial community under various and extreme environmental conditions, which is not 
possible with metagenomics.   
At this point in time, metaproteomics is better suited for understanding the actual 
functional signature of the microbiota, as it directly measures and determines the 
phenotype of the cells being studied.  Metatranscriptomics (mRNA abundance) does not 
always provide a direct correlative link to protein activity[56], since the final gene 
products (proteins) can can be constitutively expressed and post-transcriptionally 
modified.  Additionally, mRNA abundance is an unreliable estimator for the 
corresponding proteins’ abundance[57,58,59].  Therefore, protein expression should not 
be directly predicted from mRNA expression data.  Unlike metatranscriptomics, 
metaproteomics directly provides measurement information about protein abundances, 
turnover, post-translation modifications, and protein-protein interactions not possible 
with metatransciptomics.  We will focus on proteomics and metaproteomics in the 
human microbiome from this point on. 
1.3: Metaproteomics of Microbial Communities 
Shotgun proteomics is a term commonly used to represent a variety of experimental 
(2D-PAGE and LC) and analytical methodologies (mass spectrometry) that identify the 
composite set of expressed gene products (proteins/proteome) collected from cells of a 
microorganism, organ, or tissue.  Similarly but distinct, metaproteomics, as first defined 
by Wilmes and Bond, is identification of the suite of proteins that are derived directly 
from an environmental consortia that can contain a mixture of several microorganisms, 
and that cannot be binned into species or organism types[60].  Like shotgun DNA 
sequencing, shotgun proteomics consists of digesting proteins into peptides, which can 
be more easily separated by gel electrophoresis and/or liquid chromatography prior to 
analysis via mass spectrometry.  Traditionally, shotgun proteomics has been used to 
catalogue all proteins from a single prokaryote (e.g., E. coli) or eukaryotic organism 
(e.g., S. cerevisiae) grown in culture under variable, but controlled, growth conditions to 
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evaluate the phenotypic changes as reflected by the measured proteome.  Meanwhile, 
developments in high resolution mass spectrometry, LC-based separation, and genomic 
sequencing led to the viability of community proteomics of natural environmental 
samples (metaproteomics) as first demonstrated by the large-scale proteome 
measurements of the microorganisms inhabiting the AMD[42].  From this point on, 
shotgun proteomics was also no longer restricted to using cultivable organisms or 
artificially created mixtures of known proteins in culture.  With the current state and 
adaptation of MS, metaproteomics has transitioned from low complexity communities 
consisting of few dominant organisms[5], to much more complex ecosystems such as 
soil with 103 – 106 taxa per gram of soil[28,61], human gut microbiome with 500-3,000 
bacteria species[62], and the oral microbiome with 500-700 bacteria 
species[18,20,63,64,65]. 
In an attempt to identify the entire protein complement of a microbial community, 
shotgun MS-based proteomics has been the most effective and comprehensive tool to 
date.  This involves the generation and identification of thousands of peptides in a single 
sample.  Protein identifications are generated by matching experimental tandem mass 
spectra (MS/MS) against a peptide sequence database(s) using well-established 
programs, such as SEQUEST, Mascot, and X!Tandem, to identify peptides (peptide-
spectrum matching)[66,67,68].  The accurate interpretation and assignment of MS/MS 
spectra is the first step in the informatics data processing pipeline, called database 
searching (discussed further in chapter two).  Therefore, a relevant genome or 
metagenome (protein database) is the necessary starting point to infer biological 
meaning from complex environmental metaproteomes.  Hence, the depth and quality of 
DNA sequencing have a significant impact on protein database searching. Relative to 
single microbial isolates, the complexity and sequence diversity (strain- and species-
level variation) and reduced coverage of community metagenomic sequences can pose 
many challenges for metaproteomics.  As additional metagenomes are acquired and the 
sequencing technologies and depth of coverage improve, this will correlate with an 
increase in protein identification and deeper proteome coverage of complex, human 
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microbial community metaproteomes using a metagenome(s) as the foundation for MS 
peptide-spectrum matching.   
1.4: Human microbiome  
Like other environmental microbial communities, the human microbiome is a complex 
and dynamic system that plays an important role in many aspects of human physiology.  
The human microbiome (i.e., the host of our microbial symbionts) not only consists of 
microbes living outside the body, but internally within the oral cavity, gastrointestinal 
tract, and vagina.  Together, these microbes (microbiota) outnumber the human somatic 
and germ cells by 10:1 (Figure 1.4).  A deep understanding of human genetic and 
physiologic diversity requires characterization of our microbiome by focusing on factors 
that influence its assembly, stability, functions, and functional variations.  The Human 
Microbiome Project (HMP) is currently focused on generation of large datasets 
describing the microbial lineages and genes present in our gut communities.  A central 
challenge will be to move beyond compositional information and develop ways of 
determining how these communities operate to influence human health as well as 
disease predisposition. 
 
Figure 1.4: The complex healthy human gut microbiome (mixture of human, bacteria, 
and digested food components) and microbial diversity in human feces. Micrograph 
courtesy of Janet Jansson, LBNL. 
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Fortunately, with the advent of the HMP[14,69], a multitude of human-habitat 
associated microbial metagenomes have been sequenced and are publically available 
for researchers to use for additional investigations to help improve our understanding of 
the human microbiome. In addition, a number of human-derived microbial reference 
genomes[70] have been sequenced and are publically available; however, the vast 
majority of microorganisms have yet to be cultured.  Currently, >1,000 microbial 
reference genomes collected from various sites of the human body including the mouth, 
skin, gut, and vagina are publically available.  Therefore, when a metagenome is not 
available or representative for a particular sample, the human-derived microbial 
reference genomes could be used as a substitute for a metagenome(s).  
Metaproteomics can also take advantage of these metagenomes and human-derived 
reference genomes for protein database searches against relevant human proteome 
samples.  While metagenomic predicted protein sequence database searches provide 
highly relevant proteome information, it can be difficult to unambiguously assign 
microbial species/strain information to many proteins.  The reference genomes can be 
used to overcome this by providing definitive species/protein identifications, which can 
be used separately or as a complement to metagenomic predicted protein database 
searches[71].  Several common experimental, analytical, and informatics workflows 
suitable for MS-based proteomics will be explored in more detail with respect to their 
applicability and challenges with the human gut microbiome. 
The objective of this dissertation research is a comprehensive and mechanistic 
understanding of the microbial functional signature in the gut microbiome.  To achieve 
this goal, it was necessary to begin with a lower complexity, synthetic gut microbiome 
and then progress to a more realistic and complex human gut microbiome.  Challenges 
are present in both approaches, but both approaches provide different information that 
will eventually contribute to an overall larger understanding of how the human gut, 
normal or diseased, functions with our microbial counterparts.  For both approaches, 
liquid chromatography coupled with tandem mass spectrometry will be used to 
characterize the gut microbial community proteomes of human twins and gnotobiotic 
mice. 
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1.4.1: Shotgun proteomics of a model human gut microbiome 
It has become clear that the human gut manages to function in symbiosis with an 
indefinite number of microorganisms which are necessary for normal gut function.  For a 
less complex, systematic approach, gnotobiotic mice were used as a model system due 
to the ability to control what microbial flora is present in the gut.  Collaborator Dr. Jeffrey 
Gordon (Washington University, St. Louis, MO) has sequenced a multitude of genomes 
from members of the two dominant phyla present in the normal distal human gut 
microbiota: the Firmicutes and the Bacteroidetes[62,72].  To explore the interactions 
between the Bacteroidetes and Firmicutes in vivo, adult germ-free mice were colonized 
by the Gordon group with either: two, seven, or twelve human-derived microorganisms.  
For example, to examine the fundamental interactions between these two phyla in gut 
biomes, germ-free mice were colonized with either B. thetaiotaomicron or E. rectale, or 
both (chapter 3). These gnotobiotic mice provided a novel model system in which to 
study not only microbial mono- versus bi-association, but up to twelve microbial 
inhabitants at a single point in time.  The overall goal of this initial two-member 
community study was to demonstrate proteomic measurements on gut microbiomes 
from gnotobiotic mice.  With increasing complexity, the goal was to (i) improve 
experimental and informatics applications to resolve closely-related species within a 
low-complexity system (chapter 4) and (ii) elucidate information about the functional 
activities of these low complexity microbial systems under various dietary conditions 
(chapter 5).  The results presented in chapters 3, 4, and 5 emphasize the value of 
combining gnotobiotics with high resolution proteomics as a strategy for developing the 
experimental and computational pipeline needed to characterize gene expression in 
more complex, human body habitat-associated microbial communities.   
1.4.2: Metaproteomics of the human gut microbiome 
The composition and stability of the gut microbiota can be disrupted by external factors 
influencing the likelihood of developing inflammatory bowel diseases (IBD) and the 
propensity for obesity.  IBD can be divided into two disease categories: Ulcerative 
Colitis and Crohn’s Disease. Crohn’s is a chronic, relapsing, immunologically mediated 
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disorder that can have severe physical consequences.  The current hypothesis is that 
this disease is due to an overly aggressive immune response to a subset of commensal 
enteric bacteria.  Studies to date on IBD have suggested that the disorder may be 
caused by a combination of bacteria and host susceptibility.  Until recently, no study has 
reported the use of advanced integrated systems biology techniques such as 
metagenomics and metaproteomics, for the characterization of the natural microflora in 
Crohn’s patients.  
A non-targeted MS-based approach is ideal for studying complex communities 
based on its ability to directly measure expressed proteins from complex environmental 
matrices.  This approach was applied to elucidate the differences and functional 
activities of commensal microbiota between monozygotic concordant (genetically 
identical twins with the same trait) and discordant (genetically identical twins, but differ 
phenotypically for a trait) human twins with and without Crohn’s disease with a focus on 
biological inference (chapter 6 and 8) in addition to method development (chapter 7).  
1.5: Metaproteomics informatics for the gut microbiome 
A challenge in MS-based proteomics is “protein inference” and the ability to accurately 
assign a peptide to the protein from which it originated.  This peptide-protein 
assignment is often complicated by homology between proteins of different microbial 
strains/species found in environmental communities.  In a protein database containing 
multiple bacterial reference genomes, gene redundancy between multiple 
strains/species belonging to the same genera can make it difficult to accurately assign a 
unique peptide to a MS/MS spectrum.  Erickson et al. published a method whereby i) 
only matched metagenomic derived protein databases were searched against the same 
samples’ tandem mass spectra (multiple metagenomes are not concatenated into one 
FASTA protein database) and ii) for proteins identified across multiple samples used for 
comparison, a clustering approach was used to cluster identified proteins with peptides 
that have >80% sequence identity to reduce the level of peptide and protein 
redundancy[71].  For the human gut microbiome, Cantarel et al., Erickson et al. and 
Roojers et al. suggest that if a matched metagenome is available, it should be used as 
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the protein database for the same metaproteome sample to comprehensively identify 
many MS/MS spectra without massive redundancy.  If a matched metagenome is not 
available, a synthetic metagenome can be created by concatenating available 
metagenomes with relevance to the body site of interest, as proposed by Verberkmoes 
et al. and/or use some combination of the publically available human-derived reference 
genomes from the human microbiome project (HMP)[73]. 
Although matched metagenomes are highly desirable for several reasons, the 
human-derived bacterial reference genomes have sufficient sequencing coverage 
where the protein sequences are full length.  Metagenomic sequencing of 
environmental samples are not often sequenced to a sufficient depth to contain the 
complete gene repertoire; as a result, the predicted genes are often fragmented, 
resulting in incomplete protein sequences in a database.  However, because many of 
the genomic sequences captured from an environmental sample do not map to any 
available reference genome, relying solely on reference genomes for metaproteomic 
protein identification limits the proteins identified to only those in found in sequenced 
organisms, which is a very small proportion of the total bacteria that is cultivable from 
the HM.  Additionally, the human microbiome is estimated to contain trillions of bacterial 
cells and thousands of bacterial species, many of which are uncharacterized.  Because 
the majority of these bacteria have not been sequenced, their proteomes are likewise 
undecipherable.  As a result, these ‘unknown’ bacteria and proteins (hypotheticals) 
cannot be assigned to MS/MS spectra with a protein database that contains only a 
collection of known sequenced reference isolate genomes.  Additionally, the human-
derived reference genomes do not have any disease-representation or individual 
sequence/strain variations, whereas a matched metagenome is usually derived from the 
same human individual sample that may be associated with some disease (e.g., ileal 
Crohns disease or gingivitis).  An approach that uses either a metagenome or 
genome/metagenome database search strategy will be able to capture the presence of 
these unknown microorganisms/proteins and sequence variations which can more 
accurately represent and reflect the entire metaproteome of the human microbiota being 
studied.  Finally, careful attention should be given to using only reference isolate 
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genomes, because unidentified and uncharacterized microorganisms and their proteins 
are equally important in revealing the function of the human microbiome. 
In conclusion, the quality of environmental protein databases, whether it be a 
matched or relevant metagenome(s) or a collection of reference genomes, and 
database searching is a critical step and in many MS-based studies it is the bottleneck 
in the informatics workflow and metaproteomics pipeline.  With the exponential increase 
in size, availability, and complexity of metagenomic sequence data from the human 
microbiome[25], metaproteomics investigators will be severely affected and hindered by 
the quality of the metagenomes in terms of obtaining full length contigs (incomplete 
protein encoding genes) and subsequently the accuracy of annotation, degree of 
technological sequencing errors, and impractical size of databases to generate reverse 
databases and accurately predict false discovery rates (FDRs) using traditional 
methods.  There is a strong need for a new database search engine that is compatible 
with large environmental protein databases that takes into account many of the 
complications described above.  Additionally, new informatics workflows that may 
include a combination of both protein database searching and de novo peptide 
sequencing may prove to be highly beneficial for covering the range of both known 
(database predicted proteins; chapter 7) and assist in revealing the unknown proteins 
that may not be sequenced (ie, due to low abundance) and/or are missed in the 
assembly of metagenomic sequence reads. 
1.6: The future of metaproteomics in the HM 
While metaproteomics has advanced significantly beyond low resolution two-
dimensional gel electrophoresis (2DE), many obstacles still remain.  Not only is 
metaproteomics heavily reliant upon mass spectrometry technologies, but also on the 
foundation of protein database searching, the metagenomes.  To improve protein 
identification using MS-based proteomics, we will need the quality (e.g., sequence 
lengths, assembly and annotation) of metagenomic-predicted protein databases to 
improve in parallel.  However, given the error rates in genomic sequencing, 
technologies that rely solely on database searching with genomes and/or metagenomes 
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may not be as effective or desired in the future, but some alternative(s) and/or a 
combination of methodologies that will provide for metaproteomics to achieve a deeper 
and wider level of proteome coverage in the human microbiome.  The initial lack of 
metagenomic information hindered many environmental community studies from 
performing comprehensive and reliable protein identification.  However, investigators 
are now readily sequencing environmental communities (ie, cost of sequencing has 
decreased with the simultaneous improvement of DNA sequencing techologies such as 
Illumina) where they can also be used for matched and/or relevant metagenomic–
predicted protein database searches.  With large-scale DNA sequencing efforts, 
metaproteomics-based functional analyses will simultaneously improve for protein 
identification in microbial communities inhabiting the human microbiome. 
In order to cope with the large and increasing quantities of sequence data that 
has been acquired by large-scale sequencing efforts in the human microbiome, 
metaproteomics will equally require advanced technology and vast informatics 
resources to manage and preserve its significance within the ‘omics’ field.  However, 
given the advancement and cost of sequencing technologies, the scientific community is 
driving towards smaller and smaller sequence read lengths from Sanger (~1,000bp) to 
454 (~500bp) and now Illumina (75-100bp), which could potentially impede the 
advancement of metaproteomics by limiting the ability to achieve full length protein 
sequences in communities.  While the sequencing depth of coverage and error rate is 
equally important for metagenomics and metaproteomics, the lack of full-length protein 
sequences can be equally if not more detrimental to protein identification and biological 
inference.  Revolutionary tools and integrated ‘omic’ studies are highly sought after to 
enable the study of the web of events rather than a static snapshot of the activities 
taking place in the human microbiome.   
Future MS-specific developments include the optimization of up-front cellular 
lysis and protein extraction methods in addition to the development of new high-
throughput hybrid mass spectrometers capable of higher resolution and mass accuracy.  
While protein extraction methods are straightforward when applied to culture-based 
microorganisms, these methods are not always efficient or non-biased for the in situ 
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extraction of proteins from complex environmental matrices.  As seen with soil and 
sediment samples, efficient cell lysis and extraction can be technically challenging.  
However, as investigators continue to adapt and improve lysis and extraction protocols 
for environmental samples[74] (chapter 4), protein identification will benefit significantly 
by increasing the accessibility, depth, and coverage of proteins contained in 
complicated environmental matrices such as human feces.  Additionally, a direct cell 
lysis and protein extraction method of samples collected from the human microbiome 
may prove to be more efficient and/or representative of the microbial community 
compared to indirect methods that enrich for microorganisms.  To characterize the 
metaproteome of the human microbiota one step further would incorporate the analysis 
of post-translational modifications and strain-level variants in addition to 
protoegenomics, where we can use metaproteomics and identified peptides to refine 
metagenomes and gene predictions to assist in the identification of false starts/stops, 
misassembled contigs, gene boundaries, and incorrect protein annotations.  However, 
in order to accurately assess and correct these critical issues with high confidence, the 
acquirement of and use of high mass accurate mass spectrometric data is vital.  High 
mass accurate mass spectrometers that are capable of discriminating all amino acids 
will be essential to filter and control for false positives as the size and redundancy 
increases with higher complexity environmental communities such as those in soil and 
the human microbiome. 
As described above, protein redundancy and peptide degeneracy is a challenge 
and scales substantially with environmental communities such as the human gut.  Due 
to the level of protein redundancy found in higher complexity microbial communities, it is 
difficult to assign and suggest that one species/strain is uniquely responsible for a 
specific function within the community using MS/MS spectral abundance.  With current 
informatics workflows, it is often challenging to identify 1) to which proteins the 
measured peptides originated from, 2) to which organisms the identified proteins belong 
to, and 3) to estimate an accurate peptide or protein false discovery rate[75,76].  Even 
with the use of high mass accuracy, the available informatics algorithms are not capable 
of differentiating and classifying peptides that are not only shared amongst multiple 
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proteins, but between species and strains regardless of the database type (reference 
genomes and/or a matched or relevant metagenome) that is used for complex 
environmental communities.  While many algorithms assign and differentiate unique 
from non-unique (shared) peptide identifications, a large portion of the peptide 
identifications are non-unique, complicating the accuracy of biological inference in 
environmental communities.  Adaptations of either the available informatics workflows 
or the generation of new algorithms may prove to be more effective, accurate, and 
computationally higher throughput due to the sizes of metagenomic-derived protein 
databases for dealing with peptide and protein redundancy on a large-scale with 
environmental communities. 
Other challenges that remain include the ability to assess the “complete” or entire 
bacterial functionality of the human microbiome due to i) the biological dynamic range of 
low abundant proteins and on a broader level, microbial species/strains with variable 
abundance in the same sample and ii) dynamic range limitations of the mass 
spectrometer instrumentation.  With improvements in peptide separations (LC) and 
technological developments over the past couple of years, the dynamic ranges have 
increased by 1-2 orders of magnitude[77].  Technological developments have increased 
ion transmission and speed while delivering ultra-high resolution and accurate mass 
data as seen in the LTQ-Velos and LTQ-Oribtrap Velos[78] that have provided new 
capabilities to achieve deeper coverage of less abundant proteins.  More recently, the 
Orbitrap Elite was released with a novel high-field mass analyzer that increases the 
speed, sensitivity, and dynamic range of complex proteome samples.  Nevertheless, in 
spite of these partially solved challenges, metaproteomics is already providing 
remarkable insight into the functional activities of the gut and oral microbiota with 
technological advancements that will provide unrivaled capabilities for future 
metaproteomics analyses of the human microbiome.  
With increasing large-scale DNA sequencing efforts, metagenomics will drive the 
emerging field of metatranscriptomics and metaproteomics in the human microbiome.  
With innovation and new developments emerging in MS-based proteomics, the scientific 
community will have access to many more capabilities to study the metaproteome of the 
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human microbiome.  For example, it is anticipated that proteomics will be capable of 
identifying all isoforms and modifications (e.g., PTMs) on a large scale in the future.  To 
achieve this, not only will shotgun proteomics (bottom-up) continue to prevail in its 
applications, but also higher-throughput top-down analysis of proteins will emerge as a 
necessity.  It is the combination of both approaches, with advancement of all areas 
within mass spectrometry-based proteomics including technology and informatics 
workflows, which may serve as the revolutionary tool to fully characterize environmental 
community metaproteomes in the human microbiome. 
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1.7: Scope of the dissertation  
This dissertation encompasses a set of experimental and informatics methods and 
advancements that have enabled biological inference of the highly complex and diverse 
human gut microbiome.  As described above, the human gut microbiome is highly 
complex and diverse with thousands of microbial species.  Therefore, to 
comprehensively identify and characterize the metaproteome of each microbial member 
inhabiting the gut can be challenging as described throughout this dissertation.  Chapter 
2 will provide a detailed experimental and methodological overview and platform for 
successful applications of MS-based proteomics to microbial communities collected 
from complex gut-related sample matrices (ceca and feces).  As described in chapter 2, 
different approaches have been proposed and described as viable methods to 
effectively characterize the proteomes of gnotobiotic mice and metaproteomes of 
human individuals.  An approach that focuses on a less complex and carefully designed 
gut microbiota allows for the focused study of human-derived microbial structure, 
cooperation, competition and adaptation in vivo as described in chapters 3-5.  Chapter 3 
will introduce the first application of MS-based proteomics to a human-derived microbial 
community in gnotobiotic mice.  In this chapter, we define the interactions between two 
members of the Firmicutes and the Bacteroidetes that are commonly represented in the 
human gut microbiota.  The functional differences between B. thetaiotaomicron and E. 
rectale are revealed through an integrated approach of genomics, transcriptomics and 
proteomics.  This chapter lays the framework for comparing and developing new 
methods to increase protein identifications and coverage of individual microbes within a 
defined consortium as described in chapter 4. Chapter 4 will describe and compare 
several up-front sample processes for the lysis and extraction of proteins from a higher 
complexity, 7-member microbial community composed of only phylotypes belonging to 
Bacteroidetes.  Chapter 5 will use the previous two chapters as a guide for both 
experimental applications and biological inference of a 12-member microbial 
consortium. This chapter will not only focus on characterizing the community proteome 
as a single entity, but each individual species and their responses to diet perturbations.     
In contrast to chapters 3-5, an approach that directly measures the expressed 
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metaproteome of a highly complex gut microbiome derived from feces can more 
accurately represent the diversity and abundances of a human gut microbiome as 
described in chapters 6-8.  Chapter 6 will introduce the first application of high 
throughput MS-based metaproteomics to human gut microbiomes.  This chapter 
specifically describes the capabilities of the first LC-MS application to healthy gut 
microbiomes collected from adult feces and establishes a baseline for the biological 
inference of healthy metaproteomes.  This work lays the groundwork for developing new 
integrated informatics workflows to increase the identification and coverage of 
metaproteomes using a variety of metagenomic sequencing and assembly strategies as 
described in chapter 7.   Chapter 7 will deliver a new integrated 
metagenomic/metaproteomic approach that uses metagenomic sequence reads as a 
database to search against matched tandem MS/MS spectra collected from a healthy 
human twin pair.  Using the new methodology and informatics workflow discussed in 
chapter 7, chapter 8 will highlight the benefits of this method with increased protein, 
peptide, and spectra identifications in both healthy and diseased gut microbiomes.  
Compared to the previous two chapters, this chapter highlights the significant 
improvements and capabilities of MS-based metaproteomics in the revelation of a core 
gut microbiome in addition to the shared and functional differences in healthy and 
diseased (Crohn’s disease) metaproteomes.  Finally, chapter 9 will summarize the 
experimental, technological and informatics methods that served as the platform to 
permit in-depth biological inference of complex human-gut microbial metaproteomes of 
healthy and disease. 
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Chapter Two 
Development of an integrated experimental/computational omics platform for 
human gut microbiome research 
Part of the introduction is adapted from the ‘proteomics and metaproteomics’ 
chapter in ‘The Human Microbiome’ book (CABI with editor Dr. Julian Marchesi) 
written by Alison R Erickson (2012 release date). 
2.1: Introduction 
Metaproteomics has advanced from the protein identification in low-complexity 
ecosystems (AMD)[42] to highly complex microbial communities inhabiting the soil, 
ocean, and the human microbiome (HM).  The capability to identify hundreds to 
thousands of proteins in the HM is predicated on experimental optimization of sample 
collection and lysis/preparation methods, high throughput liquid chromatographic 
separation coupled to tandem mass spectrometry (MS/MS), and integration with 
genomics and metagenomics to perform sequence database searching (Figure 2.1). 
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Figure 2.1: Experimental design for human gut microbiome sample collection and 
integrated metagenomic / metaproteomic MS characterization. 
The collection of microbial cells and extraction of proteins from the human gut-
associated microbiota is the one of the most important steps in the experimental design 
of MS-based proteomics to insure accurate representation of the collective microbiota 
that is sampled and sufficient biomass for all downstream processes and MS analysis.  
The primary goals for MS-based community proteomics are: efficient sample 
processing, peptide separation, high sequence coverage of proteins and the proteome, 
and coverage of high and low abundant organisms (dynamic range).  Presently, a 
multitude of sample processing methods for microbial cell lysis, protein extraction, 
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denaturation and digestion, and purification are available to perform error-prone tandem 
mass spectrometry.  In general, there are two general methods for microbial cell lysis 
where a sample is collected for proteomics and either i) derived, processed, and lysed 
directly (in situ) from the source (i.e., feces, tissue biopsy) where both microbial and 
human cells are included (direct approach) or ii) the collected sample is enriched for 
microbial cells to eliminate all human proteins and contaminants via centrifugation 
(ultra- or differential centrifugation; indirect approach).  Currently there is no widely 
accepted or approved method suggesting that either the direct or indirect approach is 
better or worse than the other for metaproteomics of HM related samples, and this will 
be a key focus of part of the research under this dissertation.  
Mass spectrometry is the most comprehensive tool available for large-scale 
proteomics[79] and metaproteomics for several reasons.  MS is high-throughput, 
reproducible, unbiased, and highly versatile, with applications to a variety of sample 
types ranging from solids, gases, small molecules, to peptides and proteins (single, 
mixtures, or communities).  MS can provide high detection sensitivity, resolution, and 
mass accuracy, unlike traditional methods of Western blotting.  In addition, MS can be 
coupled with separation techniques to increase the dynamic range of higher complexity 
samples.  A multitude of mass spectrometers are increasingly available and range 
based on their i) ionization source, ii) mass analyzer, and iii) data processing and ion 
detection source.  The first component in the proteome measurement is the ionization 
source for proteins and peptides to be analyzed by MS.  This can be accomplished with 
two primary ionization methods: matrix-assisted laser desorption ionization (MALDI)[80] 
and electrospray ionization (ESI)[81].  The second critical component is the mass 
analyzer, which sorts and measures ions based on their mass-to-charge ratios (m/z).  
The most common mass analyzers include 1) trapping mass spectrometers: Ion trap, 
Orbitrap, and Fourier transform-ion cyclotron resonance (FT-ICR) that use dynamic 
electrostatic or magnetic confinement, 2) ion-beam mass spectrometers: quadrupoles 
(Q) and time-of-flight (TOF) that utilize spatial resolution.  Ion traps are generally most 
suited for bottom-up proteomics and LC-MS/MS of complex proteomes and mixtures.  
FT-ICR instruments are generally suited for top-down proteomics and PTM identification 
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due to its wide m/z range, high resolution (500,000 FWHM) and accuracy (< 1 ppm), 
however, the scan rate is much slower compared to the linear ion trap.  The widely used 
triple quadrupole (QqQ) instrument contains a series of three quadrupoles (Q) that 
allows for selected/multiple ion reaction monitoring (SRM and MRM).  Most 
investigators use the QqQ platform for targeted proteomics investigation rather than 
comprehensive proteome identification and coverage.  Finally, TOF mass analyzers can 
be used for either top-down or bottom-up proteomics with high duty cycle, unlimited 
mass range, and low cost, however, low resolution limits its general application.  Novel 
hybrid instruments integrating more than one mass analyzer (e.g., LTQ-FT-ICR, LTQ-
Orbitrap, and QqTOF) have evolved from single mass analyzer instruments to combine 
multiple features (Figure 2.2) to provide more superior, faster, and robust measurement 
possibilities.  For example, the newest revolution is the novel dual-pressure linear ion 
trap mass spectrometers LTQ Velos and LTQ-Orbitrap Velos with increased ion 
transmission, more efficient isolation and dissociation, greater resolution, and faster 
scan rates (compared to the LTQ-XL)[78].  For complex metaproteomes, this instrument 
permits higher acquisition rates while simultaneously isolating more low-abundant 
peptides and proteins. 
 
Figure 2.2: Schematic of the hybrid LTQ-Orbitrap[82].  The Orbitrap performs high 
resolution full MS scans and the linear trapping quadrupole performs MS/MS.  
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For the technical reasons described previously, mass spectrometry is an 
unparalleled analytical tool that has shown to be successful in its application to human 
microbiome-related samples.  Briefly, several studies have applied a variety of MS 
platforms to the human gut and oral microbiome, such as the work by Klaassens et al. 
to use MALDI-TOF mass spectrometry to analyze the infants’ gastrointestinal tryptic 
peptides[47].  While this study established the role of MS and metaproteomics in the 
human microbiome, it was very limited in protein and proteome coverage, with 55 
excised protein spots and only one identified microbial protein with 91% identity to 
Bifidiobacterium.  The lack of identifications may have been a result of the experimental 
technique (i.e., low resolution 2D gels), MS platform, and lack of peptide separation.  
VerBerkmoes et al. and Erickson et al. applied 2D-ESI-LC-MS/MS on a LTQ-Orbitrap 
mass spectrometer, specifically exploiting its’ high mass accuracy capabilities to acquire 
low false discovery rates of peptides and proteins in these complex microbial 
communities[26,71].  Similarly, Rooijers et al. used an LTQ-Orbitrap mass 
spectrometer, but did not focus on high mass accurate identifications for their analyses 
of the human gut microbiota[83].  Hongwei and Rudeny et al. both used an LTQ mass 
spectrometer without the Orbitrap for all MS analysis on human whole saliva[48,84].  
Grant et al. used a 7 T LTQ FT mass spectrometer for the analysis of human GCF to 
study the oral microbiome[49].  LC-ESI-MS/MS and hybrid mass spectrometers are the 
technology of choice for high-throughput peptide and protein identification[78] featuring 
greater sensitivity, acquisition rates, and resolution to accurately and comprehensively 
identify and characterize complex metaproteomes as those in the human microbiome.   
While up-front sample collection, preparation, and selection of the most 
appropriate MS platform are important for complex human microbiota samples, the final 
post-MS/MS steps are critical for data interpretation and biological inference.  Finally, 
the last step in the shotgun proteomics methodology and pipeline is informatics.  Protein 
identifications are generated by matching MS/MS spectra against a sequence 
database(s) to identify the most accurate peptide-spectrum matches (Figure 2.3).  The 
correct interpretation and assignment of such MS/MS spectra to peptides is the major 
step in the informatics data processing pipeline, called database searching.  This step is 
	   26	  
not only heavily reliant upon MS/MS quality, but the quality and accuracy of a sequence 
database.  A ‘sequence database’ is a FASTA formatted file that contains the entire 
theoretical proteome and sequences that are predicted from a genome (e.g, bacterial 
isolate) or metagenome (e.g., microbial community).  Thus, we are limited to only 
matching spectra to the peptides that are found in the sequence database, hence, 
mutated or alternatively spliced genes, and post-translationally modified peptides will 
not be identified.  Although having a sequenced genome or metagenome for the exact 
same biological (protein) sample is extremely valuable for MS-based peptide-spectrum 
matching, a metagenome is of higher complexity compared to a single genome.  The 
simplicity of peptide-spectrum matching with, for example, a well-characterized bacterial 
genome (e.g., E. coli), via MS database searching is not as straightforward with a 
metagenome(s).  The traditional isolate/genome-based approaches and methodology 
for DNA sequencing, assembling, and predicting genes, thus, proteins for well-studied 
model organisms, although routine and widely accepted, may not provide the most 
expansive and reliable gene sequences for increasing both protein identifications and 
proteome coverage via MS-based proteomics for community samples. 
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Figure 2.3: Mass spectrometry protein database searching workflow. 
For each of the methodological steps and parameters described previously, this 
dissertation will focus on using a variety of sample processing methods (indirect and 
direct), hybrid ion trapping mass spectrometers (LTQ-Orbitrap), and protein database 
searching to optimize and examine the metaproteomes to provide an unprecedented 
molecular level glimpse into the complex human gut microbiome of both human 
individuals and gnotobiotic mice.     
2.2: Reagents and solvents 
All salts, chemical reagents (i.e., guanidine HCl, urea, acetic acid, dithiothreitol (DTT), 
sodium dodecyl sulfate (SDS)) were acquired from Sigma Chemical Co. (St. Louis, MO) 
and were used as supplied without further purification.  Modified sequencing grade 
trypsin (Promega, Madison, WI) was used for all protein digestions. HPLC-grade water 
and acetonitrile were obtained from Burdick & Jackson (Muskegon, MI), and 99% formic 
acid was purchased from EM Science (Darmstadt, Germany). 
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2.3: Sample collection 
The selection of host subjects and body sites is a critical step for representing the 
collective metaproteome of the human microbiota.  The majority of subjects that have 
been selected to represent the metaproteome of the HM include human, but also 
gnotobiotic mice that have been colonized with human-derived microbes to control for 
and monitor a less complex, but representative human gastrointestinal microbiota[37].  
The use of culture-independent techniques for the collection of cells representative of a 
specific microbial metaproteome niche(s) within the human microbiome can be 
challenging for several reasons.  The invasiveness, quantity, quality, and preservation 
of sample collection is important for maintaining an intact, native proteome that has not 
been altered or disrupted such that biological and technical variation is minimal.  For 
example, biological variation would occur if the proteome were not treated (lysed and 
denatured) immediately upon removal from freezing temperatures where the proteome 
would begin experience changes as a result of active endogenous proteases. 
Therefore, minimization of both technical (LC-MS/MS-related) and biological variation 
will provide for more accurate biological inference relative to the microbiota, sampling 
subject, and site.  Sampling sites have included feces and ceca to represent the human 
gastrointestinal microbiome[26,37,47,71,83] where microbial cells are typically 
separated and enriched from the raw human fecal material to remove exfoliated human 
epithelial cells, interfering food debris and other contaminating compounds.  Klassens et 
al. was one of the first to apply metaproteomics to processed human fecal samples 
(infant).  Klassens and colleagues used mechanical homogenization with glass beads 
and centrifugation to enrich for microbial cells and remove debris.  Proteins were then 
extracted via bead beating. A second, more comprehensive study was performed on 
adult human fecal samples described from Verberkmoes et al. where healthy human 
feces was processed with a five-cycle differential centrifugation method published by 
Apajalahti et al.[85].  Microbial cells were lysed and proteins extracted via a small-scale 
microbial biomass protocol[86].  This protocol was also adapted by Mahowold et al. for 
gnotobiotic mice (chapter 3) and by Erickson et al. for healthy and diseased human 
subjects (chapter 8). 
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2.3.1: Gnotobiotic mice 
Gnotobiotic mice were used as a human model system to control the microbial diversity 
of the microbiota present in the gut.  A collaborator, Dr. Jeffrey Gordon and his research 
group at the Washington University in St. Louis performed all microbial inoculations and 
cultivations of the gnotobiotic mice (Figure 2.4).  Dr. Gordon has sequenced genomes 
from several members of the two dominant phyla present in the normal distal human gut 
microbiota: the Firmicutes and the Bacteroidetes.  To explore the interactions between 
the Bacteroidetes and Firmicutes in vivo, adult germ-free male mice were gavaged with 
a mixture of sequenced human-derived microorgansims, ranging from a binary mixture 
of two bacteria (binary community), seven-members, and finally, a twelve-member 
community.  qPCR analysis of both feces and cecal contents indicated that at the time 
of sacrifice, the microbial species had colonized the distal gut of recipient mice.  Unlike 
the binary communities containing two evolutionarily distinct microbes (Bacteroides 
thetaiotaomicron and Eubatcterium rectale), a second set of adult germ-free mice were 
colonized with 7 sequenced human gut-derived microbes belonging to the same phyla, 
Bacteroidetes.  After comparing the proteomes of these binary communities to the 
proteomes acquired from the 7-member communities, the focus shifted to sample 
processing optimization to better suite “cecum” and feces.  The traditional method of cell 
lysis was not as efficient for lysing cecal material nor did it provide a thorough sampling 
of the individual microbes’ proteome.  Thus, the initial goals for the 7-member 
community study were to achieve deeper and wider coverage of the ceca proteome 
prior to in depth biological analyses.  Lastly, with the improvements and accumulation of 
an advanced mass spectrometer (LTQ-Orbitrap Velos), Dr. Gordon scaled up the 
complexity of the microbial consortium to twelve human gut-derived microorganisms 
consisting of the same seven phylotypes used in the 7-member consortium in addition 
to four Firmicutes and one Actinobacteria. 
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Figure 2.4: Gnotobiotic mouse isolator used to rear pups to adulthood (figure courtesty 
of Dr. Jeffrey Gordon at Wash. Univ.). 
 Adult male germ-free mice belonging to the NMRI inbred strain were colonized 
via gavage with of either 108 Colony Forming Units (CFU) of B. thetaiotaomicron VPI-
5483 or a log-phase culture of E. rectale, or both.  All mice were fed a standard diet rich 
in complex plant polysaccharides.  Organisms were present in equivalent numbers in 
the inoculum.  Distinct microbial samples were obtained from the distal gut (cecum) of 
eight gnotobiotic mice provided by Dr. Jeffrey Gordon and Michael Mahowald.  Two 
mice were not colonized with any bacteria (germ-free control); two were colonized only 
with B. thetaiotaomicron; two were colonized with a mixture of both B. thetaiotaomicron 
and E. rectale; and the last two were colonized only with E. rectale.  
Dr. Gordon’s group provided a total of seven cecal samples for the 7-member 
community proteomics experiments.  The C57BL/6 mice, labeled as 2, 3, 5, and 7-10, 
were gavaged with an equal inoculum of the following species: Bacteroides caccae, B. 
ovatus, B. uniformis, B. WH2, B. thetaiotaomicron, B. vulgatus, and Parabacteroides 
distasonis and fed a standard BK diet ab libitum.  The total microbial does was ~ 8.7 x 
107 corresponding to 1.2-1.3x107 CFUs/microbe.  
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Dr. Gordon’s group provided a 12-member community of gut-derived 
microorganisms consisting of the same seven phylotypes used in the 7-member 
consortium (Bacteroides caccae, B. ovatus, B. uniformis, B. WH2, B. thetaiotaomicron, 
B. vulgatus, and Parabacteroides distasonis) in addition to four Firmicutes (Dorea 
longicatenta, Ruminococcus obeum, Clostridium spiroforme, and C. scindens) and one 
Actinobacteria (Collinsella aerofaciens).  This 12-member consortium was selected for a 
diet oscillation study in fourteen gnotobiotic mice where ORNL only received the ceca 
belonging to four mice.  There are two treatment groups for which two mice consumed a 
high fat and simple sugar diet (termed ‘western’ diet) and the other two other mice 
consumed a standard high-protein BK diet.  
2.3.2: Human gut swedish twin cohort 
Human fecal samples from normal, concordant, and discordant human twins with and 
without Crohn’s Disease were provided by a collaborator, Dr. Janet Jansson (Lawrence 
Berkeley National Lab).  The purpose of these studies is to apply proteogenomic 
techniques to understand the physiology of complex microbial communities in 
concordant and discordant twins with Crohn’s disease.  Highly representative, complex 
gut microbiomes were extracted from bulk human fecal samples (estimated >1011 
bacteria cells/g of feces) from a total of 6 monozygotic twin pairs (Table 2.1) including: 1 
set of healthy twins (6a and 6b), 1 set of concordant twins with Crohn’s disease 
inflammation localized in the colon (CCD; 9a and 9b), 2 sets of concordant twins with 
Crohn’s disease inflammation localized in the ileum (ICD; 10a and 10b, 15a and 15b) 
and 2 sets of ICD discordant twins (16a and 16b, 18a and 18b, ICD and healthy 
respectively), via differential centrifugation[85] to obtain enriched microbial pellets.  The 
resulting bacterial cell pellets were immediately frozen at –70°C and shipped overnight 
to the Oak Ridge National Laboratory (ORNL).   
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Table 2.1: Twin cohort sample descriptions and details for all subjects, healthy, ileal Crohn’s disease (ICD), and colonic 
Crohn’s disease (CCD). 
 
Sample ID Birth year Phenotype Sex NOD2 Status Gastro-enteritis Age at diagnosis Surgery (year)
6a 1951 Healthy F nd Yes - -
6b 1951 Healthy F nd No - -
9a 1947 CCD, Non-stricturing, Non-penetrating M wt No 41 -
9b 1947 CCD, Non-stricturing, Non-penetrating M wt No 40 -
10a 1962 ICD, Stricturing F wt Yes 23 ileal res + right hemi (1985)
10b 1962 ICD, Stricturing F wt Yes 24 ileocec res (1986)
15a 1953 ICD, Non stricturing, Non-penetrating M snp 8 m/w No 23 ileal res (1980)
15b 1953 ICD, Non-stricturing, Non-penetrating M snp 8 m/w No 23 ileocec res (1976)
16a 1954 ICD, Penetrating F wt No 20 ileal res + right hemi (1974)
16b 1954 Healthy Co-twin F wt No - -
18a 1953 ICD, Non-stricturing, Non-penetrating M wt No 20 ileal res + right hemi (1973)
18b 1953 Healthy Co-twin M wt No - -
Abbreviations: ileal res, ileal resection; right hemi, right sided hemicolectomy; ileocec res, ileocecal resection; nd, no data; wt, wildtype
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2.4: MS-Based Sample Preparation 
There are several major steps in MS-based shotgun proteomics that follow in the order 
of i), separation and/or in situ lysis of the bacteria from the environmental matrix and, ii) 
extraction, denaturation, and digestion of proteins into peptides and, iii) separation and 
fragmentation of peptides in a mass spectrometer and, iv) peptide-spectrum matching 
(PSM) (Figure 2.5).  Several protocols are available and complement the delicate 
intricacies (e.g., quantity biomass, complexity of sample matrix, and diversity of 
community membership) that come with processing samples collected from the 
environment for metaproteomics.  Widely accepted methods for the cellular lysis and 
extraction of proteins from complex microbial communities for metaproteomics analysis 
include a thermally assisted detergent-based cellular lysis (sodium dodecyl sulfate, 
SDS) method[74], a small-scale microbial biomass experimental approach[86], 
sonication[87,88], freeze-thaw cycles[89], French press[60] and published methods 
described above for HM-related metaproteome samples. 
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Figure 2.5: General MS-based proteomics experimental, analytical, and informatics 
pipeline. 
Available and tested cellular lysis buffers include detergents (e.g., SDS, CHAPS, 
and Triton X-100), chaotropes (urea and guanidine), acid-labile surfactants (PPS silent 
surfactant) and many other commercially available buffers to disrupt bacterial cells with 
or without physical or mechanical disruption prior to protein extraction.  Several 
precautions must be taken if a detergent is selected due to interference with binding, 
elution, and ionization of peptides during tandem MS experiments.  To eliminate 
contamination and interference with detergents and mass spectrometers, several 
metaproteomics studies[26,42,86,90] selected to use an indirect extraction approach 
and chaotropes (ie, guanidine) to enrich and lyse microbial cells and denature proteins.  
These methods were also dependent upon the type of peptide separation that would be 
applied following protein denaturation and digestion, that is, an online 2D-LC separation 
rather than 2D-PAGE.  For the third and fourth major steps, protocols for protein 
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denaturation and digestion of microbial environmental metaproteomes range where 
several methods include protein precipitation (ie, trichloroacetic acid (TCA) or ethanol) 
prior to denaturation and digestion to concentrate proteins away from contaminants (ie, 
small molecules and interfering environmental-related compounds) that were not 
eliminated further upstream with indirect extraction methods by centrifugation.  Chourey 
et al. has shown that protein precipitation (TCA) was beneficial in eliminating humic 
compounds and other interfering substances commonly found in soil 
metaproteomes[74] and could be also improve protein purification for other complex 
environmental matrices such as human feces. Protein digestion is one of the most 
critical steps because it involves the reduction of intact proteins to peptides that are 
suitable for MS analysis (10-20 amino acids), which relies heavily upon sufficient lysis 
and solubilization of all cells in order for proteases (e.g., trypsin) to access the entire 
surface area of proteins for effective digestion.  The final selection of one method 
should be based on the available starting biomass quantity and environmental sample 
type and quality (matrix type (ie, degree of exopolysaccharides and interfering humic 
and phenolic compounds) and feasibility for purification).   
Although many of the described protocols are suitable for a variety of samples, 
there are potential biases that range with: i) the indirect (enrichment) approach and its’ 
efficiency of bacterial extraction via density and differential centrifugation, ii) presence of 
other organisms (e.g., fungi, protozoa, and eukaryotes), iii) lysis of bacteria with certain 
properties (i.e., gram negative versus positive), iv) extraction of proteins with diverse 
properties (i.e., cytosolic versus membrane proteins and fractions) directly from natural 
environments, and v) the efficiency of digestion has not all been resolved for complex 
samples collected from the HM.  There are many challenges that stem from processing 
environmental communities for efficient recovery of proteins including those mentioned 
above in addition to contamination with other interfering compounds imbedded in the 
surrounding matrix if they are not eliminated prior to MS analysis and bias in the 
quantitative and qualitative recovery of proteins. 
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2.4.1: Gnotobiotic mice and human twin cohort 
The gnotobiotic mouse gut microbial communities were treated differently for each 
study.  Similar to the human twin cohort studies, the binary community cecal contents 
were processed via a single tube cell lysis method[86] and proteins digested into 
peptides with trypsin.  All eight samples were coded and mass spectrometry 
measurements conducted in a blinded fashion. Each of the individual cecal contents 
collected for the 7-member community were processed differently for method 
comparisons and development and is described in more detail under chapter 4.  Using 
the results from chapter 4, the 12-member microbial community cecal contents were 
solubilized in SDS lysis buffer and lysed mechanically by sonication and heat.  
Following a TCA precipitation, the precipitates were resolubilized and reduced in 8M 
urea and DTT and digested with trypsin. 
The bacterial cell pellets (~100mg) that were extracted from bulk human fecal 
samples were lysed; proteins were denatured and reduced, and digested into peptides 
with trypsin using the protocol developed by Thompson et al.[86].  These samples were 
used throughout chapters 6-8. 
2.5: Liquid Chromatography 
Complex biological samples often contain thousands to hundreds of thousands of 
proteins and can be a challenge in terms of total comprehensive intact protein 
identification.  Therefore, proteins and proteomes are generally digested into smaller 
products (peptides) that are technically easier to separate, measure, and identify 
compared to intact proteins.  However, following proteolytic digestion, a complex 
environmental sample can contain hundreds of thousands to millions of peptides.  
Therefore, complex peptide digests are fractionated by either a one or multiple 
chromatographic dimensions or electrophoretic steps to reduce the complexity of 
peptides analyzed at a single time point by mass spectrometry (Figure 2.1). 
Since the use of and coupling of two-dimensional gel electrophoresis (2DE), 
SDS-PAGE, and mass spectrometry with environmental communities[60,91], the 
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scientific community has moved towards using other gel-less alternatives, such as, 
higher throughput protein and peptide separation via LC coupled to mass 
spectrometers.  This transition has enabled the high resolution identification of a few 
thousands of proteins from cultured bacteria (e.g., R. palustris[92]) to an environmental 
microbial community[42].  For LC-MS, either a single-dimensional (1D) or orthogonal 
two-dimensional chromatographic system could be used to separate proteins or 
peptides online or offline[93], however, complex mixtures can overwhelm the capacity of 
a single dimension.  Therefore, a “multi-dimensional” separation is better suited for 
complex mixtures and it is the current standard for large-scale proteomics consisting of 
two- or three-step peptide fractionation.  Yates and colleagues founded the technique 
that is referred to as “multidimensional protein identification technology” (MudPIT) 
where orthogonal 2D chromatography is used to separate complex peptide mixtures 
prior to MS analysis[94,95,96].  The most popular MudPIT setup consists of i) strong 
cation exchange (SCX) chromatography followed by ii) reversed-phase (RP) 
chromatography to achieve peptide separation prior to MS/MS[96].  SCX 
chromatography serves as the primary dimension that separates peptides based on 
charge where it has an increased loading capacity compared to RP which separates 
peptides by their hydrophobicity while simultaneously eliminating any salts in the 
sample.  Compared to 2DE and 1D-LC, the MudPIT technique has the advantage of 
being higher throughput, higher resolution and reproducible with both the 
chromatography and identified proteins, and it is unbiased to a range of proteins with 
variable and extreme pIs, MW, location (membrane or cytosol) and abundance. 
In the human microbiome, both separation technologies have been applied in a 
variety of ways.  Klaassens et al. demonstrated for the first time that 2D-PAGE and 
protein identification via matrix-assisted laser desorption (MALDI)-time of flight (TOF) 
mass spectrometry was applicable to study the metaproteome of the gut microbiome in 
human infants using infant fecal material[47].  On the contrary, LC-MS-based 
proteomics was first demonstrated in the adult human gastrointestinal 
microbiome[26,71] with the application of 2D-(SCX-RP)-LC-MS/MS to human fecal 
material.  Rooijers et al., on the other hand, used gel electrophoresis for protein 
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separation followed by in gel protein digestions[83].  The tryptic peptides were then 
separated via 1D-(RP)-LC coupled to electrospray MS/MS on a Thermo LTQ-Orbitrap.  
For the oral microbiome, Hongwei et al. separated tryptic peptides via a 3-step 
fractionation method[84].  First, peptides were separated by isoelectric focusing (IEF) 
using a free-flow electrophoresis system (FFE) and fractionated into a 96-microtiter 
plate.  Each pI fraction was subjected to preliminary MS/MS to identify fractions with the 
highest complexity of peptides to be characterized and separated further.  For the final 
selected IEF fractions, the peptide fractions were purified (to remove high MW 
polymers) and fractionated by SCX (second fractionation step) using a step-gradient.  
The SCX peptide fractions were then desalted, concentrated, and loaded onto and 
separated on a RP column (third fractionation step) where peptides were directly eluted 
and analyzed by ESI-MS/MS on a thermo LTQ linear ion trap.  Similarly, Rudney et al. 
adapted the same protocol[84] to focus on the metaproteomics analysis of the bacterial 
component, taxonomy and metabolic activity, of the human oral microbiome using 
human whole saliva.  Grant et al. also investigated the oral microbiome in healthy 
humans using gingival crevicular fluid (GCF) and a non-invasive gingivitis model that is 
used to study the inflammatory response as a result of increasing bacteria over 21 
days[49].  GCF samples were pooled and treated with dithiothreitol, heat, and 
proteolytically digested with trypsin prior to quantitative labeling with iTRAQ (discussed 
in further detail under ‘quantitative proteomics in the HM’).  iTRAQ labeled samples 
were separated and fractions collected offline using SCX-HPLC.  The fractions were 
vacuum centrifuged, desalted, and peptides acidified with formic acid prior to LC-
MS/MS.  Lastly, tryptic labeled peptides were separated online using 1D-(RP)-LC and 
eluted directly into a thermo LTQ-FT mass spectrometer.  In conclusion, 
metaproteomics can be applied to complex samples collected from the human 
microbiota using a variety of separation technologies as described (2DE, 1D- or 2D-LC, 
and/or multiple fractionation steps online or offline).  In my opinion, an approach that 
uses a “multidimensional” separation approach (e.g., MudPIT) will provide the most 
comprehensive and representative coverage of peptides and proteins from the human 
microbiome. 
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2.5.1: Gnotobiotic mice and human twin cohort 
For all gnotobiotic mouse (chapters 3-6) and human twin (chapters 6-8) studies, the 
microbial proteins were extracted and processed for 2D-LC-MS/MS using an Ultimate 
HPLC system (Dionex, Sunnyvale, CA) coupled to a LTQ, LTQ-Orbitrap, or LTQ-
Orbitrap Velos (Thermo Fisher Scientific, San Jose, CA).  At a flow rate of ~100 µL/min 
(set on the Ultimate pump), the peptide mixtures of all twelve samples were separated 
across a split-phase column (packed in-house with SCX and C18 reverse-phase 
chromatographic resins) that was connected to a 15-cm C18 analytical column by a 12 
step, multidimensional high-pressure liquid chromatographic elution consisting of eleven 
salt pulses (0-500 mM ammonium acetate) followed by a 2 hour reverse-phase gradient 
from 100% solvent A (A: 95% H2O, 5% acetonitrile, 0.1% formic acid) to 50% solvent B 
(B: 30% H2O, 70% acetonitrile, 0.1% formic acid).  The last salt pulse was followed with 
a gradient from 100% solvent A to 100% solvent B.  During a single chromatographic 
separation (~22-24 hr run), mass spectral data acquisition was performed in data-
dependent mode under the control of Xcalibur software (version 2.0.7; Thermo Fisher 
Scientific). 
2.6: Mass spectrometric measurements 
As described previously under 2.1, the selection of a mass spectrometer is important 
and dependent upon several factors including: (i) the proposed biological questions (ie, 
comprehensive characterization or targeted analysis of a subset of proteins) and (ii) the 
type and complexity of the biological sample (single or mixture of proteins or 
environmental sample; dynamic range of proteins).  A linear ion trap mass spectrometer 
would be best suited for a comprehensive characterization of a proteome whereas a 
QqQ platform is preferred for targeted proteomics investigation.  Due to the complexity 
of the samples (i.e., microbial communities) used in both the human microbiome and 
gnotobiotic mice, and the desire to comprehensively characterize the proteomes, ion 
trap mass spectrometers and hybrid mass spectrometers are ideally best suited for 
these bottom up studies due to their rapid scan time, resolution, and mass accuracy.   
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2.6.1: Gnotobiotic mice and human twin cohort 
All cecal and fecal samples were analyzed in technical duplicates using a two-
dimensional (2D) nano-LC MS/MS system with a split-phase column (RP-SCX)[97] on a 
LTQ-XL, LTQ-Orbitrap (Figure 2.2), or LTQ-Orbitrap Velos (Thermo Fisher Scientific) 
with 22 hr runs per sample (LC as previously described). The mass spectrometer 
settings were as follows: one full MS scan was acquire in the Orbitrap (m/z 400-1,700) 
at 30k resolution followed by five or ten data-dependent MS/MS in the LTQ at 35% 
normalized collision energy. Two microscans were averaged for both full and MS/MS 
scans and centroid data were collected for all scans, with dynamic exclusion enabled at 
1. 
2.7: Proteome informatics 
Comparative and quantitative proteomics is the evaluation of how similar and/or 
different environmental conditions affect protein expression and abundance.  Following 
the acquisition of qualitative and in many studies quantitative proteome MS data, 
bioinformatics tools, such as DTASelect[98] and software packages, such as 
Scaffold[99,100,101] sort and filter through these massive MS datasets to provide the 
best quality peptide-spectrum matches (PSM) and their corresponding protein 
identifications.    
As described previously, protein database searching, an informatics workflow 
that deduces the amino acids of a peptide sequence and assigns it to a corresponding 
tandem mass spectrum (MS/MS) (Figure 2.3), has been widely adopted by MS-based 
proteomics for the high throughput identification of proteins.  Database search engines, 
such as SEQUEST[66], Mascot[67], and Xtandem![68], assign peptide sequences to 
MS/MS spectra by correlating the experimentally identified peptide to a theoretical 
peptide sequence derived in silico from a known FASTA formatted protein database.  
The peptide sequences with the highest correlation scores are reported in the final 
output.  As a result, the protein database informatics platform is high throughput and 
applicable to range of protein complexity, from a single or mixture of proteins to a 
complex environmental community metaproteome.  The alternative approach to assign 
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MS/MS is de novo peptide sequencing where no prior knowledge of proteins or a 
protein database is required. 
2.7.1: PSM and database searching 
For the first informatics platform, protein database searches, mass spectrometers first 
collect precursor ions (intact peptide ions; MS scan) that are selected for fragmentation 
by collision with inert gas (e.g., collisional induced dissociation; CID) into fragment ions 
(amino acids; MS/MS scan).  In total, three to ten of the most abundant precursor ions 
(MS) are selected for MS/MS generating thousands of MS/MS during one experiment 
(2-24hrs) that represent fragmented peptides of a samples’ protein(s).  It is the quantity, 
quality (signal versus noise), and complexity of these MS/MS that necessitates the need 
for informatics workflows that can sort, filter, and confidently assign PSMs with high 
accuracy at a computationally reasonable speed.  Currently, there are several open-
source and commercial tandem mass spectrometry database search engines that are 
widely available.  The freely open-source search engines include X!Tandem[68], 
OMSSA[102], Myrimatch[103].  The commercially available search engines Mascot[67], 
from Matrix Science, and SEQUEST[66], from Thermo Fisher Scientific, have become 
the most widely used and are referred to as the golden standards.  However, each 
database search algorithm has its advantages and disadvantages in terms of spectral 
filtering, scoring, configuration, compatible formats, and speed/performance.  Several of 
these factors are dependent on the quality and relevance of the protein database to the 
measured sample and its’ proteome.  For example, if a high quality experimentally 
identified PSM cannot be assigned to a protein because it is missing in the protein 
database, these high quality PSMs will go unidentified.  As demonstrated by Cantarel et 
al. with the human gut microbiome, up to several thousands of high-quality MS/MS may 
not be identified as a result of the database even with having a matched 
metagenome(s)[76].  Therefore, the quality and selection of a protein database and/or 
metagenomes(s) is a critical component of the protein database search informatics 
workflow.  Additionally, the larger and all-inclusive protein sequence database(s) will 
often take longer to search hindering the performance of several search engines and 
increase the number of false positive-identifications. 
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 Currently, there are many ways of estimating error associated with peptide 
identifications.  Until the field of proteomics comes to a conclusion on the proper way of 
reporting proteomic data, different versions will exist.  For these large-scale studies, 
false discovery rates were used in order to differentiate between true and false peptide 
identifications.  The overall false discovery rate (FDR) was estimated using the formula:  
FDR= 2[nrev/(nrev + nreal)]*100 where nrev is the number of peptides identified from the 
reverse database and nreal is the number of peptides identified from the real 
database[96]. 
2.7.1.1: Gnotobiotic mice and human twin cohort 
All MS/MS spectra were searched with the SEQUEST algorithm[66] [(enzyme type, 
trypsin; Parent Mass Tolerance, 3.0; Fragment Ion Tolerance, 0.5; up to 4 missed 
cleavages allowed (internal lysine and arginine residues), and fully tryptic peptides only 
(both ends of the peptide must have arisen from a trypsin specific cut, except N and C-
termini of proteins)] and filtered with DTASelect/Contrast[98] at the peptide level [Xcorrs 
of at least 1.8 (+1), 2.5 (+2) 3.5 (+3) and deltCN of either 0.08 or 0.0].  Only proteins 
identified with two fully tryptic peptides from the MS runs were considered for further 
biological study. Monoisotopic theoretical masses for all peptides identified by 
SEQUEST were generated and compared to observed masses.  Observed high 
resolution masses were extracted from .raw files from the full scan preceding best 
identified spectra; parts per million (ppm) calculations were made comparing each 
identified peptides’ observed and theoretical mass.  When quality MS/MS spectra didn’t 
have an observed mass (low intensity) due to an unassignable charge state for the 
precursor ion, a mass of 0 was reported and ppm was calculated as infinity.   
Detailed database descriptions and search strategies can be found for each of 
the following chapters under their “experimental methods.”  The FDRs were also 
calculated for the majority of experiments and are described in more detail for each 
chapter.  
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2.7.2: De novo peptide sequencing in the microbiome 
As mentioned, the second alternative workflow for protein identification from tandem 
mass spectra is de novo peptide sequencing[104,105,106].  Protein identification via 
database searching will not be able to identify peptides that are not in the database.  
Additionally, with the use of high mass resolution and mass accuracy MS data, de novo 
peptide sequencing can be used for the identification of amino acid polymorphisms and 
post-translation modifications (PTMs).  De novo sequencing calculates the mass 
difference between two peaks in a single mass spectrum and if the difference 
corresponds to an amino acids’ mass, the algorithm is able to assume that the two 
peaks are adjacent fragment ions in the peptide sequence.  However, to assess this 
mass difference, differentiate signal versus noise, and identify a specific amino acid with 
high accuracy, investigators need high mass accuracy MS/MS data to eliminate the 
degree of interference.  Several de novo sequencing algorithms are currently available 
and include PepNovo[105,107], DirecTag[108], PEAKS[109], MSNovo[110] and 
Vonode[111].  As described by Cantarel et al., the first de novo peptide sequencing 
application (high confidence sequence tags found by both PEAKS and PepNovo) to the 
human gut microbiome, conservative de novo sequencing can be highly beneficial for its 
revelation of novel peptides that were not identified using a database search engine 
(SEQUEST) and increase in protein discovery[76].  Additional details and results are 
described in chapter 7. 
2.8 Summary 
The experimental and analytical methods described above provides a robust, high-
throughput, and highly reproducible platform for the application of MS-based proteomics 
to characterize complex human gut microbiomes collected from gnotobiotic mice ceca 
and human feces.  Each step of the general MS-based proteomics workflow: i), sample 
collection, ii) MS-based sample preparation, iii) liquid chromatography, iv) MS/MS 
measurement and, v) peptide-spectrum matching is important and intended to provide a 
solid foundation for optimum identification and coverage of human gut metaproteomes.  
This workflow results in the assignment of hundreds of thousands of spectra and the 
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identification of thousands of proteins and peptides with a deeper characterization and 
understanding of the gut microbiota as highlighted in the following analyses. 
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Chapter Three 
Characterizing a model human gut microbiota composed of members of its two 
dominant bacterial phyla 
Portions of the included text are adapted from: 
Michael A. Mahowald, Federico E. Rey, Henning Seedorf, Peter J. Turnbaugh, 
Robert S. Fulton, Aye Wollam, Neha Shah, Chunyan Wang, Vincent Magrini, 
Richard K. Wilson, Brandi L. Cantarel, Pedro M. Coutinho, Bernard Henrissat, 
Lara W. Crock, Alison Russell, Nathan C. Verberkmoes, Robert L. Hettich, and 
Jeffrey I. Gordon. “Characterizing a model human gut microbiota composed of 
members of its two dominant bacterial phyla.” PNAS, 2009, volume 106, issue 
14, pages 5859-5864. 
Alison R. Erickson’s contributions include experimental preparation of ceca samples for 
proteomics and all experimental LC-MS/MS measurements and analysis. 
3.1: Introduction 
The adult human gut houses a bacterial community containing trillions of members 
comprising thousands of species-level phylogenetic types (phylotypes). Culture-
independent surveys of this community have revealed remarkable interpersonal 
variations in strain- and species-level phylotypes, and two commonly abundant bacterial 
phyla, the Firmicutes and the Bacteroidetes[112]. This phylum-level composition is not a 
unique feature of humans: a global survey of the guts of 59 other mammalian species 
showed a similar phylum level pattern[113]. 
Comparative analysis of five sequenced human gut Bacteroidetes revealed that 
each genome contains a large repertoire of genes involved in acquisition and 
metabolism of polysaccharides: this repertoire includes (i) up to hundreds of glycoside 
hydrolases (GHs) and polysaccharide lyases (PLs); (ii) myriad paralogs of SusC and 
SusD, outer membrane proteins involved in recognition and import of specific 
carbohydrate structures[114]; and (iii) a large array of environmental sensors and 
regulators[115]. These genes are assembled in similarly organized, selectively 
regulated polysaccharide utilization loci (PULs) that encode functions necessary to 
detect, bind, degrade and import carbohydrate species encountered in the gut habitat – 
	   46	  
either from the diet or from host glycans associated with mucus and the surfaces of 
epithelial cells[116,117,118]. Studies of gnotobiotic colonized with human gut-derived 
Bacteroides thetaiotaomicron alone have demonstrated that this organism can vary its 
pattern of expression of PULs as a function of diet: e.g., during the transition from 
mother’s milk to a polysaccharide-rich chow consumed when mice are weaned[116], or 
when adult mice are switched from a diet rich in plant polysaccharides to a diet devoid 
of these glycans and replete with simple sugars (under the latter conditions, the 
organism forages on host glycans)[117,118]. 
Our previous functional genomic studies of the responses of B. thetaiotaomicron 
to co-colonization of the guts of gnotobiotic mice with Bifidobacterium longum, an 
Actinobacterium found in the guts of adults and infants, or with Lactobacillus casei, a 
Firmicute present in a number of fermented dairy products, have shown that B. 
thetaiotaomicron responds to the presence of these other microbes by modifying 
expression of its PULs in ways that expand the breadth of its carbohydrate foraging 
activities[119]. 
These observations underscore the notion that gut microbes may live at the 
intersection of two forms of selective pressure: bottom-up selection, where fierce 
competition between members of a community that approaches a population density of 
1011-1012organisms/ml of colonic contents drives phylotypes to assume distinct 
functional roles; and top-down selection, where the host selects for functional 
redundancy to insure against the failure of bioreactor functions that could prove highly 
deleterious[120,121]. 
The content, genomic arrangement and functional properties of PULs in 
sequenced gut Bacteroidetes illustrate the specialization and functional redundancy 
within members of this phylum. They also emphasize how the combined metabolic 
activities of members of the microbiota undoubtedly result in interactions that are both 
very dynamic and overwhelmingly complex (at least to the human observer), involving 
multiple potential pathways for the processing of substrates (including the order of 
substrate processing), varying patterns of physical partitioning of microbes relative to 
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substrates within the ecosystem, plus various schemes for utilization of products of 
bacterial metabolism. Such a system likely provides multiple options for processing of a 
given metabolite, and for the types of bacteria that can be involved in these activities.  
All of this means that the task of defining the interactions of members of the 
human gut microbiota is daunting, as is the task of identifying general principles that 
govern the operation of this system. In the present study, we have taken a reductionist 
approach to begin to define interactions between members of the Firmicutes and the 
Bacteroidetes that are commonly represented in the human gut microbiota. In the 
human colon, Clostridium cluster XIVa is one of two abundantly represented clusters of 
Firmicutes. Therefore, we have generated the initial two complete genome sequences 
for members of the genus Eubacterium in Clostridium cluster XIVa, (the human gut-
derived E. rectale strain ATCC 33656 and E. eligens strain ATCC 27750) and compared 
them with the draft sequences of 25 other sequenced human gut bacteria belonging to 
the Firmicutes and the Bacteroidetes. The interactions between E. rectale and B. 
thetaiotaomicron were then characterized by performing whole genome transcriptional 
profiling of each species after colonization of gnotobiotic mice with each organism 
alone, or in combination under three dietary conditions. Transcriptional data collected by 
Wash. Univ. were verified by mass spectrometry of cecal proteins collected by ORNL, 
plus biochemical assays of carbohydrate metabolism. Lastly, we examined colonization 
and interactions between these microbes from a host perspective; to do so, we 
performed whole genome transcriptional analysis of colonic RNA prepared from mice 
that were germ-free or colonized with one or both species. Our results illustrate how 
members of the dominant gut bacterial phyla are able to adapt their substrate utilization 
in response to one another and to host dietary changes, and how host physiology can 
be affected by changes in microbiota composition. 
3.2: Experimental Methods 
3.2.1: Genome comparisons 
All nucleotide sequences from all contigs of completed genome assemblies containing 
both capillary sequencing and pyrosequencer data, produced as part of the HGMI, were 
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downloaded from the Washington University Genome Sequencing Center’s website 
(http://genome.wustl.edu/pub/organism/Microbes/Human_Gut_Microbiome/) on 
September 27, 2007.  The finished genome sequences of B. thetaiotaomicron VPI-
5482, Bacteroides vulgatus ATCC 8482, and B. fragilis NCTC9343 were obtained from 
GenBank.   
For comparison purposes, protein-coding genes were identified in all genomes 
using YACOP[122].  Each proteome was assigned InterPro numbers and GO terms 
using InterProScan release 16.1. Statistical comparisons between genomes were 
carried out, as described previously[115] using perl scripts that are available upon 
request from the authors. 
3.2.2: GeneChip analysis 
Previously described methods were used to isolate RNA from a 100-300 mg aliquot of 
frozen cecal contents, synthesize cDNA, and to biotinylate and hybridize the cDNAs to a 
custom bacterial GeneChip[123]. The only modification was that in RNA isolation 
protocol 0.1mm zirconia/silica beads (Biospec Products, Bartlesville, OK) were used for 
lysis of bacterial cells in a bead beater (Biospec; 4 min run at highest speed). Genes in 
a given bacterial species that were differentially expressed in mono- versus 
biassociation experiments were identified using CyberT (default parameters) following 
probe masking and scaling with the MAS5 algorithm (Affymetrix; for details about the 
methods used to create the mask, see the Methods section of Supplementary 
Information).   
RNA was purified from proximal colon using Mini RNeasy kit (Qiagen) with on-
column DNase digestion. Biotinylated cRNA targets were prepared from each sample 
(n=4/treatment group). cRNA was hybridized to Affymetrix Mouse Genome Mo430 2 
GeneChips, and the resulting data sets analyzed using Probe Logarithmic Error 
Intensity Estimate method (PLIER+16). Fold-changes and p-values were calculated 
using Cyber-t. Significance was defined by maintaining a FDR <1% using Benjamini-
Hochberg correction[124]. 
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3.2.3: Proteomic methods 
Cecal contents were processed via a single tube cell lysis and protein digestion method 
as follows.  Briefly, the cell pellet was re-suspended in 6M Guanidine/10 mM DTT, 
heated at 60°C for 1h, followed by an overnight incubation at 37°C to lyse cells and 
denature proteins.  The guanidine concentration was diluted to 1 M with 50mM 
Tris/10mM CaCl2 (pH 7.8), and sequencing grade trypsin (Promega, Madison, WI) was 
added (1:100; wt/wt).  Digestions were run overnight at 37°C.  Fresh trypsin was then 
added followed by additional 4h incubation at 37°C.  The complex peptide solution was 
subsequently de-salted (Sep-Pak C18 solid phase extraction; Waters, Milford, MA), 
concentrated, filtered, aliquoted and frozen at -80°C.  All eight samples were coded and 
mass spectrometry measurements conducted in a blinded fashion.   
Cecal samples were analyzed in technical triplicates using a two-dimensional 
(2D) nano-LC MS/MS system with a split-phase column (SCX-RP)[97] on a linear ion 
trap (Thermo Fisher Scientific) with each sample consuming a 22 hr run as detailed 
elsewhere[92,125].  The linear ion trap (LTQ) settings were as follows: dynamic 
exclusion set at one; and five data-dependent MS/MS. Two microscans were averaged 
for both full and MS/MS scans and centroid data were collected for all scans.  All 
MS/MS spectra were searched with the SEQUEST algorithm[66] against a database 
containing the entire mouse genome, plus the B. thetaiotaomicron, E. rectale, rice, and 
yeast genomes (common contaminants such as keratin and trypsin were also included).  
To find potential food proteins, yeast and rice databases were included. The breakdown 
of each database component can be found in Table 3.1. The SEQUEST settings were 
as follows: enzyme type, trypsin; Parent Mass Tolerance, 3.0; Fragment Ion Tolerance, 
0.5; up to 4 missed cleavages allowed (internal lysine and arginine residues), and fully 
tryptic peptides only (i.e., both ends of the peptide must have arisen from a trypsin-
specific cut, except the N- and C-termini of proteins).  All datasets were filtered at the 
individual run level with DTASelect (22) [Xcorrs of at least 1.8 (+1 ions), 2.5 (+2 ions) 
3.5 (+3 ions)].  Only proteins identified with two fully tryptic peptides were considered.   
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Table 3.1: Protein sequence database components for binary microbial community 
SEQUEST database searches. 
 
For this study, false-positive rates (FPR) were used to estimate the error 
associated with peptide identifications.  The overall FPR was estimated using the 
formula: FPR = 2[nrev/(nrev + nreal)]*100 where nrev is the number of peptides identified 
from the reverse database and nreal is the number of peptides identified from the real 
database[96].  Reverse and shuffled databases were created in order to calculate 
FPRs[96,126].  A reverse database was created by precisely reversing each protein 
entry (i.e., N-terminus became C-terminus in each case) and then appended these 
reversed sequences onto the original database.  Two runs - samples 705, Run 1 and 
710, Run 2 - were randomly selected for estimating a FPR.  The observed FPR rates 
were 0.55% and 0.31% respectively for these two runs.  An additional database was 
created by randomly shuffling the amino acids of each protein rather than simply 
reversing the N-terminus and C-terminus.  A FPR was estimated using a similar formula 
as that described above except that the number of identified reverse peptides was 
replaced with the number of shuffled peptides.  A FPR was estimated for both samples, 
705, Run 1 (0.45%) and 710, Run2 (0.31%) and was similar to the rate determined by 
the reverse database method.  Datasets for calculating FPR rates are available on the 
website mentioned above. 
In addition to differentiating between true and false peptide identifications with 
FPRs, label-free quantitation methods were used to estimate relative protein 
abundance.  Several protein quantitation methods are currently available and routinely 
performed for shotgun proteomics analyses.  To estimate relative protein abundance in 
complex protein mixtures and communities, spectral counts and normalized spectral 
Database Proteins Size (MB)
B. thetaiotaomicron 4,958 2.3
E. rectale 3,188 1.36
M. musculus 34,966 19.2
Rice 66,710 36
Yeast 6,345 3.33
contaminants 36 0.02
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abundance factors (NSAF)[127] are commonly used.  Spectral counting is based on the 
theory that the more abundant peptides are typically sampled more frequently, resulting 
in higher spectral counts.  Liu et al. has shown that spectral copy number provides a 
more accurate correlation to protein abundance than peptide count and % 
coverage[128]. NSAF, on the other hand, is based on spectral counts, but takes into 
account protein size and the total number of spectra from a run, thus normalizing the 
relative protein abundance between samples[127].    
3.3: Results and Discussion 
3.3.1: Comparative genomic studies of human gut-associated Firmicutes and 
Bacteroidetes 
Wash. Univ. produced finished genome sequences for Eubacterium rectale, which 
contains a single 3,449,685 bp chromosome encoding 3,627 predicted proteins, and 
Eubacterium eligens which contains a 2,144,190 bp chromosome specifying 2,071 
predicted proteins, plus two plasmids. We also analyzed 25 recently sequenced gut 
genomes, including (i) 9 sequenced human gut-derived Bacteroidetes [includes the 
finished genomes of B. thetaiotaomicron, B. fragilis, B. vulgatus, and Parabacteroides 
distasonis, plus deep draft assemblies of the B. caccae, B. ovatus, B. uniformis, B. 
stercoris and P. merdae genomes generated as part of the human gut microbiome 
initiative (HGMI; http://genome.wustl.edu/hgm/HGM_frontpage.cgi], and (ii) 16 other 
human gut Firmicutes where deep draft assemblies were available through the HGMI. 
We classified the predicted proteins in these two genomes using Gene Ontology (GO) 
terms generated via Interproscan, as well as according to the scheme incorporated into 
the Carbohydrate Active Enzymes (CAZy) database [www.cazy.org;[129], and then 
applied a binomial test to identify functional categories of genes that are either over- or 
under-represented between the Firmicutes and Bacteroidetes phyla. This analysis 
emphasized among other things that the Firmicutes, including E. rectale and E. eligens, 
have significantly fewer polysaccharide-degrading enzymes and more ABC transporters 
and PTS systems than the Bacteroidetes[130]. We subsequently chose E. rectale and 
B. thetaiotaomicron as representatives of these two phyla for further characterization of 
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their niches in vivo, because of their prominence in culture-independent surveys of the 
distal human gut microbiota[62,131], the pattern of representation of carbohydrate 
active enzymes in their glycobiomes and E. rectale’s ability to generate butyrate as a 
major end product of fermentation[132,133]. These choices set the stage for an 
‘arranged marriage’ between a Firmicute and a Bacteroidetes, hosted by formerly germ-
free mice. 
3.3.2: Functional genomic analyses of the minimal human gut microbiome  
3.3.2.1: Creating a “minimal human gut microbiota” in gnotobiotic mice - Young 
adult male germ-free mice belonging to the NMRI inbred strain were colonized with B. 
thetaiotaomicron or E. rectale alone (monoassociations) or co-colonized with both 
species (biassociation).  10-14 d after inoculation by gavage, both species colonized the 
ceca of recipient mice, fed a standard chow diet rich in complex plant polysaccharides, 
to high levels (n=4-5 mice/treatment group in each of 3 independent experiments). 
Moreover, cecal levels of colonization for both organisms were not significantly different 
between mono- and biassociated animals.  
3.3.2.2: B. thetaiotaomicron’s response to E. rectale - A custom, multispecies, 
human gut microbiome Affymetrix GeneChip was designed and used to compare the 
transcriptional profile of each bacterial species when it was the sole inhabitant of the 
cecum, and when it co-existed together with the other species. A significant number of 
B. thetaiotaomicron genes located in PULs exhibited differences in their expression 
upon E. rectale colonization [55 of 106; p<10-15 (cumulative hypergeometric test). Of 
these 55 genes, 51 (93%) were upregulated. 
As noted in the Introduction, two previous studies from our lab examined 
changes in B. thetaiotaomicron’s transcriptome in the ceca of monoassociated 
gnotobiotic mice when they were switched from a diet rich in plant polysaccharides to a 
glucose-sucrose chow[117], or in suckling mice consuming mother’s milk as they 
transitioned to a standard chow diet[116]. In both situations, in the absence of dietary 
plant polysaccharides, B. thetaiotaomicron adaptively forages on host glycans.  The 
genes upregulated in B. thetaiotaomicron upon co-colonization with E. rectale have a 
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significant overlap with those noted in these two previous datasets (p<10-14, cumulative 
hypergeometric test).  In addition, they involve several of the genes upregulated during 
growth on minimal medium containing porcine mucosal glycans as the sole carbon 
source[118]. For example, in co-colonized mice and in vitro, B. thetaiotaomicron 
upregulates several genes (BT3787-BT3792; BT3774-BT3777) used in degrading α-
mannosidic linkages, a component of host N-glycans as well as the diet. (Note that E. 
rectale is unable to grow in defined medium containing α -mannan or mannose as the 
sole carbon sources). B. thetaiotaomicron also upregulates expression of its starch 
utilization system (Sus) PUL in the presence of E. rectale (BT3698-3704).  This well-
characterized PUL is essential for degradation of starch molecules containing ≥6 
glucose units[134].  
Thus, it appears that B. thetaiotaomicron adapts to the presence of E. rectale by 
upregulating expression of a variety of PULs so that it can broaden its niche and 
degrade an increased variety of glycan substrates, including those derived from the host 
that E. rectale is unable to access. There are a number of reasons why the capacity to 
access host glycans likely represents an important trait underpinning microbiota function 
and stability: (i) glycans in the mucus gel are abundant and are a consistently 
represented source of nutrients; (ii) mucus could serve as a microhabitat for 
Bacteroidetes spp. to embed in (and adhere to via SusD paralogs), thereby avoiding 
washout from the ecosystem; and (iii) the products of polysaccharide 
digestion/fermentation generated by Bacteroidetes spp. could be shared with other 
members of the microbiota that are also embedded in mucus[118].  
3.3.2.3: E. rectale’s response to B. thetaiotaomicron - E. rectale’s response to B. 
thetaiotaomicron in the mouse cecum stands in marked contrast to B. 
thetaiotaomicron’s response to E. rectale. Carbohydrate metabolism genes, particularly 
GHs, are significantly overrepresented among the E. rectale genes that are 
downregulated in the presence of B. thetaiotaomicron compared to monoassociation; 
i.e., 12 of E. rectale’s predicted 51 GHs have significantly reduced expression while only 
two are upregulated. The two upregulated GH genes (EUBREC_1072, a 6-P-b-
glucosidase and EUBREC_3687, a cellobiose phosphorylase) are predicted to break 
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down cellobiose. Three simple sugar transport systems with predicted specificity for 
cellobiose, galactoside, and arabinose/lactose (EUBREC_3689, EUBREC_0479, and 
EUBREC_1075-6, respectively) are among the most strongly upregulated genes. 
Phosphoenolpyruvate carboxykinase (EUBREC_2002) is also induced with co-
colonization (GeneChip data verified by qRT-PCR assays in 2 independent experiments 
involving 3-4 mice/treatment group).  This enzyme catalyzes an energy conserving 
reaction that produces oxaloacetate from phosphoenolpyruvate. In a subsequent 
transaminase reaction, oxaloacetate can be converted to aspartate, linking this 
branching of the glycolytic pathway with amino acid biosynthesis.  
Additional data support the notion that E. rectale is better able to access nutrients 
in the presence of B. thetaiotaomicron. For example, a number of peptide and amino 
acid transporters in E. rectale are upregulated, as are the central carbon and nitrogen 
regulatory genes CodY (EUBREC_1812), glutamate synthase (EUBREC_1829) and 
glutamine synthetase (EUBREC_2543) (note that these genes are also upregulated 
during growth in tryptone glucose medium). 
3.3.2.4: Changes in E. rectale’s fermentative pathways - E. rectale possesses genes 
(EUBEC733-737; EUBEC1017) for the production of butyrate that show high similarity 
to genes from other Clostridia. This pathway involves condensation of two molecules of 
acetylCoA to form butyrate and is accompanied by oxidation of NADH to NAD+. 
Transcriptional and high resolution proteomic analyses (see below) disclosed that the 
enzymes involved in production of butyrate are among the most highly expressed in 
cecal extracts prepared from mono- and biassociated mice containing E. rectale.  
In vitro studies have shown that in the presence of carbohydrates, E. rectale 
consumes large amounts of acetate for butyrate production[133]. Several observations 
indicate that E. rectale utilizes B. thetaiotaomicron-derived acetate to generate 
increased amounts of butyrate in the ceca of our gnotobiotic mice.  First, E. rectale 
upregulates a phosphate acetyltransferase (EUBREC_1443; EC 2.3.1.8) - one of two 
enzymes involved in the interconversion of acetyl-CoA and acetate. Second, cecal 
acetate levels are significantly lower in co-colonized mice compared to B. 
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thetaiotaomicron monoassociated animals. Third, although cecal butyrate levels are 
similar in E. rectale mono- and biassociated animals, expression of mouse Mct-1, 
encoding a monocarboxylate transporter whose inducer and preferred substrate is 
butyrate[135], is significantly higher in the distal gut of mice containing both E. rectale 
and B. thetaiotaomicron versus E. rectale alone (p<0.05).  The cecal concentrations of 
butyrate we observed are similar to those known to upregulate Mct-1 in colonic 
epithelial cell lines[135]. Higher levels of acetate (i.e. those encountered in B. 
thetaiotaomicron monoassociated mice) were insufficient to induce any change in Mct-1 
expression compared to germ-free controls. 
The last enzyme in E. rectale’s butyrate production pathway, butyrylCoA 
dehydrogenase/electron transfer flavoprotein (Bcd/Etf) complex (EUBREC_0735-0737; 
EC 1.3.99.2), offers a recently discovered additional pathway for energy conservation, 
via a bifurcation of electrons from NADH to crotonylCoA and ferredoxin[136]. Reduced 
ferredoxin, in turn, can be reoxidized via hydrogenases, or via the membrane-bound 
oxidoreductase, Rnf, which generates sodium-motive force. The upregulation and high 
level of expression of these key metabolic genes when E. rectale encounters B. 
thetaiotomicron indicates that E. rectale not only employs this pathway to generate 
energy, but to also accommodate the increased demand for NAD+ in the glycolytic 
pathway. Consistent with these observations, we found that the NAD+/NADH ratio in 
cecal contents was significantly increased with co-colonization. A high NAD+/NADH 
ratio promotes high rates of glycolysis, since NAD+ is a required cofactor and may 
represent an adaptation by E. rectale to increased nutrient uptake.  
The pathway for acetate metabolism observed in this simplified model human gut 
community composed of B. thetaiotaomicron and E. rectale differs markedly from what 
is seen in mice that harbor B. thetaiotaomicron and the principal human gut 
methanogenic archaeon, Methanobrevibacter smithii. When B. thetaiotaomicron 
encounters M. smithii in the ceca of gnotobiotic mice, there is increased production of 
acetate by B. thetaiotaomicron, no diversion to butyrate (and no induction of Mct-1; 
[123] and B. Samuel and J. Gordon, unpublished observations), increased serum 
acetate levels, and increased adiposity compared to B. thetaiotaomicron mono-
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associated controls. In contrast, serum acetate levels and host adiposity (as measured 
by fat pad to body weight ratios) are not significantly different between B. 
thetaiotaomicron monoassociated and B. thetaiotaomicron-E. rectale co-colonized 
animals (n=4-5 animals/group; n=3 independent experiments; data not shown).  
3.3.2.5: Colonic transcriptional changes evoked by E. rectale-B. thetaiotaomicron 
co-colonization – We subsequently used Affymetrix Mouse 430 2 GeneChips to 
compare patterns of gene expression in the proximal colons of mice that were either 
germ-free, monoassociated with E.rectale or B. thetaiotaomicron, or  co-colonized with 
both organisms (n=4 mice per group; total of 16 GeneChip datasets). In contrast to the 
small number of genes whose expression was significantly changed (1.5-fold cut off, 
<1%FDR) after colonization with either bacterium alone relative to germ-free controls, 
co-colonization produced significant alterations in the expression of 508 host genes. 
Expression of many of these genes also changed with monoassociation with either 
organism, and in the same direction as seen after co-colonization, but in most cases the 
changes evoked by B. thetaiotaomicron or E. rectale alone did not achieve statistical 
significance. Unsupervised hierarchical clustering of average expression intensity 
values derived from each of the four sets of GeneChips, revealed that the E.rectale 
monoassociation and E.rectale-B.thetaiotaomicron bi-association profiles clustered 
separate from the germ-free and B. thetaiotaomicron monoassociation datasets.  
 Ingenuity Pathway Analysis (www.ingenuity.com) disclosed that the list of 508 
host genes affected by co-colonization was significantly enriched in functions related to 
cellular growth and proliferation (156 genes), as well as cell death (142 genes). A 
number of components of the canonical wnt/β catenin pathway known to be critically 
involved in controlling self-renewal of the colonic epithelium were present in this list. 
Many of the changes observed in biassociated mice are likely to be related to the 
increased influx of butyrate, generated by E. rectale, into colonic cells.  Butyrate, a 
histone deacetylase inhibitor that evokes pronounced transcriptional changes in 
different types of cultured epithelial cell line[137,138,139,140], is the preferred energy 
substrate for colonic enterocytes[141].  While transcriptional changes caused by 
butyrate differ depending upon the cell lineage, state of cellular differentiation, and 
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cellular energy status[139,140,142,143] in vitro and in vivo studies have shown that it 
affects expression of genes involved in proliferation, differentiation and 
apoptosis[137,142]. 
 As mentioned above, as part of its adaptation to the presence of E. rectale, B. 
thetaiotaomicron upregulates a number of genes involved in the harvest of host glycans. 
Included among these B. thetaiotaomicron genes are components of a fucose utilization 
operon linked to the production of a bacterial signal that induces synthesis of intestinal 
mucosal fucosylated glycans, and also catabolism of fucose from O-glycans[144]. 
GeneChip profiling of colonic gene expression disclosed that co-colonization results in 
increased expression of Fut2 (α-1,2 fucosyltransferase), Fut4  (α-1,3-
fucosyltransferase), plus nine other genes involved in the synthesis of mucosal glycans 
(glycosphingolipids and O-glycans). By increasing host production of glycans, B. 
thetaiotaomicron can benefit itself, and through its metabolic products, E. rectale.  
3.3.2.6: E. rectale’s colonization levels and production of butyrate are affected by 
host diet - In a final series of experiments, we assessed how E. rectale and B. 
thetaiotaomicron were affected by changes in host diet. Groups of age- and gender-
matched co-colonized mice were fed one of three diets that varied primarily in their 
carbohydrate and fat content: (i) the standard low-fat, plant polysaccharide-rich diet 
used for the experiments described above (abbreviated ‘LF/PP’ for low-fat/plant 
polysaccharide), (ii) a high-fat, ‘high-sugar’ Western-type diet (abbreviated HF/HS) that 
contained sucrose, maltodextrin, corn starch as well as complex polysaccharides 
(primarily cellulose) that were not digestible by B. thetaiotaomicron or E. rectale, and (iii) 
a control diet that was similar to (ii) except that the fat content was 4-fold lower (‘LF/HS’ 
for low-fat, high-sugar; n=5 mice per group). Whereas B. thetaiotaomicron’s colonization 
levels were similar in all three diets, colonization of E. rectale was significantly reduced 
(five-fold) in mice fed either the LF/HS or HF/HS diets (p<0.01, heteroscedastic t-test).   
Whole-genome transcriptional profiling of both organisms showed that relative to 
the standard polysaccharide-rich chow diet (LF/PP), both the Western style HF/HS diet 
and its LF/HS control produced a significant upregulation of B. thetaiotaomicron PULs 
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involved in harvesting and degrading host polysaccharides, and a downregulation of 
several PULs involved in the degradation of dietary plant polysaccharides. E. rectale’s 
response to the HF/HS and LF/HS diets was to downregulate several of its GHs as well 
as a number of its sugar transporters. Moreover, levels of butyrate were five-fold lower 
in co-colonized mice fed these compared to the standard chow LF/PS diet [0.496 
±0.0051 µmol/g wet weight cecal contents; (LF/PP) vs. 0.095±0.002 (HF/HS) vs 
0.080±0.008 (LF/HS) (p<0.05 ANOVA)].  
These dietary manipulations lend further support to the view that B. 
thetaiotaomicron functions in this model two-member human microbiota to process 
complex dietary plant polysaccharides and to distribute to the products of digestion to E. 
rectale which, in turn, synthesizes butyrate. The response of E. rectale to the HF/HS 
and LF/HS diets can be explained by the fact that this Firmicute does not have 
predicted GHs and PLs that can process host glycans. In addition, it could not utilize 
most of the sugars we tested that are derived from mucosal polysaccharides. Finally, 
the host possesses enzymes in its glycobiome that can directly process the simple 
sugars present in these two diets. Indeed, human subjects that are fed diets deficient in 
complex polysaccharides harbor lower levels of butyrate-producing gut bacteria, 
including members of the E. rectale-containing clade[145]. Our simplified gnotobiotic 
model of the microbiota underscores the functional implications of diet-associated 
changes in the representation of this clade, not only as they relate to the operations of 
the microbiota itself but also potentially as they relate to butyrate-mediated changes in 
gut epithelial homeostasis. 
3.3.3: Proteomic studies of this simplified two-component model of the human 
gut microbiome 
Model communities such as the one described above, constructed in gnotobiotic mice, 
where microbiome gene content is precisely known and transcriptional data are 
obtained under conditions where potentially confounding host variables such as diet and 
host genotype can be constrained, provide a way to test the efficacy of mass 
spectrometric methods for characterizing gut microbial community proteomes. 
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Therefore, we assayed luminal contents, collected from the ceca of 8 gnotobiotic mice 
fed the standard polysaccharide-rich LF/PP diet: (germ-free, monoassociated, and co-
colonized; n=2 mice/treatment group representing two independent biological 
experiments).  
The measured proteomes had high reproducibility in terms of total number of 
proteins observed and spectra matching to each species.  A total of ~6,300-21,000 
spectra were identified per sample and differ based on inoculations.  For a complete list 
of the total number of identified spectra, peptides and proteins per sample and run, see 
Table 3.2.  Interestingly, the total number of identified spectra was, for the most part, 
distinct and unique to each bacterial species.  Unlike B. thetaiotaomicron and E. rectale, 
the number of identified spectra belonging to mouse was redundant: thus, a higher 
number of spectra were non-unique spectra.  The difference is evident when the total 
spectra counts are compared to unique spectra counts only.  The total average spectra 
count identified in the control (germ-free) mouse was 10,767 for sample 700 and 11, 
221 for sample 799.  The total average unique spectra count, however, decreased to 
4,394 and 4,168.  Therefore, the majority of identified mouse peptides are not unique 
within the database.  The total number of unique spectra counts per species and run 
can be found in Table 3.3.  The two co-colonized mice (710 and 810) had a total of ~ 
77% unique spectra belonging to B. thetaiotaomicron, 20% unique spectra belong to E. 
rectale, and only 3% of the two species’ combined spectra counts were non-unique.  
This suggests that the majority of identified proteins belonging to B. thetaiotaomicron 
and E. rectale are true unique identifications and these species can be easily 
differentiated by proteomics.   These values were calculated by summing the total 
number of unique spectra per species per run, followed by an average per species 
across all runs (Table 3.3). 
 
 
 
	   60	  
Table 3.2: High resolution proteomic analyses of cecal contents from gnotobiotic mice – 
total proteins, peptides, and spectra for each sample. 
 
 
 
 
 
  
Sample Protein IDs Peptide IDs Spectra Species Inoculation
700 Run 1 716 3505 7561
700 Run 2 702 3448 7067
700 Run 4 596 2965 7019
705 Run 1 1526 11515 21228
705 Run 2 1538 11534 20051
705 Run 3 1513 9577 17119
710 Run 2 1335 9270 17910
710 Run 3 1482 9256 16839
710 Run 4 1612 10484 17635
715 Run 1 914 6388 12243
715 Run 2 894 6241 12257
715 Run 5 945 6040 11358
799 Run 1 571 2809 6338
799 Run 2 471 2355 6575
799 Run 3 449 2213 6995
806 Run 1 1407 9366 18071
806 Run 2 1424 9400 18915
806 Run 3 1358 8867 15864
810 Run 1 1409 7798 14102
810 Run 2 1509 8505 14659
810 Run 3 1431 7658 14217
817 Run 1 837 4779 10294
817 Run 2 791 4519 10346
817 Run 3 881 4880 10829
B. thetaiotaomicron+and+E. rectale
E. rectale
None (control)
B. thetaiotaomicron 
B. thetaiotaomicron+and+E. rectale
E. rectale
None (control)
B. thetaiotaomicron
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Table 3.3: High resolution proteomic analyses of cecal contents from gnotobiotic mice – 
breakdown of unique spectral counts for all species in the database for Sample Set 1 
and 2. 
 
 
  
Sample Set 1
Sample ID: 700 Run1 700 Run2 700 Run4 705 Run1 705 Run2 705 Run3 710 Run2 710 Run 3 710 Run4 715 Run1 715 Run2 715 Run5
B. thetaiotaomicron 9 8 6 17329 16455 14149 10723 10104 10596 7 23 2
E. rectale 36 23 31 22 15 6 3596 3494 3843 6817 6790 6294
M. musculus 4591 4377 4216 2324 2122 1852 1911 1827 1847 3426 3438 3317
Rice 232 254 269 171 142 105 69 46 45 121 112 98
Yeast 13 8 13 2 4 5 9 4 16 23 12 8
contams 40 32 30 37 33 19 30 24 26 30 35 27
Total: 4921 4702 4565 19885 18771 16136 16338 15499 16373 10424 10410 9746
Sample Set 2
Sample ID: 799 Run1 799 Run2 799 Run3 806 Run1 806 Run2 806 Run3 810 Run1 810 Run2 810 Run3 817 Run1 817 Run2 817 Run3
B. thetaiotaomicron 0 0 0 14403 15034 12693 9115 9562 8933 4 4 3
E. rectale 4 1 2 6 11 5 1600 1736 1658 4749 4686 5068
M. musculus 3949 4250 4306 2318 2384 1932 2260 2183 2366 3582 3739 3743
Rice 272 226 243 56 113 34 62 114 107 140 113 135
Yeast 14 12 7 4 0 4 5 9 5 16 11 3
contams 15 13 15 5 0 4 7 6 8 3 7 5
Total: 4254 4502 4573 16792 17542 14672 13049 13610 13077 8494 8560 8957
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Table 3.4 provides a summary of our analyses, including the percentage of 
mRNAs called ‘Present’ in the GeneChip datasets for which there was an identified 
protein product.  These data suggest that RNA and protein identifications are not always 
correlative.  While both datasets provide valuable insight into the two microbes function 
in the gut, there are differences for which many mRNAs were identified, but were not 
present or identified in the final protein product. The most abundant identified products 
from both microbes included ribosomal proteins, elongation factors, chaperones, and 
proteins involved in energy metabolism.  Many conserved hypothetical and pure 
hypothetical proteins were identified, as well as 10 genes in B. thetaiotaomicron whose 
presence had not been predicted in our initial annotation of the finished genome.  
Together, the results provide validation of experimental and computational procedures 
used for proteomic assays of a model gut microbiota, and also illustrate some of the 
benefits in obtaining this type of information. 
Table 3.4: Summary of proteins detected by mass spectrometry of the cecal contents of 
gnotobiotic mice. 
 
3.4: Prospectus 
These studies of a model two component human gut microbiota created in gnotobiotic 
mice support a view of the Bacteroidetes, whose genomes contain a disproportionately 
large number of glycan-degrading enzymes compared to sequenced Firmicutes, as 
responding to increasing diversity by modulating expression of their vast array of 
polysaccharide utilization loci. B. thetaiotaomicron responds to the presence of E. 
rectale by upregulating a variety of loci specific for host-derived mucin glycans that E. 
rectale is unable to utilize. E. rectale, which like other Firmicutes has a more specialized 
capacity for glycan degradation, broadly downregulates its available GHs in the 
Mono$association Bi$association Total Mono$association Bi$association Total
Detected&by&MS/MS 661 453 680 1608 1367 1687
Detected&by&GeneChip 2139 2010 2150 3798 3865 3995
GeneChip2/&MS/MS+ 7 7 8 40 21 23
MS/MS2&/GeneChip+&a 1608 1638 1603 2280 2569 2357
aPositive:is:defined:as:having:a:‘Present’:call:in:≥75%:of:GeneChips.
E.&rectale B.&thetaiotaomicron
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presence of B. thetaiotaomicron, even though it does not grow efficiently in the absence 
of carbohydrates. It also becomes more selective in its harvest of sugars and its 
transcriptional profile suggests improved access to other nutrients (e.g. there is a 
generalized upregulation of amino acid biosynthetic genes as well as a set of nutrient 
transporters that can harvest peptides). 
We have previously used gnotobiotic mice to show that the efficiency of 
fermentation of dietary polysaccharides to short chain fatty acids by B. thetaiotaomicron 
increases in the presence of M. smithii [123]. Co-colonization increases the density of 
colonization of the distal gut by both organisms, increases production of formate and 
acetate by B. thetaiotaomicron and allows M. smithii to use H2 and formate to produce 
methane, thereby preventing the build-up of these fermentation end-products (and 
NADH) in the gut bioreactor, and improving the efficiency of carbohydrate 
metabolism[123]. Removal of H2 by this methanogenic archaeon allows B. 
thetaiotaomicron to regenerate NAD+, which can then be used for glycolysis. This 
situation constitutes a mutualism, in which both members show a clear benefit.  The 
present study, characterizing the co-colonization with B. thetaiotaomicron and E. 
rectale, describes a more nuanced interaction where both species colonize to similar 
levels if carbohydrate substrates are readily available. Moreover, certain aspects of 
bacterial-host mutualism become more apparent with co-colonization, including 
increased microbial production and host transport of butyrate, and increased host 
production and microbial consumption of mucosal glycans: this mutualism is likely vital 
for the co-existence of these species. 
It seems likely that as the complexity of the gut community increases, 
interactions between B. thetaiotaomicron and E. rectale will either be subsumed or 
magnified by other ‘similar’ phylogenetic types (as defined by their 16S rRNA sequence 
and/or by their glycobiomes). Synthesizing model human gut microbiotas of increasing 
complexity in gnotobiotic mice using sequenced members of our intestinal communities 
should be very useful for exploring two ecologic concepts: (i) the neutral theory of 
community assembly which posits that most species will share the same general niche 
(profession), and thus are likely to be functionally redundant[146], and (ii) the idea that 
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both bottom-up selection, where fierce competition between members of the microbiota 
drives phylotypes to assume distinct functional roles, and top-down selection, where the 
host selects for functional redundancy to insure against failure of bioreactor functions, 
operate in our guts. 
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Chapter 4 
Optimization of a cellular lysis/mass spectrometric proteome characterization 
approach for a model 7-member gut microbial community in gnotobiotic mice 
Alison R. Erickson, Nathan P. McNulty, Nathan C. VerBerkmoes, Jeffrey I. Gordon, and 
Robert L. Hettich 
4.1: Introduction 
Mass-spectrometry (MS)-based proteomics has become very powerful in providing 
comprehensive and unbiased characterization of proteins and proteomes.  With the 
onset of multidimensional protein separations interfaced to high-performance tandem 
mass spectrometry, this experimental approach can handle substantial protein or 
peptide complexity and simultaneously achieve protein identification[95].  However, the 
complexity and ‘dynamic range’ of microbial proteomes containing thousands of 
bacterial species have hindered the ability to identify whole community proteomes, as 
compared to traditional single bacterial isolates (e.g., E. coli).  
The ‘standard’ shotgun proteomics strategy includes cellular lysis (with or without 
fractionation), protein denaturation and digestion, peptide separation via LC and 
identification via tandem mass spectrometry (MS/MS).  While much optimization has 
been invested in LC-MS/MS, experimental methods involving sample preparation (i.e., 
cellular fractionation and lysis), peptide separation (i.e., gel electrophoresis and LC), 
and MS/MS are equally important to enhance overall protein identifications in MS-based 
shotgun proteomics of complex microbial samples (i.e., soil, ocean, feces).   
Environmental microbial samples pose several challenges not characteristic of 
laboratory –based systems, such as increased dynamic range (abundance) of microbial 
species and proteins, and interferences derived from the environmental matrix.  In 
general, there are two options available where a microbial community sample is either i) 
derived, processed, and lysed directly (in situ) from the source (i.e., feces, cecum, 
tissue) with both bacterial and host cells included (‘direct approach’) or ii) enriched for 
bacterial cells to eliminate all host proteins and contaminants via centrifugation 
(‘indirect’ approach).  Environmental matrices can be problematic for the ‘direct’ lysis 
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and protein extraction approach[89] without any pre-fractionation or enrichment (i.e., 
differential centrifugation) of bacterial cells due to inference with downstream processes 
and analysis (i.e., peptide signal suppression)[74].  Widely accepted protocols for cell 
lysis and extraction of proteins from complex microbial communities for proteomic 
analysis include a thermally assisted detergent-based cellular lysis (sodium dodecyl 
sulfate, SDS) method[74], a small-scale microbial biomass experimental approach[86], 
sonication[87,88], freeze-thaw cycles[89], and French press[60].  Available and tested 
lysis buffers include detergents (e.g., SDS, CHAPS, and Triton X-100), chaotropes 
(urea and guanidine), acid-labile surfactants (PPS silent surfactant) and many other 
commercially available buffers to disrupt bacterial cells with or without physical or 
mechanical disruption prior to protein extraction.  Several precautions should be taken if 
a detergent is selected due to their interference with binding, elution, and ionization of 
peptides during tandem MS experiments.  To eliminate contamination and interference 
of detergents with mass spectrometers, several proteomics studies[26,42,43,86] opted 
to use an ‘indirect’ approach and chaotropes (i.e., guanidine) to enrich and lyse 
bacterial cells and denature proteins.  In this study, we focused on comparing methods 
that are used prior to proteolysis and LC-MS/MS with emphasis on identifying an 
efficient in situ lysis and protein extraction method.   
Due to the growing interest and desire to understand the human 
microbiome[14,69], MS-based proteomics has begun to emerge as a key player in 
understanding the functional signatures of the human gut and oral 
microbiome[26,37,47,48,49,83].  Therefore, to achieve comprehensive proteome 
coverage of samples collected from the human gut microbiota, optimization of 
experimental MS-based methods for their direct application to complex community 
samples (i.e., feces or ceca) would help increase protein identification and our 
understanding of the host-microbiota functional signatures.  A variety of methods 
including one protein fractionation (ultracentrifugation) method, five bacterial lysis 
methods, and protein (TCA) precipitation were evaluated to identify the best performing 
method for MS-based analysis of human-derived gut microbiota in germ-free 
(gnotobiotic) mice (Figure 4.1).  A model human gut microbiota of seven bacterial 
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species (B. WH2, B. ovatus, B. vulgatus, B. thetaiotaomicron, B. caccae, and 
Parabacteroides distasonis) belonging to one of two dominant gut phyla, Bacteroides, 
was inoculated in gnotobiotic mice to measure the proteomes of the microbial 
community, in addition to each individual species.  The method that provided the most 
efficient lysis and higher peptide recovery, thus, increased protein identification would 
be identified as the best overall performing method that could be applied in situ to any 
future fecal or cecal samples. 
 
Figure 4.1. Experimental design for method optimization of microbial and host cell lysis 
and protein extraction of a model human-derived gut microbial community in gnotobiotic 
mice. 
 
1mL$cecal$material$containing$tubes$labeled:$$
2,$3,$7,$8,$9,$10$$
Freeze/Thaw$
#$3$
HomogenizaConD$
Bead$BeaCng$
#$2$and$7$
1.  Preferred Lysis Method 
2.  Fractionation (# 7 only) 
Part$1:$
Determine$Best$Lysis$
Method$
Part$2:$
Determine$whether$
FracConaCon$helps$
Part$3:$
Determine$whether$protein$
precipitaCon$helps$with$eliminaCng$
these$viscous$polysaccharides$&$
interfering$compounds$$
1.  Preferred Lysis Method  
2.  Fractionation 
3.  Protein Precipitation (# 7 only) 
Guanidine/Heat$
#$9$
SDS/SonicaCon/Urea$
#$10$
SonicaCon$
#$8$
	   68	  
4.2: Experimental Methods 
4.2.1: Sample collection 
Dr. Jeffrey Gordon and Nate McNulty (Wash. Univ) provided a total of six ceca samples 
for the 7-member community proteomics experiments.  The C57BL/6 adult male germ-
free mouse cecum, labeled as either 2, 3, 7, 8, 9 and 10, were gavaged with an equal 
inoculum of the following species: Bacteroides caccae, B. ovatus, B. uniformis, B. WH2, 
B. thetaiotaomicron, B. vulgatus, and Parabacteroides distasonis and fed a standard BK 
diet ab libitum.  The total microbial does was ~ 8.7 x 107 corresponding to 1.2-1.3x107 
CFUs/microbe. The cecum was harvested at 14 days post-gavage, frozen in liquid 
nitrogen immediately, and shipped overnight on dry ice to ORNL.   
4.2.2: Bacterial lysis and protein extraction 
A total of five bacterial lysis methods were each performed on single mouse cecum (~1 
mL).  As described in Figure 4.1, the following widely-accepted bacterial lysis methods 
were applied and varied with respect to each of their individual protocols: sonication (8), 
freeze-thaw cycles (3), bead-beating (2 and 7), no physical disruption (9), and chemical 
disruption via sodium dodecyl sulfate (SDS) (10) with a brief description of the protocols 
to follow.  Cecum 2 (bead-beating) was first solubilized with 1mL 6M guanidine in 0.1 
mm zirconia/silica beads and beat using a RETSCH Mixer Mill MM 400 for a total of 2 
minutes (30 second intervals with 2 minute break) at room temperature with a frequency 
of 20Hz.  The homogenized cecum was centrifuged for 5 minutes at 3,000 rpm to 
remove excess debris and pellet all beads.  The supernatant was removed and beads 
washed with 6M Guanidine.   
Cecum 7 (bead-beating) was treated using the same steps described above for 
cecum 2; however, the cecum was solubilized in 50mM Tris/10mM CaCl2 instead of 6M 
guanidine to allow for proper cell separation via ultracentrifugation.  Following 
homogenization, the collected supernatant was transferred to a glass test tube and 
centrifuged at room temperature for 1 hour at 100,000x g using a Ti 40 fixed angle rotor 
ultracentrifuge (Beckman Coulter).  The supernatant (soluble fraction) was extracted 
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away from the pellet (membrane fraction) and treated separately for protein 
denaturation and digestion.   
Cecum 3 (freeze-thaw lysis method) was initially frozen in liquid N2 for 1 minute 
followed by 60°C treatment in a water for 1 minute and repeated for a total of three 
cycles.   
Cecum 8 (sonication only method) was initially solubilized in 6M Guanidine and 
exposed to sonication for a total 5 minutes at 20% amplitude on ice.   
Cecum 9 (no physical or chemical disruption) wa processed via single tube cell 
lysis[86] and protein digestion.  The cecum  (~1mL) was suspended in 6M 
Guanidine/10mM DTT at 60°C for 1 hour to lyse cells and denature proteins.  
Lastly, cecum 10 was solubilized in 1mL SDS lysis buffer (4% w/v SDS, 100mM 
Tris•HCl, pH 8.0, 10mM dithiothreitol (DTT)) and lysed mechanically by sonication 
followed by incubation for 5 minutes at 95°C.  Cells were centrifuged at 21,000 x g.  
Following an overnight tricholoroacetic acid (TCA) precipitation, the TCA precipitates 
(protein mixtures) were resolubilized in 500uL of 8M urea, 100mM Tris•HCl, pH 8.0, and 
reduced by incubation at a final concentration of 10mM DTT for 1 hr at room 
temperature.  Samples were sonicated and an aliquot taken to determine the protein 
concentration using a bicinchonic acid-(BCA) based protein assay kit (Pierce).  
Approximately 3mg of protein was extracted were diluted with 100mM Tris•HCl, 10mM 
CaCl2, pH 8.0 to a final urea concentration below 4M.  Proteolytic digestions were 
initiated with sequencing grade trypsin (1/100, w/w; Promega) overnight at room 
temperature.  A second aliquot of trypsin was added (1/100) and diluted with 100mM 
Tris•HCl, pH 8.0 to a final urea concentration below 2M.  Following a 4 hr incubation at 
room temperature, samples were reduced to a final concentration of 10mM DTT.  The 
peptides were acidified (protonated) in 200mM NaCl, 0.1% formic acid, filtered, and 
concentrated with a 10k molecular weight cutoff spin column (Sartorius).  A total of 
~100mg of peptides were used for each LC-MS/MS experiment. 
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For ceca 3, 8, and 9 the lysed cecum (~1mL) was centrifuged at room 
temperature for 10 minutes at 3,000 rpm to pellet all debris and any small contaminating 
molecules.  An aliquot was taken from all six ceca to determine the protein 
concentration using a BCA (Pierce).  A total concentration of 3mg protein was extracted 
for protein denaturation in 6M Guanidine and proteolytic digestions as follow.  For ceca 
2, 3, 7, 8, and 9 protein extractions, the guanidine concentration was diluted from 6M to 
1M with 50mM Tris buffer/10mM CaCl2 and proteolytic digestions initiated with 
sequencing grade trypsin (1/100, w/w; Promega) overnight at 37°C to digest proteins 
into peptides.  A second aliquot of trypsin was added (1/100) and incubated for 4 hours 
at room temperature. Samples were reduced to a final concentration of 10mM DTT.  
The complex peptide solution was desalted via C18 solid phase extraction, concentrated 
and filtered (0.45um filter).  For each LC-MS/MS analyses below, ~100mg of the total 
peptide sample was used for LC-MS/MS. 
4.2.3: LC-MS/MS analysis 
Peptides were loaded onto a two-dimensional (C18 and SCX) 15cm length column 
packed in-house and separated with a 12 step, multidimensional high-pressure liquid 
chromatographic elution method using an Ultimate HPLC system (Dionex, Sunnyvale, 
CA) consisting of eleven salt pulses followed by a 2 hr reverse-phase gradient from 
100% solvent A (A: 95% H2O, 5% acetonitrile, 0.1% formic acid) to 50% solvent B (B: 
30% H2O, 70% acetonitrile, 0.1% formic acid).  The HPLC system was coupled on-line 
with an LTQ-Orbitrap XL (Thermo Fischer Scientific) via the Proxeon nanospray source.   
Full MS scans were acquired in the Orbitrap mass analyzer (from 400-1700 m/z) with 
resolution 30,000 followed by five data dependent tandem MS/MS scans in the LTQ 
with normalized collision energy of 35%.  For all sequencing events, dynamic exclusion 
was enabled.   
4.2.4: Data analyses and informatics 
All MS/MS spectra were searched with the SEQUEST v 0.27 algorithm[66] and filtered 
with DTASelect/Contrast[98] at the peptide level [Xcorrs of at least 1.8 (+1), 2.5 (+2), 
3.5 (+3)] with a deltCN 0.08.  Only proteins identified with two fully tryptic peptides from 
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the 22 hr runs were considered for further biological inference.  Tandem MS/MS spectra 
were searched against a protein sequence database (Table 4.1) containing the 7 
relevant Bacteroides species (B. WH2, B. ovatus, B. vulgatus, B. thetaiotaomicron, B. 
caccae, and Parabacteroides distasonis) in addition to 8 distractor (non-relevant) 
species, the host (mouse) genome, diet components (rice and yeast), and common 
contaminants. 
Table 4.1: Protein sequence database composition for the 7-member database 
searches. Bolded genome names are relevant microbes that were gavaged in the 
gnotobiotic mice. 
 
Genome Proteins Size (MB)
Bacteroides caccae 3855 1.772
Bacteroides ovatus 5536 2.536
Bacteroides thetaiotaomicron 4778 2.376
Bacteroides uniformis 4663 1.952
Bacteroides vulgatus 4065 1.932
Bacteroides WH2 5244 2.656
Collinsella aerofaciens 2367 0.996
Clostridium scindens 3995 1.528
Clostridium spiroforme 2465 1.016
Dorea longicatena 2970 1.18
Eubacterium rectale 3631 1.42
Faecalibacterium prausnitzii_M212 3493 1.368
Parabacteroides distasonis 3850 1.86
Ruminococcus obeum 4175 1.536
Ruminococcus torques 2875 1.124
Mouse 34966 19.2
Yeast 6345 3.33
Rice 66710 36
Common contams 36 0.02
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4.3: Results and Discussion 
4.3.1: General MS-based proteome metrics  
As first demonstrated in chapter 3, MS-based proteomics for the human gut microbiome 
in gnotobiotic mice has proven successful and applicable to in vivo gut-derived 
ecosystems[37].  However, with increasing complexity and diversity of the microbial 
community(s) membership, traditional up-front sample processing methods were 
evaluated and optimized for increased depth and coverage of proteomes derived in situ 
from cecum.  All MS experiments were performed in duplicate for each method and 
demonstrated high technical reproducibility, with an R2 ≥ 0.9184 for all six ceca 
samples.  Using general MS-based proteomics metrics (i.e., assigned spectra and 
protein identifications), a comparison of all six samples and methods suggest that 
fractionation via ultracentrifugation and protein precipitation (TCA) of the soluble fraction 
provided the greatest identification of non-redundant spectra, peptides and proteins 
(Table 4.2).   Thus, the approach used for the ‘soluble fraction’ significantly improved 
the quantity of protein and peptide identifications with a 2.72X gain in protein 
identifications from, on average, 411 to 1,118 proteins and 2.925X gain in peptide 
identifications from, on average, 1,907 to 5,578 peptides per run.  Therefore, from this 
point on, we will only focus on using the protein precipitated soluble fraction to represent 
the soluble fraction of sample and method #7. 
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Table 4.2: Proteome sample metrics of total non-redundant protein, peptide and spectra 
counts per method. 
 
 
The results found in Table 4.2 demonstrate that method #7, ultracentrifugation 
and protein precipitation performed the best based on overall MS-based metrics with a 
total sum of, on average, 4,272 proteins (3,154 membrane and 1,118 soluble proteins 
per run).  However, these numbers can be misleading due to insufficient fraction purity 
and degree of protein overlap between the two fractions.  As described further below 
(Figure 4.2), a total of 3,118 and 521 proteins are unique to the membrane and soluble 
(protein precipitation) fractions, respectively, with 1,248 shared proteins for a total of 
4,887 non-redundant proteins.  Although method #7 (ultracentrifugation) significantly 
out-performs method #2 (without ultracentrifugation) and all other methods, a gain of 
only 521 proteins were uniquely identified from the soluble TCA fraction.  Following 
closely is the second best performing lysis method #10 with, on average, 3,068 
proteins, 10,574 peptides, and 21,121 spectra per run.  Of the physical disruption 
techniques (methods 2, 3 and 8), 8 and 3 (sonication and freeze-thaw, respectively) 
performed the best followed by #9 and #2 (guanidine only and bead-beating, 
respectively) which provided the least assigned spectra, peptide and protein 
identifications.   Because an equal quantity of tandem MS/MS spectra were acquired for 
each method and MS run, the variation in assigned spectra is not a reflection of the 
Sample Run Proteins Peptides Spectra PPMs (%) Method
1 3159 11675 23901 86.88
2 3149 11607 23338 86.99
4 1188 5961 14789 88.91
5 1047 5194 13220 88.94
1 424 1935 10331 87.7
2 398 1879 10709 88.6
1 3204 11162 20265 89.51
2 2931 9986 21976 89.63
1 2207 6874 16730 85.6
2 2079 6422 17107 85.79
1 2062 6470 16641 85.45
2 2178 6845 16467 86.29
3 1826 5416 11951 86.55
4 1834 5448 11380 87.43
2 1832 5908 13404 85.57
3 1728 5573 14175 86.889
Bead-beating; Ultracentrifugation; 
Guanidine
Bead-beating; Ultracentrifugation; TCA; 
Guanidine
7 (membrane)
7 (soluble)
10
8
2
3
Bead-beating, Ultracentrifugation; 
Guanidine
Boiling SDS; TCA; Urea
Sonication, Guanidine
Bead-beating, Guanidine
Freeze-Thaw, Guanidine
Guanidine only
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technical (mass spectrometer) variability, but rather a reflection of the lysis and protein 
extraction method. 
 
 
Figure 4.2: A comparison of identified proteins that are shared (1,248) between and 
unique to the membrane (left circle; 3,118 proteins) and soluble (TCA; right circle; 521 
proteins) fractions for method 7 only.  A total of 4,366 and 1,769 non-redundant proteins 
were indentified in the membrane and soluble (TCA) fraction, respectively.   
4.3.2: Protein-level comparison 
A four-way protein comparison of methods: 2 (bead-beating), 3 (freeze-thaw), 8 
(sonication), and 9 (no physical disruption) identified 1,972 shared proteins (~61-73% of 
all protein identifications) across all four methods, with 6-9% of all identified proteins 
unique to only one method (Figure 4.3).  A three-way protein comparison of methods 
containing physical disruption only (2, 3, and 8) identified 2,292 shared proteins (81%, 
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73%, and 71%, respectively, of all identified proteins) (Figure 4.4).   These two 
comparisons suggest that the methods 2, 3, 8, and 9 do not vary significantly from one 
another, since the majority of identified proteins are similar in one or more methods (i.e., 
only 6-9% of all identified proteins are unique to a single method).  On the other hand, 
these methods (with and without physical disruption) vary significantly from a method 
that uses a combination of chemical lysis (SDS) and physical disruption (sonication) 
simultaneously to lyse microbial and host cells, where only ≤ 48% of all identified 
proteins are shared with methods 2, 3, 8, and 9 and ≥ 30% are unique to method 10 
only (data not shown).  
 
 
Figure 4.3: A four-way comparison of identified proteins from four different methods: 2 
(bead-beating), 3 (freeze-thaw), 8 (sonication), and 9 (no physical disruption). 
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Figure 4.4: A three-way comparison of identified proteins from three methods 
containing physical disruption only (2, 3, and 8). 
For method 7, on average, 3,154 proteins were identified in the membrane 
fraction per run (Table 4.1) with a total of 4,366 non-redundant proteins across both 
runs.  On the other hand, an average of 1,118 and 411 proteins were identified per run 
for the soluble fraction with and without protein precipitation, respectively, for a total of 
1,769 and 676 non-redundant identified proteins.  As mentioned previously, a 
comparison of both fractions from method 7 indicated that 3,118 proteins were uniquely 
identified in the membrane fraction, as compared to 521 in the soluble fraction, with 
1,248 proteins shared between the two fractions.  Therefore, a total of 4,887 proteins 
were identified for method 7 (both membrane and soluble TCA fraction shared and 
unique proteins summed).   
Based on total spectra, peptides, and proteins identified, method # 7 (with protein 
precipitation) is the best overall performing method, with a total of 4,887 non-redundant 
proteins, followed by method # 10 with 4,495 non-redundant proteins.  Of all proteins 
identified, a two-way comparison of methods 7 and 10 indicate that 3,506 proteins are 
shared (72 and 78% of all identified proteins, respectively) with 1,381 and 989 proteins 
unique to methods 7 (28%) and 10 (22%), respectively (Figure 4.5).  While a significant 
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portion of identified proteins were found using both methods, method # 7 had ~40% 
more unique proteins relative to method 10.  Although method # 7 has out-performed 
the other four lysis methods, we wanted to determine whether any potential biases 
existed on a functional level as a result of each lysis and extraction method. Functional 
comparisons will be explored in more detail below. 
 
Figure 4.5: A comparison of identified proteins that are shared (3,506 proteins) between 
and unique to method 7 (membrane and soluble fractions combined; left circle) and 10 
(right circle). 
4.3.3: Comparison of methods based on protein-species assignments 
Due to the differences in lysis methods (i.e., chemical or physical), we wanted to 
evaluate whether any of the methods were biased and preferentially lyse one or more 
specific bacterial species within the 7-member consortium.  For example, does any 
method preferentially lyse one particular species better than another or enrich for 
proteins with specific functional roles, such as outer membrane receptor proteins?  A 
comparison of identified protein counts per species (Figure 4.6) suggested that the 
majority of proteins were derived from B. WH2 and B. thetaiotaomicron for all methods, 
with the exception of method 9 (guanidine only) and the soluble fractions (# 7).  
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Contrary to the majority of methods, B. thetaiotaomicron was one of the least abundant 
microbes in method # 9.  These results may suggest that additional chemical (SDS) 
and/or physical (i.e., sonication) disruption is necessary for the complete lysis of all 
Bacteroides.  Interestingly, M. musculus was the most abundant contributor based on 
protein counts followed by B. WH2 in both soluble fractions contrary to the membrane 
fraction for method 7.  
 
Figure 4.6: Distribution of identified protein counts for all relelvant database 
components (microbial and host) for all 7 cecal samples. 
Due to protein sequence redundancy between the seven-closely related 
Bacteroides phylotypes, a similar comparison was performed with only unique peptides 
(Figure 4.7) and total spectra counts (Figure 4.8) to determine whether similar trends 
were observed.  The distribution of unique peptides also suggest that B. WH2 and B. 
thetaiotaomicron are the most abundant microbial species for all methods, including 
method 9 (guanidine only), with the exception of both soluble fractions (# 7).  In 
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agreement with the protein count distribution, M. musculus was the most abundant 
based on unique peptide and spectra counts, followed by B. WH2 for both soluble 
fractions.   While the spectra counts distribution agrees with the protein and unique 
peptide distribution, slightly more spectra were assigned to B. thetaiotaomicron relative 
to B. WH2 for the majority of methods (exception are the soluble fractions). 
 
Figure 4.7: Distribution of unique peptide counts for all relevant database components 
(microbial and host) for all 7 cecal samples. 
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Figure 4.8: Distribution of total assigned spectra counts for all relevant database 
components (microbial and host) for all 7 cecal samples. 
Why the soluble fractions contain significantly more host-related (M. musculus) 
proteins, peptides, and assigned spectra relative to the membrane fraction and other 
methods (Figure 4.6-4.8) is unclear.  Although the unique peptide and protein counts 
agree with the majority of identifications belonging to B. WH2 and B. thetaiotaomicron 
for most of the methods, we have yet to determine why these two microbes dominate 
the community proteome relative to the other five species belonging to Bacteroides.  It 
may be that B. WH2 and B. thetaiotaomicron contain significantly more ‘unique’ 
peptides in the genome (predicted proteome) relative to the other microbes; hence, 
more unique peptides were identified for these two species.  Alternatively, there may be 
a biological (non-technical) difference between these two species relative to the other 
members of the consortium.  To assess whether a subset of proteins related to a 
specific function are enriched in one method compared to the others, we classified the 
identified proteins in Clusters of Orthologous Groups (COGs). Figure 4.9 indicated that 
P.#distasonis#
B.#uniformis#
B.#caccae#
B.#ovatus#
B.#vulgatus#
M.#musculus#
B.#thetaiotaomicron#
B.#WH2#
0#
2000#
4000#
6000#
8000#
10000#
12000#
14000#
2# 3# 8# 9#
10
#
7#(
so
lub
le)
#
7#(
so
lub
le#
TC
A)#
7#(
me
mb
ran
e)#
To
ta
l&S
pe
ct
ra
&C
ou
nt
&
Method&
	   81	  
we are not enriching for specific functional subsets of proteins with any particular 
method.  However, proteins classified with functions related to translation and metabolic 
pathways commonly involved in the gastrointestinal tract were highly abundant across 
all six methods.  Therefore, while differences are evident between the types of COGs 
present in the proteomes, there are insignificant biases in the methods’ enriching for 
specific functional groups of proteins.  Although method # 7 identified more proteins 
relative to the other five methods, Figure 4.10 (A and B) suggests that methods 7 and 
10 provide very similar results in terms of identified protein COGs.  In conclusion, while 
method # 7 has the overall best performance for proteome identification relative to the 
other methods, method 10 may be equally sufficient in the in situ lysis of microbial 
communities derived from the cecum of mice, with the advantage of less sample 
handling, fewer surface exposures, less time-consuming, and does not require 
additional expensive instrumentation (i.e., ultracentrifuge). 
 
Figure 4.9: COG classification of all identified proteins for all cecal samples. 
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Figure 4.10: Distribution of identified proteins for (A) method 7 (membrane and soluble 
TCA fraction combined) and (B) compared to method 10 based on COG categories. 
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Figure 4.10 (B) 
 
4.4: Conclusions 
The method that demonstrated the greatest performance for the lysis and extraction of 
microbial and host (mouse) proteins from a model 7-member human microbial gut 
community is bead-beating homogenization, ultracentrifugation, and protein 
precipitation of the soluble fraction with a total of 4,887 non-redundant proteins.  
Although this method performed the best based on overall MS-based proteome metrics, 
the soluble fraction (TCA) only contributed 521 unique proteins.  Method #10 (lysis via 
SDS solubuilization and sonication) followed closely with a total of 4,495 non-redundant 
proteins and may be more successful for some research groups whom do not have 
access to an ultracentrifuge.   
Based on the host and microbial protein, unique peptide, and spectra count 
distributions per species, the abundance-levels were not evenly distributed among all 
seven phylotypes of Bacteroides and the host, but rather skewed with a higher 
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abundance of B. WH2 and B. thetaiotaomicron in all six methods with the exception of 
the soluble fraction in method 7.  We believe that this is not a reflection of technical or 
instrumental variation, but is a result of the microbial community dynamics and 
functional signature differences because the abundance-level trends are very similar 
across all lysis and protein extraction methods.  A classification of all microbial proteins 
by general function (e.g., COG) suggests that all six methods provide very similar 
functional trends with translation and metabolic pathways highly abundant across all 
methods.  Therefore, the five different methods described in this study are not biased 
and do not preferentially lyse one species or functional group (COG) more efficiently 
relative to others within the 7-member consortium.  
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Chapter 5 
Temporal profiling of a defined 12-member human gut microbial community in 
gnotobiotic mice in response to changing diets 
Alison R. Erickson, Nathan P. McNulty, Nathan C. VerBerkmoes, Jeffrey I. Gordon, 
Robert L. Hettich 
5.1: Introduction 
The human gut microbiome is host to a large population of microbes that heavily rely 
upon the host (human) and diet for maintenance and growth.  It is the microbial 
inhabitants that shape the establishment, diversity, and stability of the host-associated 
microbial community.  While the phylogenetic composition and membership differs 
between human individuals[62], [112], gut microbiomes are functionally very 
similar[112].  Although host genetics accounts for a small fraction of the variation 
observed between human individuals[147] and mice[148], studies have indicated that 
environmental conditions (e.g., diet) and stochastic factors affect the relative 
abundances of microbes in the gut community of both humans and 
mice[149,150,151,152].  As our diets have evolved over time, from a starch-rich diet to 
high-starch plant and dairy foods)[153], the host and gut microbiota subsequently 
adapted by competing for dietary substrates.  For example, the modern Western diet, 
low in complex carbohydrates but high in simple sugars and fat, has shown a relatively 
higher abundance of Firmicutes[131,154] relative to other phyla.  As a result, the host 
selects for simple carbohydrates while the microbes consume and degrade complex 
polysaccharides (e.g., starch).  To understand the interrelationship between the host-gut 
microbiota and diet, studies have focused on using gnotobiotic mice inoculated with a 
defined quantity of sequenced human gut bacteria and monitored their response to diet 
perturbations[155]. 
We have demonstrated effective proteomic methods for binary microbial 
communities and optimized the MS-based sample preparation methodology such that 
we are ready to scale up to more complex, interactive systems.  Here, we used high 
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resolution MS-based proteomics to evaluate the functional differences and estimate the 
relative abundance of closely-related species within a defined microbial community in 
gnotobiotic mice in response to diet perturbations.  An in vivo model microbial 
community was designed at Wash. Univ. to represent the diversity in the human gut and 
was comprised of 12 human gut-derived phylotypes belonging to the Firmicutes, 
Bacteroidetes, and Actinobacteria.  The microbial consortium consisted of the same 
seven phylotypes used in the 7-member consortium (Bacteroides caccae, B. ovatus, B. 
uniformis, B. WH2, B. thetaiotaomicron, B. vulgatus, and Parabacteroides distasonis) in 
addition to four Firmicutes (Dorea longicatenta, Ruminococcus obeum, Clostridium 
spiroforme, and C. scindens) and one Actinobacteria (Collinsella aerofaciens).  The 
gnotobioic mice and their 12-member consortium were exposed to two diet oscillation 
perturbations for which several mice initially consumed a high fat and simple sugar diet 
(‘western’ diet) and others consumed a standard BK diet.  Expression profiling of the 12-
member endpoint communities was performed using transcriptomics and MS-based 
proteomics to explore community robustness and system-wide microbial responses in 
the context of dietary disturbances.  We wanted to gain insight into the communities’ 
establishment, assembly, and adaption prior to and after a change in diet (Figure 5.1).  
Additionally, we wanted to investigate to what extent we can characterize the function of 
entire defined communities with significant dynamic range between species at the level 
of both transcription and protein expression.   
There are several challenges associated with the 12-member consortium, (i) the 
Actinobacteria and Firmicutes are not as abundant as the Bacteroides in these samples 
(0.5-2.0% of the community), which complicates the ability to achieve complete 
proteome coverage of the lesser abundant species and (ii) an increased number of 
degenerate peptides (peptides that match to multiple proteins due to sequence overlap) 
and protein redundancy.  The GeneChip expression data was also used to compare the 
protein abundance data to determine how well these methodologies agree and disagree 
in their revelation of the microbiotas’ functional signature and differences in response to 
diet. 
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A challenge in mass spectrometry-based proteomics is the ability to accurately 
assign a PSM to the protein from which it originated.  When studying microbial 
communities, this assignment is complicated by homology between proteins of different 
microbial strains/species.  In several environmental communities, the majority of 
identified PSMs are non-unique, and spectral counting may not be sufficient to estimate 
a protein’s abundance and concomitant phylogenetic origin.  Thus, with increasing 
complexity and microbial composition, differentiation of closely-related species 
compared to species that are more evolutionarily divergent becomes challenging for 
mass spectrometry.  Although proteomics is not the preferred method to evaluate the 
abundance of species or to differentiate between species, the use of either unique 
peptide counts or total spectra counts with the total number of identified proteins (per 
species) have been evaluated for their ability to differentiate and estimate the relative 
abundance of each species on a proteome level.  
5.2: Experimental Methods 
Adult germ-free mice were gavaged with: Bacteroides thetaiotaomicron, B. caccae, B. 
ovatus, B. uniformis, B. vulgatus, B. WH2, Parabacteroides distasonis, Clostridium 
scindens, C. spiroforme, Ruminococcus obeum, Dorea longicatena, and Collinsella 
aerofaciens.  Proteins were extracted from the cecum of four gnotobiotic mice fed a diet 
rich in plant polysaccharides (BK diet) or a ‘Western’ diet high in fat and sugars.   
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Figure 5.1: Experimental setup and example of sample collection timepoints for host-
microbial community diet oscillations.  Fecal and cecal collections were used for 
GeneChip expression experiments.  Cecal collections were also used for MS 
experiments. 
5.2.1: Sample preparation 
Cecal contents were collected from four mice and analyzed via nano-2D (strong cation 
exchange – reverse phase)-LC-MS/MS on a hybrid LTQ – Orbitrap Velos mass 
spectrometer (Thermo Fisher Scientific).  Cecal contents were solubilized in 1mL SDS 
lysis buffer (4% w/v SDS, 100mM Tris•HCl, pH 8.0, 10mM dithiothreitol (DTT)) and 
lysed mechanically by sonication followed by incubation for 5min at 95°C.  Cells were 
centrifuged at 21,000xg.  Following an overnight tricholoacetic acid (TCA) precipitation, 
the TCA precipitates (protein mixtures) were resolubilized in 500uL of 8M urea, 100mM 
Tris•HCl, pH 8.0, and reduced by incubation at a final concentration of 10mM DTT for 1 
hr at room temperature.  Samples were sonicated and an aliquot taken to determine the 
protein concentration using the widely available bicinchonic acid-(BCA) based protein 
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assay kit (Pierce).  Samples were diluted with 100mM Tris•HCl, 10mM CaCl2, pH 8.0 to 
a final urea concentration below 4M.  Proteolytic digestions were initiated with 
sequencing grade trypsin (1/100, w/w; Promega) overnight at room temperature.  A 
second aliquot of trypsin was added (1/100) and diluted with 100mM Tris•HCl, pH 8.0 to 
a final urea concentration below 2M.  Following a 4 hr incubation at room temperature, 
samples were reduced to a final concentration of 10mM DTT.  The peptides were 
acidified (protonated) in 200mM NaCl, 0.1% formic acid, filtered, and concentrated with 
a 10k molecular weight cutoff spin column (Sartorius).   
5.2.2: LC-MS/MS data collection and analyses 
Peptide mixtures were desalted and separated utilizing a split phase 2D-LC column 
(SCX-C18) over a 12-step gradient with 22 hr runs per sample.  All MS analyses were 
performed in positive ion mode.  One full MS scan was acquired in the Orbitrap Velos at 
30K resolution followed by ten data-dependent MS/MS scans (m/z 400-1700) at 35% 
normalized collision energy with dynamic exclusion enabled at 1.  The data was 
searched using SEQUEST against a database containing the following predicted 
proteomes to be encoded by the genomes of the 12-member community:  Bacteroides 
caccae, B. ovatus, B. thetaiotaomicron, B. uniformis, B. vulgatus, B. WH2, Clostridium 
scindens, C. spiroforme, Collinsella aerofaciens, Dorea longicatena, Parabacteroides 
distasonis, and Ruminococcus obeum in addition to potential food components (e.g., 
rice and yeast) and common contaminants (e.g., keratins).  Additionally, Eubacterium 
rectale, Faecalibacterium prausnitzii M212 and R. torques were included as distractors 
that were not expected to be present.  The SEQUEST settings were the following: 
enzyme type, trypsin; parent mass tolerance, 3.0; fragment mass tolerance, 0.5; up to 4 
missed cleavages, and fully tryptic peptides only.  All datasets were filtered with 
DTASelect, parameters included: Xcorrs of 1.8, 2.5, and 3.5 for singly, doubly, and triply 
charged precursor ions, minimum deltCN of 0.08, and a minimum requirement of two 
fully tryptic peptides per protein.  An in silico tryptic digested protein sequence database 
was used to generate a theoretical peptidome of unique peptides within a mass range of 
600-4,890Da and ≤1 miscleavages. 
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Spectral normalization by community and individual species was generated with 
the help of Chongle Pan in which the p value is calculated using the Mann–Whitney U 
test (non-parametric version of t test). The spectral count difference is the difference 
between the median spectral counts of the two diets. A protein is labeled as "UP" 
regulated if the p value is less than 0.05 and the spectral count different is greater than 
5 and equally for proteins are labeled as "DOWN.” 
5.3: Results and Discussion 
5.3.1: Overview of proteome metrics 
The proteomes displayed high technical reproducibility in terms of total number of 
assigned spectra per mouse with an R2 ≥ 0.9883 for all four mice.  The BK-fed mice 
proteomes were highly correlated with an R2 of 0.9059 for mouse 1 and 2, as compared 
to the Western-fed mice with R2 0.7815 for mouse 9 and 12.  This would suggest that 
the variation in the western fed mice is a reflection of biological variability and is not a 
result of technical deviation (i.e., mass spectrometer and HPLC effects).  On average, a 
total of 4,827 and 3,251 proteins were identified for the BK diet and Western diet, 
respectively (Table 5.1).  Of all proteins identified in the BK-fed mice, 4,220 proteins 
were found across both mice (1 and 2) and all four MS runs.  Of all identified proteins in 
the Western-fed mice, ~2,658 proteins were identified across both mice (9 and 12) and 
all four MS runs.  However, when both diets are directly compared, only ~1,824 
microbial and host proteins were identified across both diets where 2,322 proteins were 
unique to the BK diet and 805 proteins unique to the western diet (Figure 5.2).  Upon 
accumulation of all identified proteins from both diets and all MS runs, ~2-20% of each 
species’ genome was identified (Table 5.2) with the majority of proteins identified from 
B. WH2 (20%) and the least from C. spiroforme (2%).  Although the phylotypes 
belonging to Bacteroides collectively had higher proteome coverage in terms of non-
redundant protein identifications (>11%) compared to the Firmicutes and Actinobacteria 
in this study (<8%), the range of abundance varies between the two different diets.   
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Table 5.1: Overall MS metrics for the BK and western diet fed mice. 
 
 
 
Figure 5.2: Comparison of shared and unique microbial and host identified proteins 
across both diets with proteins unique to the BK diet (left; 2,322 proteins), shared 
proteins (center; 1,824 proteins) and proteins unique to the Western diet (right; 805 
proteins). 
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Table 5.2: Relevant database components and % of each species’ genome identified via MS-based proteomics. 
 
Genome Acroynmn Predicted.Proteins Identified.Proteins %.of.Predicted.Proteome.Identified
Proteins.identified.
in.BK.diet
Proteins.identified.
in.Western.diet
#.of.statistically.
differential.proteins
%.of.Total.Identified.
Proteome.per.Species
%.of.Total.BK<Identified.
Proteome.per.Species
#.of.statistically.
differential.proteins
%.of.Total.Identified.
Proteome.per.Species
%.of.Total.Western<Identified.
Proteome.per.Species
Bacteroides+caccae BACCAC 3855 669 17.35% 594 362 148 22% 25% 65 10% 18%
Bacteroides+ovatus BACOVA 5536 693 12.52% 667 277 176 25% 26% 16 2% 6%
Bacteroides+thetaiotaomicron BACTHE 4778 722 15.11% 660 343 164 23% 25% 52 7% 15%
Bacteroides+uniformis BACUNI 4663 563 12.07% 550 204 160 28% 29% 9 2% 4%
Bacteroides+vulgatus BACVUL 4065 783 19.26% 755 357 244 31% 32% 20 3% 6%
Bacteroides+WH2 BACWH2 5244 1025 19.55% 996 353 339 33% 34% 24 2% 7%
Clostridium+scindens CLOSCI 3995 220 5.51% 105 203 1 0% 1% 82 37% 40%
Clostridium+spiroforme CLOSPI 2465 39 1.58% 18 32 0 0% 0% 4 10% 13%
Collinsella+aerofaciens COLAER 2367 154 6.51% 124 101 2 1% 2% 6 4% 6%
Dorea+longicatena DORLON 2970 114 3.84% 76 91 0 0% 0% 22 19% 24%
Parabacteroides+distasonis PARDIS 3850 414 10.75% 405 118 87 21% 21% 4 1% 3%
Ruminococcus+obeum RUMOBE 4175 325 7.78% 291 231 7 2% 2% 12 4% 5%
Mus+musculus Mus 34966 881 2.52% 575 698 41 5% 7% 203 23% 29%
Relevant.Database.Components
BK.fed.mice Western.diet.fed.mice
Community<wide.analysis.and.significantly.differential.proteins.with.preference.for.one.dietTotal.Protein.Identifcations
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5.3.2: Peptidome Comparisons 
Several quantitative metrics were evaluated for their ability to differentiate and estimate 
the abundance of closely-related and divergent microbial species within a defined 
human gut consortium.  Three quantitative methods that use spectra counts only, 
spectra and protein counts, or unique peptides to estimate species abundance were 
compared to GeneChip expression data from the same samples.  All three quantitative 
methods suggest the Bacteroides phylotypes are significantly more abundant in mice 
consuming the plant polysaccharide-rich diet.  More specifically, the unique peptide 
quantitative metric indicated that B. caccae was significantly more abundant in the 
western diet, in agreement with the GeneChip expression data.  A phylotype’s 
estimated abundance based on unique identified peptides, however, may be affected by 
the proportion of unique predicted peptides assignable to that phylotype in the 
database.   
A method that estimates abundance via identified unique peptides may be biased 
and skewed by the degree of predicted unique peptides in the sequence database.  For 
example, more unique peptides belonging to Bacteroides WH2 may be present because 
there are more unique peptides in the database relative to the other species.  To 
address this potential bias, a “theoretical peptidome” was created for each species (12 
relevant species and 3 unrelated distractor species) in the sequence database with an 
in silico peptide digest that takes into account (i) tryptic miscleavages (0-4) and (ii) the 
standard peptide mass range that can be experimentally detected.  A “theoretical 
peptidome” provides the ability to compare the identified peptidome (both unique and 
non-unique peptides per species) to the predicted (theoretical) peptidome to determine 
what percentage of each species is unique relative to all of the other species within the 
entire consortium.  By comparing the percentage of each species’ predicted unique 
peptidome to the identified peptidome, you could determine whether (i) the closely-
related species (i.e., Bacteroides) are contributing any unique peptides to the entire 
predicted peptidome and (ii) whether the identified unique peptides are following the 
same trends as the predicted peptidome.   
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To generate a theoretical peptidome, several parameters (miscleavages and 
peptide mass range) were first compared for the identified peptide results prior to their 
application of the sequence database (15 microbial genomes, mouse, rice and yeast 
genomes, and common contaminants) used in this study.  The majority of 
experimentally identified peptide sequences fell within 0-1 miscleavages (94%; Table 
5.3) and a mass range of 600-4,890 Da.  Based on this data, the theoretical peptidome 
was generated in silico with the same filters for the entire protein sequence database at 
≤1 miscleaveage.   
Table 5.3: Proportion of total non-redundant identified peptides for all mice with 0, 1, 2, 
3 or 4 miscleavages. 
 
Although the mouse and diet genomes contributed the majority of unique 
predicted peptides (20.44%-34.57%), all twelve phylotypes (including closely-related 
species) contributed comparable percentages of unique peptides (~2-4%) to the entire 
unique peptidome (Table 5.4) with B. WH2 containing the majority of unique predicted 
peptides of the human-derived bacteria.  Within each individual species, ~61-89% of all 
predicted peptides are classified as “unique” (Table 5.4).  This would suggest that 
although there is significant genome sequence overlap, this is does not equate on a 
peptide level since the majority of tryptic peptides are unique per species.  Significantly, 
89% of all peptides belonging to the single species (C. aerofaciens) of Actinobacteria 
are unique, whereas only ~61-79% of peptides belonging to the majority of Bacteroides 
are unique within this protein sequence database. 
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Table 5.4: Distribution of total predicted peptides (unique and non-unique) for the 
protein sequence database with ≤1 miscleavage. 
 
While B. WH2, B. ovatus, P. distasonis, and B. thetaiotaomicron are the most 
abundant phylotypes based on the representation of unique predicted peptides in the 
theoretical peptidome, experimental phylotype abundance estimated using unique 
identified peptides did not follow this same trend (Figure 5.3).  Instead, B. WH2, B. 
vulgatus, R. obeum, B. caccae, and C. scindens are most abundant in the ‘Western’ 
diet.  Although there is significant sequence overlap in the microbiota, less sequence 
overlap exists on a peptidome level, suggesting that a unique peptide quantitative 
metric, rather than spectra counts, can be used to quantitate the relative abundance of 
species and proteins in microbial communities with varying ranges of diversity.  In 
addition, the expression data, provided by Jeff Gordon’s group, indicates that B. ovatus 
and B. WH2 have a strong preference for the BK diet while B. caccae prefers the 
western diet.  Unlike the spectra and protein counts metric, the unique peptide counts’ 
distribution strongly supports the genechip expression data.   
Species Non-Unique % Non-Unique Unique % Unique Total
% Total of Total 
DB peptides
% Unique of Total 
DB peptides
% Unique of Total 
DB unique peptides #Proteins Size (MB)
Rice 2,733,343 56.35% 2,117,393 43.65% 4,850,736 44.86% 19.58% 34.57% 66,710 36.00
Mouse 1,174,515 48.40% 1,252,078 51.60% 2,426,593 22.44% 11.58% 20.44% 34,966 19.20
Yeast 64,216 13.40% 414,911 86.60% 479,127 4.43% 3.84% 6.77% 6,345 3.33
B. WH2 71,238 20.96% 268,594 79.04% 339,832 3.14% 2.48% 4.39% 5,244 2.66
B. ovatus 105,322 33.19% 211,964 66.81% 317,286 2.93% 1.96% 3.46% 5,536 2.54
P. distasonis 29,795 12.83% 202,464 87.17% 232,259 2.15% 1.87% 3.31% 3,850 1.86
B. thetaiotaomicron 101,982 34.06% 197,434 65.94% 299,416 2.77% 1.83% 3.22% 4,778 2.38
B. vulgatus 58,625 23.66% 189,181 76.34% 247,806 2.29% 1.75% 3.09% 4,065 1.93
B. uniformis 70,619 30.25% 162,806 69.75% 233,425 2.16% 1.51% 2.66% 4,663 1.95
R. obeum 26,276 14.96% 149,371 85.04% 175,647 1.62% 1.38% 2.44% 4,175 1.54
C. scindens 32,174 18.16% 144,987 81.84% 177,161 1.64% 1.34% 2.37% 3,995 1.53
E. rectale 26,300 15.80% 140,179 84.20% 166,479 1.54% 1.30% 2.29% 3,631 1.42
B. caccae 87,509 39.39% 134,675 60.61% 222,184 2.05% 1.25% 2.20% 3,855 1.77
F. prausnitzii M212 20,667 14.55% 121,341 85.45% 142,008 1.31% 1.12% 1.98% 3,493 1.37
D. longicatena 29,210 20.72% 111,738 79.28% 140,948 1.30% 1.03% 1.82% 2,970 1.18
R. torques 25,607 18.95% 109,523 81.05% 135,130 1.25% 1.01% 1.79% 2,875 1.12
C. spiroforme 18,658 15.44% 102,145 84.56% 120,803 1.12% 0.94% 1.67% 2,465 1.02
C. aerofaciens 11,628 11.11% 93,021 88.89% 104,649 0.97% 0.86% 1.52% 2,367 1.00
Contaminants 1,026 43.24% 1,347 56.76% 2,373 0.02% 0.01% 0.02% 36 0.02
Sequence Database: 1 Miscleavage; Peptide Mass Range: 600-4,890 Da
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Figure 5.3: Theoretical and experimental unique peptidome comparison per database 
component (genome) for the BK and Western-fed mice.  The % of unique peptides 
(predicted or identified) out of the total (unique and non-unique) peptides plotted for 
each database component. 
Finally, the predicted unique peptidome was compared to the experimentally 
identified unique peptidome distribution to identify which microbes are hurt most by 
proteome overlap with the other community members.  Although B. WH2 is the most 
abundant species followed by B. ovatus, B. thetaiotaomicron, and B. vulgatus based on 
predicted unique peptides, the western diet fed mice did not follow this same trend.  
Comparing the ratio of identified unique peptides to total predicted unique peptides per 
species, B. caccae and C. scindens continue to be the most abundant microbes in the 
western diet fed mice and are more abundant than in the BK fed mice.  Based on these 
results, our unique peptide data is not skewed by the sequence database and this 
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‘theoretical peptidome’ provides additional support for evaluating the relative distribution 
and abundance of species using MS proteomic data.   
5.3.3: Community-wide functional comparisons 
To understand to what extent we can monitor shifts in the community proteome in 
response to a diet change, we began by looking at the community as a one functional 
entity.  Within the community, all of the Bacteroides phylotypes are more abundant in 
the BK diet compared to the Western diet, with the exception of B. caccae, which is 
approximately proportional across all samples and runs, using the sum of normalized 
spectra counts (Figure 5.4).  C. scindens, on the other hand, is more abundant in the 
Western-fed mice.  This would suggest that although some species, e.g., C. scindens 
are at very low abundance based on total proteome coverage, they still contribute 
significantly to the pool of proteins and shift in response to diet.  In addition, several 
statistically differential abundant proteins were identified with higher abundance 
(preference) for one diet relative to the other.  Out of all the proteins identified within the 
12-member consortium, ~21-33% of the Bacteroides phylotypes’ identified proteins 
were identified with higher abundance in the BK diet relative to the western diet (p-value 
≤0.03).  Of the identified BK diet-only proteomes, B. WH2 and B. vulgatus expressed 
the majority of differentially abundant proteins with a preference for the BK diet (34% 
and 32%, respectively).  On the other hand, ~40% and 29% of all proteins identified as 
derived from C. scindens and Mus musculus, respectively, were significantly more 
abundant in the Western-fed mice (Table 5.2) compared to the BK diet (1% and 5%, 
respectively). 
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Figure 5.4: Community-wide normalized spectra counts for the host and relevant 
microbial proteins per MS run for both diets. 
Classification of all identified microbial proteins by Clusters of Orthologous 
Groups (COG) for the two diets indicate that proteins involved in critical gut-associated 
functions, e.g., carbohydrate metabolism and energy production, are highly abundant 
across all mice regardless of diet based on normalized spectra counts (technical 
replicates average and biological replicates summed) (Figure 5.5).  This would suggest 
that the microbial community members are actively working together to carryout vital 
metabolic functions necessary for host-microbiota gut homeostasis.  Interesting, many 
poorly characterized proteins (proteins with unknown function) are highly abundant 
across both communities and diets, with ~800 and 400 hypothetical proteins identified in 
the BK and Western-fed mice, respectively, suggesting that the gut microbiota encode 
beneficial, yet many unknown functions across both communities.  On the other hand, 
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translation was less represented in the Western-fed mice and protein functions related 
to cellular processes that include DNA replication, chromatin and nuclear structure, and 
RNA processing were not active in either diet.   
 
Figure 5.5: Classification of all differentially abundant proteins by COGs for both diets. 
The classification of differentially abundant proteins by COGs suggests that 
many of the over-abundant proteins are also involved in similar key functions in the BK 
diet (carbohydrate and amino acid metabolism, and energy production (Figure 5.6)); 
however, translation-related proteins are statistically less abundant (down-regulated) in 
the Western-diet relative to the BK diet (Figure 5.7).  While translation is present and 
active across all mice, many essential proteins associated with mRNA translation and 
its machinery: aminoacyl tRNA synthetases, ribosomes, and translation initiation and 
elongation factors are less abundant in the Western diet.  Of the 13 over-abundant 
aminoacyl tRNA synthetases identified, all 13 are derived from phylotypes belonging to 
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Bacteroides.  As a result of dietary protein deficiency or diet disturbances, protein 
synthesis by Bacteroides phylotypes may be suppressed in the western diet because 
they are growing slower since the diet does not contain the same level of nutrients that 
are needed by these species.  On the contrary, of the 19 translation-associated proteins 
that are over-abundant in the Western diet, the majority (16) belong to C. scindens.  Of 
the 332 microbial proteins identified with over-abundance in the Western diet, 16% (82 
proteins) are derived from C. scindens and 39% from M. musculus.  These findings 
suggest that the C. scindens and the host may be acting to provide one or several 
unique protein functions in the Western-fed mice that are not acquired or significantly 
active in the microbiota of the BK-fed mice.  Further investigation of these individual 
microbes (B. WH2 and C. scindens), their differences, and general role in the 
community is provided under ‘species-level functional comparisons.’ 
 
Figure 5.6: Statistically over-abundant proteins based on COG assignments in the BK 
diet relative to the Western diet. 
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Figure 5.7: Statistically over-abundant proteins based on COG assignments in the 
Western diet relative to the BK diet. 
While a similar number of proteins were identified and classified as ‘inorganic ion 
metabolism’ for both diets (225 and 144 proteins for BK and Western diet, respectively), 
the abundance of these proteins varies with higher abundance in the Western-fed mice.   
The majority of proteins classified as involved in inorganic ion metabolism belongs to 
phylotypes of Bacteroides and serve as outer membrane receptor proteins and 
superoxide dismutase.  Of those with significantly higher abundance for the Western 
diet were outer membrane receptors of B. caccae with a preference for iron, 
ferrienterochelin and colicins.  On the contrary, B. WH2 identified outer membrane 
receptors associated with iron transport were significantly more abundant in the BK-fed 
mice.  Although inorganic ion transport and metabolism is active and represented 
across both communities, these results may suggest that B. caccae and B. WH2 may 
be overcompensating or primarily responsible for iron transport relative to the other 
Bacteroides phylotypes in the Western and BK-fed mice, respectively. 
Due to protein sequence redundancy between closely-related species, 
statistically high abundance microbial proteins were clustered (UCLUST v2.1.) via 
sequence identity to group proteins with ≥97% sequence identity.  Following clustering 
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analysis of the statistically differentiated microbial proteins, the total number of over-
abundant proteins in the BK fed mice reduced from 1,330 proteins to 1,092 protein 
clusters and from 332 proteins to 303 clusters in the Western fed mice.  Many of these 
protein clusters were related to similar functions described previously confirming a lack 
of translation-related protein abundance when exposed to a western fed diet relative to 
a high protein BK diet.   
5.3.4: Species-level functional comparisons 
While the community-wide analyses provide a broad functional understanding of the 
microbiota collectively, in order to directly compare the abundance levels of specific 
proteins of interest, it was necessary to evaluate the proteomes of each microbe within 
the 12-member community individually.  In addition, by using a species-level approach, 
we can determine whether one species up- or down-regulates gene(s) in a specific 
pathway in response to the host’s diet. 
Based on the community-wide proteome analyses (Figure 5.4 and Figure 5.8) 
and GeneChip expression data, B. WH2 has a strong preference for the BK diet.  
However, why such significant abundance differences exist and the significant 
functional role of B. WH2 in the BK-fed mice relative to the other microbial proteomes is 
unclear.  Of the 1,025 B. WH2 identified proteins, 269 were statistically differentiated, 
with 199 significantly more abundant in the BK-fed mice.  The majority of these proteins 
(199) were classified with functions related to carbohydrate metabolism, amino acid 
metabolism, translation or hypothetical proteins.  On the other hand, the B. WH2 
proteins that had a preference (up-regulated) for the Western diet were related to 
inorganic ion transport, coenzyme transport, carbohydrate metabolism, and hypothetical 
proteins.  Coenzyme metabolism related proteins included an outer membrane 
cobalamin receptor, 7-keto-8-aminopelargonate synthetase, and phosphoserine 
aminotransferase that were significantly more abundant in the Western-fed mice (p 
value<0.03 and difference of 52-84 spectra).  Inorganic ion metabolism related proteins 
include superoxide dismutase and outer membrane receptors for ferrienterochelin and 
colicins (p value<0.03 and difference of 17-280 spectra).   
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Figure 5.8: B. WH2 (only) total identified proteins’ distribution based on COG categories 
for both diets. 
Due to the significant abundance of B. WH2 relative to the other 12 phylotypes 
(Figure 5.9 and Figure 5.10), is B. WH2 performing differently from the other 
Bacteroides that might explain its dominance?  After comparing each of the Bacteriodes 
phylotypes individually for each diet, carbohydrate metabolism, outer membrane-related 
proteins, and signal transduction were identified as being dominated by B. WH2 
proteins while, for example, translation is relatively proportional amongst all of the 
phylotypes (Figure 5.10).  The proteomic data may suggest that B. WH2 expresses a 
larger proportion of proteins that are involved in carbohydrate metabolism and signal 
transduction relative to the other Bacteroides phylotypes in the BK diet.  In addition, a 
significant portion of B. WH2 identified proteins were annotated as ‘unknown function.’  
In the Western-fed mice, B. WH2 identified proteins are not as functionally different from 
the other Bacteroides phylotypes (Figure 5.11 and Figure 5.12) compared to the BK-
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fed mice.  This may suggest that most members of the Bacteroides phylotypes are able 
to cooperate and function individually with respect to the host and Western diet whereas 
the BK-fed mice are heavily dependent upon B. WH2 to process certain biological 
functions.  Further investigation (ie, KEGG pathway analysis) would help reveal whether 
B. WH2 is responsible for processing specific pathways within these broad functional 
terms relative to the other phylotypes. 
 
Figure 5.9: Distribution of protein counts per COG category for each phylotype of 
Bacteroides for the BK-fed mice. 
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Figure 5.10: Distribution of identified protein counts per COG category for all 12 
phylotypes in the BK-fed mice. 
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Figure 5.11: Distribution of protein counts per COG category for each phylotypes of 
Bacteroides for the Western-fed mice. 
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Figure 5.12: Distribution of protein counts per COG category for all 12 phylotypes for 
the Western-fed mice. 
Compared to BK-fed mice, C. scindens was identified with higher abundance in 
the Western-fed mice (Figure 5.4 and Figure 5.13).  A significant portion of the 
Western-fed C. scindens proteome is involved in translation followed by carbohydrate 
metabolism.  Of the 220 C. scindens identified proteins, 36 were statistically 
differentiated, with the majority (25) being significantly over-abundant in the Western-fed 
mice.  These proteins were classified with functions in carbohydrate metabolism and 
energy production.  For example, the C. scindens ABC-type sugar transport system was 
identified with over-abundance in the Western-fed mice compared to the BK-fed mice.   
Due to differences in the dietary components, the increased abundance of C. scindens 
may be a result of their ability to grow more efficiently on sugar compared to the other 
phylotypes in mice that are fed a diet rich in fat and sugar.  The community-wide and 
individual species-level proteomic data both indicate that translation is significantly more 
abundant in the Bacteriodes phylotypes of BK-fed mice whereas particular proteins 
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involved in inorganic ion and carbohydrate metabolism and transport are more 
abundant in the Western-fed mice based on protein and/or normalized spectra counts. 
 
Figure 5.13: C. scindens (only) total identified proteins’ distribution based on COG 
categories for both diets. 
5.4: Conclusions 
Based on all of the collective analyses, shotgun proteomics methods is quite effective 
for complex consortia comprising species that share a great deal of gene content and 
should be expandable to larger, more complex communities.   In this study, we 
compared the functional differences and estimated the relative abundance of closely-
related species within a 12-member model consortium of phylotypes belonging to 
Bacteroides, Firmicutes, and Actinobacteria.  The microbial community proteomes were 
evaluated by (i) community-wide normalization (i.e., community-wide response) and (ii) 
normalization per individual species in response to diet perturbations and (iii) the 
prediction (theoretical peptidome) and identification of unique peptides as a method for 
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the relative estimation of species abundance with significant dynamic range.  These 
analyses suggested that the community structure is dictated by the host’s diet (i.e., diet 
is shaping overall community structure). 
In conclusion, B. WH2 is highly abundant across proteomes in both diets, but is a 
strong diet responder with a preference for the BK diet.  B. caccae and C. scindens, on 
the other hand, are strong diet responders with a preference for the Western diet in 
agreement with the GeneChip expression data.  We would hypothesize that either (i) C. 
scindens and B. caccae both may directly benefit from one or more compounds in 
Western diet (e.g., they share some common traits/preferences with respect to 
metabolic niches) or (ii) other species in the community that normally strongly compete 
with C. scindens and B. caccae are at a disadvantage in the Western diet where their 
loss is these two species' gain.  To confirm either or additional hypotheses, further 
analysis and supporting genomic data is necessary. 
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Chapter 6	  
Shotgun metaproteomics of the human distal gut microbiota 
The text is adapted from: 
A. L. Russell, N. C. VerBerkmoes, M. Shah, A. Godzik, M. Rosenquist, J. 
Halfvarsson, M. G. Lefsrud, J. Apajalahti, C. Tysk, R. L. Hettich, and J. K. 
Jansson. “Shotgun metaproteomics of the human distal gut microbiota.” ISME J., 
2009, volume 3, pages 179-189. 
Alison R. Erickson’s contributions include experimental preparation of microbial samples 
for proteomics, experimental LC-MS/MS measurements and analysis, and shared 
primary authorship with Nathan VerBerkmoes. 
6.1: Introduction 
The human gastrointestinal (GI) tract is host for myriads of microorganisms 
(approximately 1011/gram feces) that carry out vital processes for normal digestive 
functions of the host and play an important, although not yet not fully understood, role in 
maturation of human immunity and defense against pathogens. Recent findings suggest 
that each human has a unique and relatively stable gut microbiota, unless disrupted by 
external factors such as antibiotic treatment[156]. Increasing evidence suggests that the 
composition of the GI microbiota is linked to inflammatory bowel diseases[157], such as 
Crohn’s disease[158], and can even influence the propensity for obesity[131]. Current 
estimates based on sequencing of 16S rRNA genes in DNA extracted from feces, are 
that 800-1000 different microbial species and >7000 different strains inhabit the GI 
tract[159] and that the majority of these (> 80%) have not yet been isolated or 
characterized[62]. Therefore, there is a vast microbial diversity with largely unknown 
function that is waiting to be explored.  
Recently, metagenomic sequencing has revealed information about the 
complement of genes in the gut microbiota of two healthy individuals[22]. Although this 
data set did not represent the entire GI microbiota, analysis of identified genes revealed 
that the GI microbiome has significantly enriched capacities for glycan, amino acid, and 
xenobiotic metabolism, methanogenesis, and synthesis of vitamins and isoprenoids. 
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This indirect evidence suggested that there are unique microbial functions carried out in 
the gut environment. 
A major limitation of DNA based approaches is that they predict potential 
functions, but it is not known if the predicted genes are expressed at all or if so, under 
what conditions and to what extent. In addition, it is not possible to determine whether 
the DNA is from active viable cells, dormant inactive cells, or even dead cells. These 
limitations can be overcome by directly assessing proteins, because the genes must 
have been transcribed and translated to produce a protein product. However, to date 
only a couple of microbial proteins have been identified from the human gut and these 
were obtained by 2 dimensional polyacrylamide gel electrophoresis (2D PAGE)[47], 
followed by excision and de novo sequencing of targeted spots on the gel.  
With an established and successful method to study the proteomes of lower-
complexity microbiota in gnotobiotic mice, we expanded this methodology into higher 
complexity representative human gut microbiomes to evaluate how well this method 
would work in human feces.  Here, our aim was to develop a novel high throughput, 
non-targeted mass spectrometry (MS) approach to determine the identities of 
thousands of microbial proteins in the most complex sample type to date (i.e. feces) and 
to test the feasibility of using a non-matched metagenome data set for protein 
identification. This MS-based shotgun proteomics approach relies on detection and 
identification of all proteins in a lysed cell mixture without the need for gel based 
separation or de novo sequencing. Instead, the resulting peptides from an enzymatic 
digest of the entire proteome are separated by liquid chromatography and infused 
directly into rapidly scanning tandem mass spectrometers (2D-LC-MS/MS) via 
electrospray ionization. The resulting peptide mass information and tandem mass 
spectra are used to search against protein databases generated from genome 
sequences. To date, the shotgun metaproteomics approach has only been 
demonstrated in a limited number of studies and only for microbial communities with low 
diversity, such as acid mine drainage systems[42,43], endosymbionts[160], and sewage 
sludge water[44].  It remains a technical challenge to apply this shotgun approach to 
more complex microbial communities, such as those inhabiting the human gut.  
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For this study, it was first necessary to develop the shotgun proteomics approach 
to work with fecal samples containing large amounts of particulate matter and 
undigested food and a large diversity of microbial cells. Figure 6.1 provides an overview 
of the experimental approach developed. Fecal samples were chosen because 
sampling is non-invasive and feces have been shown to provide material that is 
representative of an individual’s colonic microbiota[62]. Our goal was the qualitative 
identification of the range and types of proteins that can be confidently and reproducibly 
measured (i.e. with high specificity and low false positive rates; 1-5% maximum) from 
gut microorganisms by comparing to available metagenome databases[22] and 
available gut isolate genomes and to determine if unmatched data sets could suffice for 
accurate protein identifications.  An additional goal was to apply a novel bioinformatics 
approach to assign putative functions to unknown proteins not covered by standard 
analysis of clusters of orthologous groups (COGs). Ultimately, our aim was to use the 
protein data to provide direct evidence of dominant and key microbial functions in the 
human gut for the first time, some of which could serve as indicators of a healthy or 
diseased state. In addition, this non-targeted approach enables identification of human 
proteins associated with the gut microbiota, thus illustrating potential interactions 
between the human microbiome and host. 
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Figure 6.1: Shotgun metaproteomics approach used to identify thousands of microbial 
proteins in human fecal samples. 
6.2: Experimental methods 
6.2.1: Fecal sample collection 
A female healthy monozygotic twin pair born in 1951 was invited to take part in a larger 
double blinded study, and details of these individuals with respect to diet, antibiotic 
usage, etc. are previously described: individuals numbered 6a and 6b[158], that 
provided Samples 7 and 8, respectively, thus were the focus of this study. The only 
differences between the individuals according to the submitted questionnaire data were 
that Individual 6a had gastroenteritis and Individual 6b had taken NSAIDs the last 12 
months. Fecal samples were collected in 20 ml colonic tubes by the twins and 
immediately sent to Örebro University Hospital on the day of collection, where they were 
placed at –70°C and stored. The Uppsala County Ethics Committee and the ORNL 
human study review panel approved the study.  
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6.2.2: Microbial cell extraction from fecal samples 
Fecal samples were thawed at +4°C and microbial cells were extracted from the bulk 
fecal material by differential centrifugation, as previously described[85]. This cell 
extraction method has previously been found to result in a highly enriched bacterial 
fraction from complex samples, such as soil and chicken feces, with negligible bacterial 
cell loss and a good representation of fecal microbiota[85]. The resulting bacterial cell 
pellets were immediately frozen at –70°C and stored until use. 
6.2.3: Cell lysis and protein extraction from cell pellets 
The microbial cell pellets (~100 mg) were processed via single tube cell lysis and 
protein digestion. Briefly, the cell pellet was resuspended in 6M Guanidine/10mM DTT 
to lyse cells and denature proteins. The guanidine concentration was diluted to 1M with 
50 mM Tris buffer/10mM CaCl2 and sequencing grade trypsin (Promega, Madison, WI) 
was added to digest proteins to peptides. The complex peptide solution was desalted 
via C18 solid phase extraction, concentrated and filtered (0.45um filter). For each LC-
MS/MS analyses below, ~1/4 of the total sample was used. 
6.2.4: 2D-LC-MS/MS 
Both samples were analyzed in technical duplicates via two-dimensional (2D) nano-LC 
MS/MS system with a split-phase column (RP-SCX-RP)[97] on a LTQ Orbitrap (Thermo 
Fisher Scientific) with 22 hr runs per sample (LC as previously described[42,43]. The 
Orbitrap settings were as follows: 30K resolution on full scans in Orbitrap, all data-
dependent MS/MS in LTQ (top five), 2 microscans for both Full and MS/MS scans, 
centroid data for all scans and 2 microscans averaged for each spectra, dynamic 
exclusion set at 1.   
6.2.5: Proteome informatics 
All MS/MS spectra were searched with the SEQUEST algorithm[66] and filtered with 
DTASelect/Contrast[98] at the peptide level [Xcorrs of at least 1.8 (+1), 2.5 (+2), 3.5 
(+3)]. Only proteins identified with two fully tryptic peptides from a 22 hr run were 
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considered for further biological study.  Tandem MS/MS spectra were searched against 
four databases.  The first database (db1) contained two human subject’s 
metagenomes[22], a human database, and common contaminants such as trypsin, 
human keratins, etc.  The existing metagenome databases[22] were deficient in 
Bacteroides sequences and as Bacteroides are known to be common and abundant in 
the human intestine[62], Bacteroides genome sequences were also included in a 
second database (metadb), plus other sequences from representatives of the normal 
gut microbiota deposited and available at the Joint Genome Institute (JGI) IMG 
database (http://img.jgi.doe.gov/cgi-bin/pub/main.cgi).  In addition, we included 
distracters that one would not commonly expect in the healthy gut. The third and fourth 
database were made by reversing or randomizing the db1 and appending it on the end 
of db1; these databases were used primarily for determining false positive rates, as 
described earlier[43,96].  
6.2.6: Hypothetical Protein Prediction 
Hypothetical proteins were submitted to the distant homology recognition server 
FFAS03[161]. For 80% of the hypothetical proteins, a statistically significant match (Z-
score below 9.5) to one of the proteins in the reference databases was obtained. 
Functions of the matching proteins were used to assign a provisional function for the 
hypothetical proteins identified in this study.  
6.3: Results and Discussion 
6.3.1: Metaproteomics of fecal samples 
Our results present the first large-scale investigation of the human gut microbial 
metaproteome. The metaproteomes were obtained from two fecal samples (samples 7 
and 8) collected from two healthy female identical twins (subjects 6a and 6b, 
respectively, see Dicksved et al. (2008) for a description of the individuals). The shotgun 
approach used enabled us to identify thousands of proteins by matching peptide mass 
data to available isolate genome and metagenome sequence databases. The total 
number of proteins identified from searching the first database (db1) that contained all 
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predicted human proteins and the gut metagenomes were 1822 redundant and 1534 
non-redundant proteins, with approximately 600 to 900 proteins identified per sample 
and replicate (Table 6.1).  From the entire non-redundant dataset, ~ 1/3 matched 
human proteins, ~ 2/3 matched predicted proteins from the microbial metagenome 
sequence data.  
Table 6.1: Number of protein, peptide, and spectra identifications for Samples 7 and 8 
(2 technical runs each) using the db1 and metadb databases (see supplementary 
material). 
db1 database  
Sample ID Protein identifications* 
Peptide 
identifications 
MS/MS 
Spectra 
Peptides between 
10 and -10 
ppm** 
Sample 7, Run 1 634 1886 4069 81.70 
Sample 7, Run 2 722 2253 4440 80.42 
Sample 8, Run 1 974 3021 5829 83.41 
Sample 8, Run 2 983 2948 6131 81.47 
 
metadb database 
Sample 7, Run 1 970 2441 4829 84.47 
Sample 7, Run 2 1098 2977 5364 81.67 
Sample 8, Run 1 1341 3586 6509 84.71 
Sample 8, Run 2 1275 3374 6635 82.92 
   *Numbers given are non-redundant identifications 
   ** Mass accuracy 
 
 
The second database (metadb) contained all of the sequences in the db1 
database above, in addition to sequences from representatives of the normal gut 
microbiota, including strains of Bacteroides, Bifidobacteria, Clostridia, and Lactobacilli, 
plus human pathogens and distracters that one would not commonly expect in the 
healthy gut, such as environmental isolates.  The rice (Oryza Sativa) genome was 
included to help identify plant (food)-related proteins. From the metadb, the total number 
of proteins identified were 2911 redundant and 2214 non-redundant; between 970 and 
1340 proteins were identified per sample and replicate (Table 6.1). The categorical 
breakdown of identified proteins from each major database type is shown Table 6.2.  In 
three out of four runs, the highest percentage of protein identifications corresponded to 
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the bacterial genome sequences that were screened.  In the fourth run (that is, run 2, 
sample 8), most protein identifications matched to one of the metagenomes. By 
contrast, 30-35% of spectra matched to the human protein database, most likely due to 
a few highly abundant human proteins in the samples with a large number of spectral 
counts.  The proteins matching to both rice and environmental isolate distracters were 
low, between 2 and 9%, indicating that the majority of the sequences matched to 
bacterial types and human sequences that one would expect in the human gut 
environment. Among the microbial genomes screened, the highest protein matches 
were to expected sequences from gut isolates. Of the ~10,000-13,000 total spectra 
observed from each run, ~2,000 matched Bacteriodes or Bifidobacterium species, with 
the Bacteriodes species always having slightly more spectra, emphasizing the 
dominance of these groups and their functional significance in the human distal 
intestine.  These data correlate well with our previously published microbial fingerprint 
data showing an abundance of Bacteroides spp. in both of the individuals studied 
here[158]. 
Table 6.2: Categorical breakdown of all identifications for each database component 
per MS run. 
 
Sample7_Run1 Sample8_Run1
Database Proteins % Spectra Total % Database Proteins % Spectra Total % 
Gut Isolate Genomes 547 38.17 2926 28.11 Gut Isolate Genomes 604 32.26 3047 22.12
Contams 7 0.49 177 1.7 Contams 5 0.27 85 0.62
Human Proteins 166 11.58 3276 31.48 Human Proteins 232 12.39 4440 32.24
Gill Metagenome Set7 205 14.31 1304 12.53 Gill Metagenome Set7 304 16.24 1835 13.32
Gill Metagenome Set8 328 22.89 1977 19 Gill Metagenome Set8 568 30.34 3720 27.01
Rice 45 3.14 226 2.17 Rice 53 2.83 273 1.98
Isolate Distracters 135 9.42 522 5.02 Isolate Distracters 106 5.66 373 2.71
Totals: 1433 10408 Totals: 1872 13773
Sample7_Run2 Sample8_Run2
Database Proteins % Spectra Total % Database Proteins % Spectra Total % 
Gut Isolate Genomes 600 38.73 3111 27.99 Gut Isolate Genomes 515 30.13 2658 20.08
Contams 6 0.39 154 1.39 Contams 3 0.18 63 0.48
Human Proteins 187 12.07 3752 33.76 Human Proteins 214 12.52 4671 35.28
Gill Metagenome Set7 243 15.69 1477 13.29 Gill Metagenome Set7 303 17.73 1810 13.67
Gill Metagenome Set8 365 23.56 2013 18.11 Gill Metagenome Set8 556 32.53 3535 26.7
Rice 57 3.68 246 2.21 Rice 34 1.99 197 1.49
Isolate Distracters 91 5.87 360 3.24 Isolate Distracters 84 4.92 305 2.3
Totals: 1549 11113 Totals: 1709 13239
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By using established methods of reverse database searching[43,96]; we 
estimated a false-positive rate at the peptide level of 1-5% for all identified peptides 
depending on the method.  If only those peptides with corresponding high mass 
accuracy measurements (<10 p.p.m.) were considered (80-85% of all identified peptides 
per run), then the rate dropped to 0.05-0.23%. 
6.3.2: COG categories in the gut metaproteome 
The proteins identified from the db1 search were classified into COG categories and 
when compared between the two samples and the two technical runs, the data were 
highly reproducible and consistent (Figure 6.2).  By comparison to the average 
metagenomes previously published from other individuals[22], we found that several 
COG categories were more highly represented in the average microbial metaproteomes 
of the individuals in the present study (Figure 6.3). The metaproteomes were 
significantly skewed, with a more uneven distribution of COG categories than those 
represented in the average metagenomes. The majority of detected proteins were 
involved in translation, carbohydrate metabolism, or energy production; together 
representing more than 50% of the total proteins in the metaproteome.  In addition, 
more proteins in the metaproteomes were representative of COG categories for post-
translational modifications, protein folding, and turnover. By contrast, other COG 
categories were under represented in the metaproteomes when compared with the 
metagenomes, including proteins involved in inorganic ion metabolism, cell wall and 
membrane biogenesis, cell division and secondary metabolite biosynthesis.  
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Figure 6.2: Microbial proteins identified from fecal samples 7 (blue bars) and 8 (yellow 
bars) according to clusters of orthologous group (COG) functions.  Bars represent 
technical proteome runs 1 and 2. 
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Figure 6.3: Comparison of average clusters of orthologous group (COG) categories for 
available human metagenomes and metaproteomes. (A) Average COG categories of 
the two metagenomes from the gut microbiota of two individuals from a previous study 
(Gill et al. 2006), (B) compared to average COG categories of the metaproteomes from 
the gut microbiota of two individuals in the present study. 
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6.3.3: Label-free estimation of relative protein abundance by normalized 
abundance factor 
We estimated the relative abundances of the thousands of proteins that were detected 
in each sample by calculating normalized spectral abundance factors (NSAF)[127,162].  
By comparing the NSAF data from each sample and technical run to each other, it was 
clear that the technical runs were highly reproducible for a given sample; R2 values of 
0.77 and 0.85 for samples 7 and 8, respectively (Figures 6.4 and 6.5).     
          
Figure 6.4: Comparison of NSAF values.  Sample 7, run 1 and run 2 NSAF values are 
plotted on a log scale.  The dark blue squares represent all of the proteins that were 
identified in both runs from metadb. 
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Figure 6.5: Comparison of NSAF values.  Sample 8, run 1 and run 2 NSAF values are 
plotted on a log scale.  The dark blue squares represent all of the proteins that were 
identified in both runs from metadb. 
The most abundant proteins based on this prediction were common abundant 
human-derived digestive proteins such as elastase, chymotrypsin C, and salivary 
amylases.  The most abundant microbial proteins included those for expected 
processes, such as enzymes involved in glycolysis (for example, glyceraldehyde-3-
phosphate dehydrogenase). Ribosomal proteins (in particular for Bifidobacterium) were 
also relatively abundant, as were DNA binding proteins, electron transfer flavoproteins, 
and chaperonin GroEL/GroES (HP60 family).  
The gut microbiomes previously published[22] were enriched for many COGs 
representing key genes in the methanogenic pathway, consistent with H2 removal from 
the distal gut ecosystem through methanogenesis. By contrast, we found very few 
proteins represented by methanogens. One example is a hypothetical protein from 
Methanobrevibacterium found in sample 8. Instead, analysis of the list of proteins based 
on the NSAF ranking in our study revealed a high relative abundance of 
formyltetrahydrofolate synthetase, a key enzyme in the acetyl-CoA pathway of 
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acetogens[163]. Acetogenic bacteria utilize H2 to reduce CO2 and form acetate. 
Although methanogenesis is an important H2 disposal route in about 30-50% of people 
in Western countries, in the remainder H2 is consumed by sulfate reduction or reductive 
acetogenesis, and this seems to be the situation for the samples we have studied here.  
Similar to the finding of COGs responsible for host-derived fucose utilization that 
were enriched in the human gut microbiome[22], we also found several proteins 
involved in fucose metabolism, including fucose isomerase and propanediol 
fermentation (later steps in the pathway). In particular, we detected proteins 
corresponding to polyhedral bodies that are assumed to protect the cell by sequestering 
the toxic propionaldehyde intermediate of this pathway[164].  
Butyrate kinase was the most highly enriched COG in the previous metagenomic 
study by Gill et al. (2006). This enzyme is the final step in butyrate fermentation. 
Although we did not identify butyrate kinase, we did find that butyryl-CoA 
dehydrogenase had a relatively high abundance based on the NSAF analyses.  This 
enzyme catalyzes one of the previous steps in the same pathway; interestingly, this 
protein was strongly expressed in sample 8 but was not detected in sample 7.  
Additional proteins of interest that were relatively abundant included NifU-like homologs 
and rubrerythrin. The role of NifU has been proposed as a scaffold protein for Fe-S 
cluster assembly[165]. Rubrerythrin is found in anaerobic sulfate-reducing bacteria and 
is a fusion protein containing an N-terminal iron-binding domain and a C-terminal 
domain homologous to rubredoxin. The physiological role of rubrerythrin has not been 
identified, but it has been shown to protect against oxidative stress in Desulfovibrio 
vulgaris and other anaerobic microorganisms[166]. 
Average NSAF values were compared to determine unique and shared proteins 
in samples 7 and 8 (Figure 6.6, metadb database; Figure 6.7, db1 database). The 
scatter plot reveals five distinct areas: proteins found in similar abundances in both 
samples along the diagonal, proteins found in only one sample on the respective axis, 
and two distinct lobes that are overexpressed in one sample or the other but present in 
both (Figure 6.6). We suggest that the group of approximately equally abundant 
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proteins (747 total) represent core gut populations and functions, supported by the 
finding that a high proportion of these proteins were from common gut bacteria 
(Bacteroides, Bifidobacterium and Clostridium) and represented housekeeping 
functions: translation (19%), energy production (14%), post-translational modification 
and protein turnover (12%) and carbohydrate metabolism (16%) (Supplementary Table 
S10, first tab). By contrast, the proteins found in only one sample contained 
proportionately fewer COG categories for housekeeping functions and from common 
gut species, but a higher proportion with unknown functions (28% compared to 11% 
found in both). These results suggest that the proteins present or over-represented in 
only one sample could represent bacterial populations and functions that change 
according to environmental influences, such as immediate diet.  For example, 33% of 
the unique proteins only found in sample 7 are prolamin proteins, that is, plant storage 
proteins having a high proline content found in seeds of cereals, suggesting recent 
ingestion of cereal grains by that individual. Although these individuals did not specify 
any particular dietary habits in the questionnaire data that accompanied the 
samples[158], we do not have any detailed information about their specific dietary 
intake immediately prior to sampling that would enable us to verify this finding. 
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Figure 6.6: Comparison of relative abundances (NSAF values) of proteins detected in 
Samples 7 and 8. NSAF values for Samples 7 and 8 were averaged amongst their 
individual technical runs and plotted on a log scale.  The dark blue squares represent all 
of the proteins identified in each sample from screening the metadb database.  The 
straight diagonal line represents the location of all proteins that had approximately equal 
expression in both samples. 
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Figure 6.7: Comparison of NSAF values for Samples 7 and 8. NSAF values were 
averaged amongst two individual technical runs pre sample and plotted on a log scale.  
The dark blue squares represent all of the proteins identified in each sample from db1.  
The straight diagonal line is for visualizing the location of all proteins that had 
approximately equal expression in both samples. 
6.3.4: Analysis of unknown hypothetical proteins 
We performed detailed analyses of the unknown proteins (116 from the published 
metagenomes[22] and 89 from bacterial isolate genomes) that could not be classified 
into COG families. The majority belonged to novel protein families that are over-
represented in genomes of gut microbes (Figure 6.8a). Five of the ten most abundant 
hypothetical proteins in the metaproteome belong to the novel protein family 
represented by hypothetical protein CAC2564, identified earlier in human 
metagenomes[22], whereas four out of the top ten belong to another novel protein 
family represented by a hypothetical protein BF3045 from Bacteroides fragilis.  
Members of both families are present in several Bacteroides, Clostridium, and Vibrio 
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species, where they are always associated with each other (see the red and green 
arrows in Figure 6.8b) and various metabolic enzymes and transport systems. The 
neighborhood of these two proteins resembles a typical amino acid metabolic pathway, 
and we hypothesize that they are involved in amino acid metabolism, most likely 
cysteine or methionine. 
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Figure 6.8: Detailed analysis of hypothetical proteins identified in human gut 
metaproteome. (A) Protein representation in the genomes of human gut associated 
microbes; scale changes from 1 (only found in human gut microbes) to -1 (never found 
there), 0 represents even distribution. Conserved genomic neighborhoods of the 
CAC2564 (B) and BT2437 (C) families. 
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Another interesting example is the CPE0573 family of hypothetical proteins, 
originally identified in the human gut metagenome[22]. A distant homolog from this 
family was recently shown to belong to a novel lacto/galacto-N-biose metabolic 
pathway, identified in Bifidobacterium bifidum[167] and Bifidobacterium longum[168]. 
Other proteins from this pathway were also found in the metaproteome samples, 
suggesting that it was active in our subjects who apparently ingested lactose in their 
diet.  Additionally, an operon formed by a hypothetical protein BT2437 from Bacteroides 
thetaiotaomicron VPI-5482 was found which codes for a putative lipoprotein[169]. 
Proteins from this family are always associated with channel forming eight-stranded 
beta-barrel proteins from the OprF family[170] (Figure 6.8c).   
6.3.5: Identification of human proteins 
Almost 30% of all identified proteins were human. The two largest groups of human 
proteins identified in our study were digestive enzymes and structural cell adhesion and 
cell-cell interaction proteins. However, the third largest category was comprised of 
human innate immunity proteins, including antimicrobial peptides, scavenger receptor 
cysteine-rich (SRCR) proteins (represented by the DMBT1 (deleted in malignant brain 
tumors) protein), and many other proteins linked to innate immunity and inflammation 
response (intellectin, resistin, and others).   Most of the abundant human proteins were 
similar in the two individuals, but some differences were found in less abundant 
proteins. 
We were particularly interested in further investigation of DMBT1 (also called 
salivary agglutinin and glycoprotein-340) that is predominantly expressed in epithelial 
cells and secreted into the lumen. This protein has several proposed beneficial 
functions including tumor suppression, bacterial binding, and anti-inflammatory 
effects[171,172]. Detailed analysis of the distribution of DBMT1 peptides shows that 
they had fairly uniform distribution along the protein, including hits from all 17 domains 
present in the DBMT1 protein (Figure 6.9), suggesting that the DBMT1 protein was 
present in our samples as a complete, intact protein, that which we postulate is 
indicative of a healthy gut environment.  
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Figure 6.9: Positions of DMBT1 peptide fragments along the length of the DMBT1 
protein are shown as blue boxes (figure is not to scale). DBMT1 has a length of 1785 
amino acids. PFAM domain names: SRCR (Scavenger receptor cysteine-rich domain); 
CUB (from complement C1r/C1s, Uegf, Bmp1) is a domain found in many in 
extracellular and plasma membrane-associated proteins; Zona pellucida, a large, 
cysteine rich domain distantly related to integrins, found in a variety of mosaic 
eukaryotic glycoproteins, usually acting as receptors. 
6.4: Conclusions 
This is the first demonstration of an overall method for obtaining metaproteomics 
datasets from complex material, in this case human feces, and successful 
demonstration of the deepest coverage of a complex metaproteome to date. By 
comparison with earlier work on environmental samples with only a few dominant 
species[42,43,44], the gut microbiota represents a highly diverse community with 
thousands of species. Therefore, we are testing the technical limit of the use of the 
shotgun proteomics approach. We were encouraged that the sample extraction and 
preparation methods worked well for fecal samples. Although there remain experimental 
and computational challenges, this general approach should be applicable to other 
complex environments, such as marine and soil microbial communities.  
We also successfully demonstrated that it was feasible to use an unmatched 
metagenome dataset to obtain valid protein identifications in fecal samples. It is 
currently more rapid and less expensive to obtain metaproteome data, as we have 
demonstrated here, than metagenome data. This finding is promising for future 
metaproteomics studies of other environments that do not have available matched 
metagenomics sequence data. 
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One particular challenge is to estimate protein abundances in complex samples.  
Here, we used label free methods based on spectral counting and NSAFs[127,162]. 
NSAF is based on spectral counts but also takes into account protein size and the total 
number of spectra from a run, thus normalizing the relative protein abundance between 
samples. Efforts are underway to develop better tools for label-free methods, such as 
the absolute protein expression (APEX) method recently developed by Lu et al.[173].  
However, the APEX method was derived specifically for isolate data and is not 
applicable to complex microbial communities because it requires an estimate of the 
number of expressed proteins in the system and this is not known, for example, in our 
case.  
Although our results present the largest coverage of the human gut microbial 
metaproteome to date, increasing the dynamic range beyond this initial study will be 
necessary in the future to more fully understand the function of the human gut 
microbiota and its interactions with the human host.  Previous studies[42] and current 
work (NCV, unpublished results with artificial mixtures) suggest that proteins can be 
detected from populations that represent at least 1% of a mixed community. However, 
the number of proteins detected (dynamic range) dramatically decreases from 
thousands to hundreds of proteins for those populations that are present at lower 
abundances.   One possibility to increase the dynamic range of detection would be to 
enhance the protein separation steps prior to analysis. The trade-off for increasing the 
number of separation steps would be the requirement for a greater amount of starting 
material and instrument time.  Enrichment or depletion techniques could also be 
attempted to increase the coverage of community members present at low levels, but 
care must be taken to not affect the proteome during any manipulations.  Increasing the 
dynamic range is a clear challenge for all proteomic applications and this will be a 
pressing area for research and method development in the future.    
We made several comparisons of our metaproteome data to the existing 
metagenome data[22]. Some matches could be made between pathways predicted to 
be functioning based on abundant genes detected in the metagenome data to abundant 
proteins we found, such as those involved in fucose and butyrate fermentation. There 
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were also some interesting discrepancies, such as the implication of methanogenesis in 
the former study and the apparent lack of methanogenesis in the samples we analyzed. 
The few, low-level, nonunique peptide hits to methanogens that we found were not 
sufficient to indicate that these organisms were present or functioning. Instead, our data 
suggest that acetogenesis was occurring in our samples, implicating different hydrogen 
scavenging routes in the subjects in the two studies.  
Although about the same percentage of proteins with ‘unknown function’ was 
found in both the metagenomes and the metaproteomes, the metaproteome data 
provide direct proof that such proteins are actually expressed. Overall, 67% of 
hypothetical proteins identified in this study could be recognized as distant homologs of 
already characterized families, allowing putative function assignments, with most of 
them further enriching the amino-acid and carbohydrate metabolism categories, but also 
including proteins involved in cell-cell signaling and active transport of nutrients across 
bacterial membranes.  Also, fold recognition level structure predictions are possible for 
55% of them, opening doors for modeling and more detailed function analysis.  
There were additional discrepancies between some proteins predicted in the 
metagenomes that were not detected in the metaproteomes and reasons for this include 
all or some of the following: (1) the microbial community compositions and proteins 
produced were different in the different individuals, (2) the proteins were produced, but 
below the dynamic range of detection, (3) they might not have been expressed at 
significant levels at the time of sampling, or (4) the proteins may have mutated to a point 
that they are no longer detected by screening an unmatched metagenome[174]. 
Therefore, although we successfully identified thousands of proteins using an 
unmatched dataset, it would still be very valuable to have matching metagenome and 
metaproteome data from the same samples and this will certainly be achieved through 
ongoing and future initiatives, such as the NIH Human Microbiome Project 
(http://nihroadmap. nih.gov/hmp/) and the European Union Meta-HIT project 
(http://www.international.inra.fr/ press/metahit). Recently, 13 additional human 
metagenome sequences were published from Japan[24] and more representative 
genome sequences from commensal gut isolates are currently being sequenced [157]. 
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Taken together, these represent valuable resources that should eventually aid in 
identification of more proteins from the human gut. 
A large proportion of the proteins detected in the samples (approximately 30%) 
were human proteins. This finding can be explained by the differential centrifugation 
method that we used to obtain a bacterial cell fraction, which is not pure but highly 
enriched in bacterial cells when compared to human cells and particulate matter in the 
original fecal sample. Any human protein that adhered to the microbial cells would have 
been collected in the bacterial pellet. Also, there are many more proteins in human cells 
than in bacterial cells. Therefore, even a minor contamination of the bacterial fraction 
with human cells could represent a significant number of human proteins. In hindsight, 
this was advantageous because it enabled us to detect and identify human proteins, 
such as antimicrobial peptides, that reflect interaction between the host and the 
microbiota.  Furthermore, this highlights the power of this technology to distinctly identify 
both microbial and human proteins in a combined mixture.    
In summary, although it is evident that this massive dataset would require 
substantial effort to completely define and characterize, our goal was to develop an 
approach to obtain a first large-scale glimpse of the functional activities of the microbial 
community residing in the human gut. A wealth of information about functional pathways 
and microbial activities could be gleaned from this data, thereby providing one of the 
first views into the complex interplay of human and microbial species in the human gut 
microenvironment. It is clear that proteomics allows us to directly see potential host-
commensal bacterial interactions. While the human immune response is usually 
described in terms of response to infection, it is clear that innate immunity proteins are 
part of a normal gut environment, shaping the gut microflora to the desired shape.   
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Chapter 7 
Strategies for Metagenomic-Guided Whole Community Proteomics of Complex 
Microbial Environments 
The text is adapted from: 
Alison R. Erickson, Brandi L. Cantarel, Nathan C. Verberkmoes, Brian K. 
Erickson, Patricia A. Carey, Chongle Pan, Manesh Shah, Emmanuel F. 
Mongodin, Janet K. Jansson, Claire M. Fraser-Liggett, and Robert L. Hettich. 
“Strategies for Metagenomic-Guided Whole Community Proteomics of Complex 
Microbial Environments.” Submitted and in review at PLoS One (2011). 
Alison R. Erickson’s contributions include experimental preparation of microbial samples 
for proteomics, experimental LC-MS/MS measurements, integrated comparisons and 
analyses of all protein database search results, and shared primary authorship with 
Brandi Cantarel. 
7.1: Introduction 
Key questions in environmental microbiology include: (i) what microorganisms are 
present in a particular environment, (ii) how are they functioning, and (iii) how does 
community structure and function vary in response to environmental 
conditions/changes?  Recent technological advances have provided powerful 
experimental approaches to address these questions, with 16S rRNA-based taxonomic 
profiling providing extensive information about microbial composition, and metagenomic 
whole-genome shotgun (WGS) sequencing/shotgun community proteomics, or 
“metaproteomics,” providing insights into the composition and functional activities of 
microbial communities.  In particular, metagenome sequencing with next-generation 
platforms has revolutionized the ability to measure and fully characterize the genomic 
repertoire in microbial communities. 
In order to successfully identify peptide sequences using mass spectrometry 
(MS)-based proteomics methods, a relevant database of predicted genes derived from 
genome or metagenome sequences is necessary.  Peptide identifications result from 
matching tandem mass spectra (MS/MS) against predicted fragmentation patterns of all 
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possible in silico digested peptides using well-established programs[66,67,68].  
Therefore, successful MS/MS sequence-database searching is critically dependent on 
the quality and accuracy of the metagenomic predicted sequence database. 
Although traditional MS-based proteomic analyses of single bacterial isolates are 
well established, applying these methods to complex microbial communities can be 
challenging for several reasons, including the lack of deep sequence coverage and 
difficulty in assembling metagenomes from 454-reads.  Considerable improvements in 
mass spectrometers and chromatography have been made over the past decade; 
however, the development of tools for optimizing metagenome-metaproteome sequence 
matching has not kept pace, especially when using the shorter sequence reads 
associated with next generation sequencing platforms such as the 454 
pyrosequencer[175] and Illumina GAII[176].   
While an increasing number of studies have developed computation methods for 
proteogenomics[177,178] and begun to integrate metagenomic sequence data with 
proteome measurements[42,43,44], these studies have primarily focused on either 
single eukaryotic genomes or populations with low diversity, allowing for sufficient depth 
of sequence coverage of abundant community members that facilitate proteome 
identifications as compared to more complex microbial communities (e.g., human 
microbiome, ocean, and soil).  In the human distal gut, there are approximately 1,000 
estimated species which represent >7,000 prokaryotic strains; therefore, the complete 
metagenome is estimated to be >100 times the human genome [159].  Based on 
previous studies of these exact same samples, we would expect ~ 30% of the proteins 
identified by proteomics to be of human origin[26].  The challenges inherent in a 
metagenomic-metaproteomic characterization of complex environmental samples 
include (i) considerable sequence diversity among closely related strains/species, (ii) 
large number of organisms for which no reference genome sequence is available and 
(iii) low nucleotide sequence coverage for the microorganisms, especially low 
abundance members.  
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In the previous chapter, we demonstrated that whole community proteome 
measurements were possible in the human gut microbiome, but were concerned with 
the accuracy for how to handle extensive microbial protein redundancy in the 
metagenomes.  Thus, we stepped back to a applying a systematic bioinformatics 
comparison and analysis of how to construct metagenomic sequence databases for 
optimum metaproteome measurements.  Here we present a benchmarking of strategies 
for integration of metagenomic and metaproteomic data derived from the same human 
gut microbiome samples.  Although the metagenomes were not sequenced to 
saturation, they were sufficient to enable us to evaluate how protein predictions based 
on metagenome data impact peptide-spectrum assignments in matched metaproteomic 
datasets (i.e., metagenome and metaproteome of the exact same sample).  Using 454 
pyrosequencing, 1,079 Mbp of DNA sequence was obtained from two fecal samples 
obtained from a pair of healthy twins[158].  Using these data, four protein sequence 
databases were created using several different assembly and gene finding strategies 
(Figure 7.1).  The resulting databases were evaluated for their utility in MS sequence-
database searching.  
 
Figure 7.1: Creation of protein sequence databases.  Protein sequence databases were 
created from metagenomic sequence reads using a variety of methods for assembly 
and gene finding. 
Assembly of metagenomic reads can potentially generate errors by joining 
sequence reads that share sequence identity but are derived from different strains or 
species.  This can be further complicated by sequencing errors, such as issues with 
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homopolymer tracts in 454 pyrosequencing datasets[179,180].  The metagenome 
assembly strategies examined in this study were (i) assembly by sample, exemplifying 
the traditional approach used for single isolate genomes, (ii) whole-dataset assembly, in 
order to increase sequence coverage, and (iii) no assembly, which will theoretically 
capture all sequence diversity present in a sample.  Since sequencing errors can also 
introduce frameshifts and in-frame stop codons, resulting in fragmented gene 
predictions, we explored homology-based gene finding, as it allows the ability to ‘gap’ 
over sequencing errors, and de novo based gene finding which uses models of known 
gene structure for prediction.   
 Proteomics approaches were also benchmarked to identify the parameters 
necessary to create accurate peptide-spectrum matches (PSMs; a match of a given 
MS/MS spectrum to a specific database peptide sequence) and increase protein 
discovery by de novo peptide sequencing.  Several MS-related parameters (spectral 
quality, delta correlation (deltCN), and high mass accuracy (±10 ppm (parts-per-million)) 
were examined and proved to be helpful in providing more comprehensive, confident 
PSMs.  Moreover, we investigated how much de novo peptide sequencing would 
increase peptide identification, since it provides novel sequences that were not originally 
present in the sequence database (e.g., polymorphisms).  By utilizing the genomic and 
proteomic tools described in this study, we identified a strategy that increased the 
number of PSMs and protein identifications in a complex microbial community that can 
provide a more comprehensive and accurate characterization of the human gut 
microbiome.  
7.2: Experimental Methods 
7.2.1: Samples, DNA and protein extraction 
Fecal samples from two healthy female human individuals (a concordant twin pair), 
numbered 6a and 6b, were collected under a separate study, as described and studied 
previously[26].  Both samples were used for DNA and protein extraction.  An additional 
three twin pairs corresponding to six human fecal samples: numbered 15a and 15b 
(concordant pair with Crohn’s disease), 16a and 16b (discordant pair, healthy 16a and 
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16b with Crohn’s disease), and 18a and 18b (discordant pair, healthy 18a and 18b with 
Crohn’s disease), were used for metagenomic sequencing only and were included in 
several of the sequence databases as described in “Protein Database Construction.”  
Therefore, a total of two healthy samples (6a and 6b) were used for metaproteomics 
and eight (four healthy: 6a, 6b, 16b, and 18b and four diseased: 15a, 15b, 16a, 16b) 
samples were used for metagenomics.  Throughout the manuscript, the diseased 
samples and individuals other than 6a and 6b are referred to as “unrelated” because we 
are only focusing on 6a and 6b samples’ metaproteomes, thus, we have a “matched” or 
“related” metagenome-metaproteome.  Since these fecal samples were collected under 
a separate research program and were supplied as de-identified information for this 
study, this work was approved in March 2010 by the Oak Ridge Site-wide Institutional 
Review Board (ORSIRB; Dr. Leigh Greeley, chair-person) as “human studies exemption 
4”, IRB REFERENCE #: ORNL EX(10)-3. 
Total genomic DNA was extracted using the MoBio PowerSoil DNA Isolation kit 
(MoBio Laboratories, Carlsbad, CA) following the manufacturer’s recommendations.  
Sample 6a was also extracted using the Zymo extraction protocol recently published by 
Ravel and colleagues[181].  Each sample was then sequenced using Roche 454 FLX-
Titanium pyrosequencing according to manufacturer specifications.  Raw sequence 
data were processed using the Roche/454 run processing software to filter short, mixed, 
and low quality reads.  The sequencing generated 418K - 627M passed-filter reads and 
170 – 381 Mbp per sample for the eight human fecal samples (15a, 15b, 16a, 16b, 18a, 
18b, 6b, and 6a).  Microbial cells (~100 mg cell pellet) and proteins were extracted and 
processed for 2D-LC-MS/MS.  The protocol for cell lysis and protein extraction has been 
rigorously tested and developed by our laboratory[74,86] with specific details 
corresponding to these samples detailed in Verberkmoes et al.[26]. 
7.2.2: Protein database construction 
Starting with 454 pyrosequencing reads, four metagenomic processing methods (NM, 
RM, RFM, and CAFM) were evaluated for the construction of predicted protein 
databases (Figure 7.1 and Table 7.1).  Sequences were first filtered for human 
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contamination by alignment of reads to the human genome (v 36) using NUCMER[182] 
using default parameters.  The Newbler-Metagene (NM) protein sequence database 
was created using the single-genome strategy by generation of a de novo assembly 
followed by de novo gene finding.   While there are a variety of gene prediction 
algorithms available, we chose to focus on MetaGene Annotator[183], a platform that 
we have extensive experience with for 454 sequencing datasets.  Certainly, newer 
approaches, such as Orphelia[184], MetaGeneMark[185], and FragGeneScan[186] 
have appeared and shown promise for Illumina datasets; the accuracy of these 
algorithms do not differ greatly for 300-400 bp reads and MetaGene Annotator is well 
suited for assembled datasets. 
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Table 7.1: Performance and comparison of the metagenomic predicted protein 
sequence databases. The database composition and SEQUEST/DTASelect search 
results (compute time, identified non-redundant spectra and peptides) with a 2-peptide 
and deltCN of 0.08 filters are shown for samples 6a (Run 2 and 3) and 6b (Run 1 and 
2). 
Metagenomic 
Predicted Protein 
Sequence Database 
 
Celera 
Assembler, 
Fastx, 
Metagene  
Newbler, 
Metagene 
Newbler, 
Metagene +  
Kurokawa/Gill 
Raw 
Reads, 
Metagene 
Raw 
Reads, 
FastX, 
Metagene 
Raw Reads, 
FastX, 
Metagene + 
Kurokawa/Gill 
Raw 
Reads, 
Metagene 
Paired 
Search 
Database Acronym CAFM NM NM_KG RM RFM RFM_KG RMPS 
Number of Sequences 
(thousand) 1,844 190 540 1,903 1,520 1,907 2,146 
Number of Amino 
Acids (million bp) 200 45 115 189 173 262 191 
Compute Time Per 
Run (minutes) 670 80 320 750 1,060 1,030 435 
Number of 
Non-redundant 
Spectra 
6a 
Run 2 5,179 6,235 10,441 9,100 9,074 10,975 13,806 
6a 
Run 3 4,326 5,376 9,272 8,152 8,538 10,330 18,401 
6b 
Run 1 4,092 5,615 10,830 8,639 8,480 11,254 12,363 
6b 
Run 2 3,873 5,800 10,724 8,775 8,573 11,167 12,212 
Total Spectra 17,470	   23,026	   41,267	   34,666	   34,665	   43,726	   56,782	  
Total number of PSMs  
within ±10ppm 14,317	   16,906	   31,289	   26,181	   25,997	   33,347	   39,681	  
Number of  
Non-redundant 
Peptides 
6a 
Run 2 4,383 3,093 5,678 4,710 4,669 5,911 7,592 
6a 
Run 3 3,655 2,403 4,617 3,804 3,963 5,068 6,303 
6b 
Run 1 3,404 2,426 5,409 3,919 3,879 5,549 5,923 
6b 
Run 2 3,216 2,297 5,088 3,747 3,690 5,238 5,605 
Total Peptides 14,658	   10,219	   20,792	   16,180	   16,201	   21,766	   25,423	  
Total NR Peptides 8,632	   5,994	   12,406	   9,618	   9,608	   13,111	   16,055	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Shotgun sequences from each sample were assembled using the Newbler 
Assembler (v2.0.01.14), and genes were predicted on contigs greater than 500 bp using 
Metagene[187], resulting in a total of 153,586 predicted open reading frames (ORFs) 
larger than 50 nt across a total of the seven metagenome samples included in this 
study.  The second database, Reads-Metagene (RM), was created by directly predicting 
ORFs from raw sequencing reads to prevent loss of sequence diversity when collapsing 
unrelated sequencing reads during genome assembly.  ORFs were predicted using 
Metagene, yielding 1,866,893 predicted ORFs larger than 50 nt.  Sequencing errors 
often seen in pyrosequencing datasets[179,180] can lead to artificially fragmented 
predicted ORFs.  Because these errors cause frameshifts and in-frame stop codons in 
gene predictions, we used protein-to-DNA alignments, generated by sequence similarity 
searches against NCBI’s NR using FASTX[188] with an expectation value threshold of 
1e-6, to predict genes by homology.  Homology-based gene finding was performed on 
raw 454 sequencing reads yielding 1,483,958 predicted ORFs larger than 50 nt, called 
Reads-FASTX-Metagene (RFM) protein database. 
 Additionally, three databases were created from assembled reads, with the intent 
of creating longer genes and fewer protein fragments.  The combination of short 
sequencing reads, averaging 369 bp, and the high bacterial diversity found in the 
human gut, produced a dataset with many fragmented genes.  Since assembled 
sequences were not much longer than raw sequencing reads, these genes were also 
fragmented, therefore, we were unable to validate proteins identified by multiple peptide 
matches.  Thus, an assembly was created by combining the shotgun sequence data 
from these samples using the Celera Assembler (v5.4), called Celera Assembler-
FASTX-Metagene (CAFM), yielding 1,807,963 predicted proteins on all contigs and 
singletons larger than 50 nt.  Homology-based gene finding was also used for this 
CAFM database, using the same parameters as RFM.  In addition to sequences 
generated in this study, we included the following published human gut metagenomic 
datasets: two metagenomes from Gill et al. [22] and thirteen metagenomes from 
Kurokawa et al.[24], that were concatenated with the NM (termed NM_KG) and RFM 
(termed RFM_KG) sequence databases to provide additional sequence variation and 
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increase proteome coverage.  The metagenomes published from Gill et al.[22] (17,688 
contigs; ORFs ≥ 20 amino acids; ~50,000 predicted proteins; available at the Joint 
Genome Institute (JGI) IMG database under NCBI project ID 16729) and Kurokawa et 
al.[24] (81,968 contigs; ORFs ≥ 50 amino acids; ~300,000 predicted proteins; available 
at CAMERA (2007)) studies were sequenced via Sanger-based methods.  The amino 
acid sequence of the proteins belonging to the two samples’ metagenomes used in this 
study (6a and 6b in addition to 15a, 15b, 16a, 16b, 18a, 18b) can be accessed through 
the NCBI Protein Database under NCBI project ID 46321. 
For each of the protein sequence databases described above (NM, CAFM, RFM, 
NM_KG, and RFM_KG), we concatenated the metagenomic protein predictions from 
multiple individuals into a single database.  For example, NM, RM, RFM, and CAFM 
each contain metagenomic sequences from seven individual human samples from this 
study (15a, 15b, 16a, 16b, 18a, 18b, and 6b), which include an unrelated healthy 
sample 16b (Figure 2 comparisons).  The NM_KG and RFM_KG protein databases 
contain the same 7 metagenomic predicted protein sequences (15a, 15b, 16a, 16b, 
18a, 18b, and 6b), but unlike NM and RFM, contain the published 13 Japanese 
metagenome sequences[24] and 2 American metagenome sequences[22] for a total of 
22 concatenated metagenomes per protein sequence database. 
 Deeper whole genome shotgun sequencing was obtained from an extra run on 
6b and an additional sample (6a), extracted using the Zymo and MioBio method, which 
resulted in a four-fold increase in sequence data for these two healthy samples (Table 
7.2).  Due to the limitations of analyzing this larger metagenomic sequence dataset, 
these sequences were processed similar to the RM strategy and compiled into 2-
independent protein databases, termed RMPS, for 6a and 6b in this assessment.  Each 
of these 8 protein databases (NM, NM_KG, CAFM, RFM, RFM_KG, RM, RMPS-6a and 
RMPS-6b) included human reference sequences (July 2007 release, NCBI; ~36,000 
protein sequences) and common contaminants (i.e., trypsin and keratin; 36 protein 
sequences).  Lastly, a 6-frame translation library was generated for sample 6a and 
searched against one MS experiment. 
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Table 7.2: Metagenomic sequencing metrics. 
  
7.2.3: Spectral analysis 
Microbial proteins were extracted and processed for 2D-LC-MS/MS as described[26] 
using an Ultimate HPLC system (Dionex, Sunnyvale, CA) coupled to a high resolution 
LTQ-Orbitrap (Thermo Fisher Scientific, San Jose, CA).  Peptide mixtures from the two 
samples, 6a and 6b, were separated by a 12 step, multidimensional high-pressure liquid 
chromatographic elution consisting of eleven salt pulses followed by a 2 hr reverse-
phase gradient from 100% solvent A (A: 95% H2O, 5% acetonitrile, 0.1% formic acid) to 
50% solvent B (B: 30% H2O, 70% acetonitrile, 0.1% formic acid).  Precursor full MS 
spectra (from 400-1700 m/z) were acquired in the Orbitrap with resolution = 30,000 
followed by five data-dependent MS/MS scans at 35% normalized collision energy in 
the LTQ with dynamic exclusion enabled.  All RAW files were converted to mzXMLs 
using ReAdW (v4.3.1; 2009) and mzXMLs subsequently converted to dta files using 
MzXML2Search (v4.3.1; 2009).  All MS/MS were searched with SEQUEST (v.27)[66] for 
fully tryptic peptides (≤ 4 missed cleavages, 3 Da parent mass tolerance window, 0.5 Da 
fragment ion window) against each of the 8 custom-made FASTA formatted protein 
sequence databases described above.  Since it is well established that trypsin cleaves 
primarily C-terminal to Arg and Lys[189], we have found in a variety of microbial 
communities[42,190,191] that using fully tryptic searches provides increased confidence 
in the peptide assignments while minimizing the potential for increased false positives 
due to incorrect candidate peptide sequences.  All SEQUEST output files were 
assembled and filtered using DTASelect (v1.9)[98] at either a 2-peptide level for all 
seven: NM, NM_KG, RM, RFM_KG, RFM, CAFM, and RMPS databases and also 1-
Metagenome LC Prep DNA Extraction Total Reads Total KiloBP Avg Read Length
15a 1 MoBio 563,893 220,685 391
15b 1 MoBio 550,360 204,845 372
16a 1 MoBio 585,262 229,389 392
16b 1 MoBio 418,759 147,547 352
18a 1 MoBio 627,543 221,475 353
18b 1 MoBio 424,935 142,718 336
6a 1 MoBio 1,079,211 403,882 374
6b 1 MoBio 584,264 220,354 377
6b 2 MoBio 599,107 188,577 315
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peptide level for the RMPS database searches with the following widely accepted 
parameters: cross correlation scores (XCorr) of at least 1.8, 2.5, 3.5 for +1, +2, and +3 
charge states[42,92,98], respectively and a minimum deltCN of either 0.08 (default) for 
all seven databases (NM, NM_KG, RM, RFM_KG, RFM, CAFM, and RMPS databases) 
and/or 0.0 for NM, NM_KG, RFM, RFM_KG, RMPS-6a and -6b, and target-decoy 
databases (described under “false discovery rates”).  Post-translational modifications 
and other fixed modifications were not included in the search criteria.   
We used the high mass accuracy capabilities of the Orbitrap with a wide mass 
tolerance to measure precursor ion (peptides) masses at low parts-per-million (ppm) 
and the ion trap to efficiently measure fragment ions at lower resolution.  A “post-
database search” filter with high precursor mass accuracy was used by comparing the 
theoretically derived peptide from the SEQUEST mass with what was observed in the 
Orbitrap in the full scan preceding the MS/MS scan.  Recently, Hsieh et al. indicated 
that a wide precursor mass window in a database search[192] and a post-database high 
precursor mass accuracy filter is a more superior method to control false positives.  
Therefore, for post-filtering the database results by high mass accuracy, the mass 
deviation (in ppm) of a PSM was calculated using the measured monoisotopic mass 
and theoretical monoisotopic mass of the peptide.  For all of the database searches 
(NM, NM_KG, RM, CAFM, RFM, RFM_KG, RMPS-6b and -6a, and target-decoy 
databases) and comparisons, DTASelect was run with a t0 option to report all MS/MS 
spectra, in which case two spectra per protein, rather than two peptides, are required for 
identification.  We compared each of the database results in a relative fashion such that 
all comparisons (degenerate peptides) are consistent to one another.  Every MS/MS 
spectrum that is assigned to a peptide (unique and non-unique peptides) was noted and 
handled by DTASelect as described[98]; therefore, we recognize peptides that are 
shared (non-unique) among multiple proteins.  While we recognize that non-unique 
peptides are somewhat problematic for label-free quantification using spectral counts, 
this was not the focus of the current study. 
Spectral quality assessment was accomplished utilizing an in-house developed 
script that parses the SEQUEST output and mzXML formatted spectral data.  All 
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spectra collected during an analysis were categorized according to type: full scan (MS1) 
or tandem mass spectra (MS/MS).  MS/MS spectra assigned to a peptide by SEQUEST 
were noted while the remaining unassigned MS/MS spectra were classified as high-
quality or poor based on the following conditions: a. the charge state of the parent ion 
must be greater than 1, b. the minimum absolute intensity must be greater than 2500 
counts, and c. greater than three fragment peaks within 20% of the based peak must be 
present (all other details in preparation to be submitted for publication).  To quantify the 
peptide-spectrum success, MS/MS were categorized as (i) assigned or unassigned to a 
peptide and (ii) if unassigned, a score of high-quality or poor as reflected by four 
methods (NM, CAFM, RFM, and RMPS) and six databases (NM, CAFM, RFM, 
RFM_KG, and RMPS-6a and -6b). 
7.2.4: False discovery rates 
A target-decoy database[96,126] was generated for each of the five metagenomic 
processing methods (NM, CAFM, RM, RFM, RMPS), for a total of six forward-reverse 
databases (RM, RFM, CAFM, KG, NM_KG, and RMPS-6b) and searched against one 
of the two samples (6b) used in this study to estimate the peptide-level false discovery 
rate (FDR) with the new metagenomic processing methods.   One sample and technical 
run (6b, Run1) was used to represent the entire sample set (2 samples; 4 runs) for each 
target-decoy database search in order to reduce the total number of target-decoy 
databases, search time, and complexity of comparisons.  All target-decoy SEQUEST 
output files were assembled and filtered using DTASelect (v1.9)[98] with the same 
XCorr filters as described previously, and either a ≥1 peptide per protein with a deltCN 
filter of 0.0, or a ≥2 peptide per protein with a deltCN of 0.0 (RMPS-6b) or 0.08 
(NM_KG, CAFM, RM, RFM, and KG), with an empirical FDR threshold of ≤ 2.0%.  The 
initial, 1-peptide filter and deltCN 0.0, forward-reverse database searches provide FDRs 
for NM_KG, CAFM, RM, RFM, KG, and RMPS-6b (read-based) database analyses 
while the latter, 2-peptide and deltCN 0.08 filter, forward-reverse database searches 
contain the same filtering criteria as the original forward databases (NM, NM_KG, RM, 
RFM_KG, RFM, CAFM, and RMPS databases; Table 1 results) described earlier.  
Finally, a forward-reverse database was also created for the final paired metagenome 
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sequence strategy (RMPS) for 6b and searched against the spectra collected from 6b, 
Run 1 and Run 2 using a deltCN 0.0, 1-peptide minimum, and high mass accuracy 
filtering.  The identified peptides (both forward and reverse) were then mapped back to 
the protein sequences derived from the assembled metagenomic sequences using a 
post-database 2-peptide filter by exact string comparisons.  Although the peptides with 
corresponding high mass accuracy measurements (±10 ppm) were considered for all 
downstream analyses, the peptide-level FDRs were estimated for both, with (-10 ≤ ppm 
≤ 10) and without (ppm < -10 and ppm > 10) high mass accuracy, for 6b, Run1 against 
six genomic processing methods (NM_KG, CAFM, RM, RFM, KG, and RMPS-6b).  
Each protein entry (sequence) was reversed, i.e., the original N-terminus became the C-
terminus.  The new reverse (false) sequences were then appended onto the backend of 
the original forward sequences where each set, forward and reverse, represents 50% of 
the entire database.  A peptide-level FDR was calculated based on the calculation: 
2[nrev/(nrev + nreal)]*100 where nrev is the number of peptides identified from the reverse 
database and nreal is the number of peptides identified from the real (forward) 
database[96].      
7.2.5: Sequences similarity searches 
Peptides obtained from our SEQUEST/DTASelect searches were searched against the 
6b and 16b protein databases using the FASTS algorithm and against raw sequencing 
reads using TFASTS[193], algorithm that compares peptides to DNA sequence, using 
an e-value cutoff of 10-5.  
7.2.6: De novo sequencing of peptides by MS   
PepNovo+[105] and PEAKS[109] algorithms were used to de novo sequence MS/MS 
spectra collected from both samples, independent of all sequence databases.  The 
PEAKS (v4.5 SP2) algorithm computes the best possible sequence among all probable 
amino acid combinations at a full peptide length confidence followed by individual amino 
acid confidence per residue in the predicted sequence for a MS/MS.  PEAKS was run 
with default parameters with a parent mass error tolerance of 0.5 Da, fragment mass 
error tolerance of 0.5 Da, and trypsin digestion.  First, a 90% confidence level was 
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required for the overall, full length prediction to be correct and second, an 80% 
confidence level was required for each residue within that sequence, which is consistent 
with Ma et al.[109].  PepNovo+ (v3.1) was executed using the following recommended 
parameters: -model CID_IT_TRYP -digest TRYPSIN -pm_tolerance 0.05 -
num_solutions 5 -output_cum_probs. The top-scoring tags of all spectra were filtered 
using a cumulative probability cutoff of 0.5.  In the sequence tags produced from both 
algorithms, the isobaric amino acid pair of Isoleucine (I) and Leucine (L) and the nearly 
isobaric pair of Lysine (K) and Glutamine (Q) are considered equivalent.  L and I were 
both substituted with the letter, J, for convenience.  Additionally, Q and K were 
substituted with the letter, U, since they are not easily resolvable (small mass difference 
of 0.036 Da) with ion trap MS/MS data.  For all three algorithms, SEQUEST, PEAKS, 
and PepNovo+, a minimum of 3 residues has to be assigned to a spectrum for it to be 
considered for any additional analysis and comparison to other algorithms.  For PEAKS, 
only the high confidence sequence tag was used for all analyses, not the predicted full-
length peptide sequence.  For the comparison of PSMs between all three algorithms, a 
“partial” consensus sequence was considered as a peptide sequence that has ≥3 amino 
acids that are exactly the same for the same mass spectrum between either SEQUEST 
peptide sequences, Peaks’ high confidence sequence string, and/or Pepnovo+s’ 
sequence tag.  If a PSM has an “exact” consensus sequence with 100% sequence 
identity between any two or more algorithms, it would be considered a shared, exact 
consensus sequence.  If a PSM does not have at least 3 residues within a peptide 
sequence string that match two or more algorithms, that spectrum would be considered 
unique to that algorithm.  The identified SEQUEST/DTASelect PSMs for RMPS-6a and -
6b sequence databases with a 1-peptide minimum and deltCN of 0.00 for 6a (Run 2 and 
3) and 6b (Run 1 and 2) were compared to the PSMs from PEAKS and PepNovo+.  The 
breakdown of partial and exact consensus sequences versus PSMs that are unique to a 
specific algorithm can be found in the Venn diagram.  We did not take into account any 
single amino acid polymorphisms in the algorithms’ consensus sequence comparisons.  
In this study, we controlled the false discovery rate by only using the high confidence 
consensus sequences tags found between the two de novo algorithms using their 
respective optimum parameters.  
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7.3: Results 
7.3.1: Protein sequence database comparison 
Four protein prediction strategies (Figure 7.1) were implemented for metagenomic DNA 
sequences obtained from two healthy human fecal samples (referred to as 6a and 6b), 
using a combination of assembly and gene prediction methods.  Each protein sequence 
database has a defined acronym (2-4 letters), designating the strategy used (Figure 7.1 
and Table 7.1).  Our goal was to increase peptide-spectrum matches (PSMs) using MS 
database searching for which the MS data was collected from the same samples as the 
DNA sequence data.  The ability to accurately match peptides to tandem mass spectra 
(MS/MS) was assessed by comparing the number of PSMs and unique peptides 
identified for each database search with SEQUEST/DTASelect at a 2-peptide level, 
deltCN 0.08, and XCorr filtering against the same 2 samples, 6a (with spectra from runs 
2 and 3) and 6b (with spectra from runs 1 and 2) (Table 7.1).  These results illustrate 
how common metagenomic processing methods (assembly and ORF finding) affect 
peptide and spectra identification (Table 7.1).  From these results, three major trends 
emerge: (A) Collapsing of the sequence data by assembly decreases the number of 
assigned spectra.  There was a decrease of assigned spectra when all reads were 
assembled from all samples compared to assembly by individual sample (NM, 23,026 
spectra vs. CAFM, 17,470 spectra).  Additionally, if reads are annotated without 
assembly, PSMs increase (NM, 23,026 spectra vs. RM, 34,666 spectra).  This can be 
largely attributed to the increased diversity of possible peptides, determined by in silico 
trypsin digestion, in the unassembled data, which is over 3 times what is found in 
assembled data (5,638,100 vs. 1,639,802).  (B) An increase in spectrum assignment 
usually translates to an increase in unique peptide identifications.  For example, the 
11,640 gains in spectral assignment translate to a 3,624 gain in identification of unique 
peptide sequences for RM compared to NM (Table 7.1).  However, this was not 
observed when comparing CAFM to NM, where the 5,556 gains in spectra assignment 
translated to a decrease of 2,638 unique peptides (Table 7.1).  (C) De novo gene 
finding methods are sufficient for optimal spectrum assignment.  The combined de novo 
and homology-based gene finding method did not increase PSMs as hypothesized 
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(RFM, 34,665 spectra vs. RM, 34,666 spectra) nor the number of identified unique 
peptides (RFM, 9,608 peptides vs. RM, 9,618 peptides; Table 7.1).  
Because of the low relative sequence coverage of our metagenomic samples, we 
wanted to evaluate whether adding metagenomic sequences from 15 unrelated 
samples in two published studies would enhance our spectrum assignment.  Therefore, 
to protein databases NM and RFM, we added the proteins sequences from predicted 
ORFs from two published human gut metagenomic studies, referred to as “KG” for 
Kurokawa et al. and Gill et al.[22,24], which are referred to as NM_KG and RFM_KG 
respectively.  The KG database contains 13 metagenomes from a Japanese cohort[24] 
and 2 metagenomes from an American cohort[22], both geographically distinct from 
samples in this study.  When compared to the metagenomic sequences in this study, 
only 9% of sequences align in KG at 99% identity or greater; thus, they provide over 2 
million additional unique peptides for MS/MS assignment, that are not identified in any 
of the matched metagenomes.  Because the assemblies from these studies are on 
average longer (average contig length of 2,300 nt for Kurokawa et al. compared to an 
average contig length of 1,128 nt in this study), the predicted proteins are more likely to 
be full-length compared to ORFs in this study (average protein length of 194.5 aa for 
Kurokawa et al. metagenomes; average protein length of 225 aa for Gill et al. 
metagenomes compared to an average protein length of 168.5 aa in this study).  By 
including metagenomic sequence from additional sources[22,24], the number of 
identified spectra increased (NM versus NM_KG (23,026 versus 41,267 spectra) and 
RFM versus RFM_KG (34,665 versus 43,726 spectra)) for 6a (Run 2 and 3) and 6b 
(Run 1 and 2) in total (Table 7.1).  However, the additional KG sequence data came at 
the cost of increased peptide degeneracy and subsequent protein redundancy (i.e., 
peptides mapping to multiple proteins or to the same protein in multiple metagenomes 
within the sequence database).  Although the level of redundancy ranges with the 
sequence diversity of a sample and has no effect on the actual database search 
algorithms, this complicates protein inference and assigning its’ corresponding 
phylogenetic origin in a complex environmental community. 
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While the four metagenomic processing methods were compared based on their 
ability to comprehensively assign all collected MS/MS spectra to peptides, the 
percentage of assigned and high-quality unassigned MS/MS is equally important to 
establish the utility of each sequence database.  For the following spectral analyses, the 
collected and assigned spectra from sample 6a (Run 2 and 3) and 6b (Run 1 and 2) 
were assessed and categorized after applying the same filters described above (2-
peptide level and deltCN 0.08 filter) with the following databases.  Of the total MS/MS 
collected during one MS experiment (70,000-81,000), on average 6,600 spectra were 
assigned to a peptide sequence in the NM database (~8% of total collected MS/MS 
spectra for a single run; Table 7.3).  In contrast, the processing strategy used to create 
RFM resulted in the assignment of an additional 1,800 MS/MS from the same sample, 
for a total of 8,430 peptide-spectrum matches on average (11% of total collected 
MS/MS).  Furthermore, the addition of unrelated KG sequences to RFM (a 25% 
increase in sequence data) resulted in an increase of the number of assigned spectra 
by only 2-3%.  Finally, the strategy used to create RMPS resulted in an additional 4,000 
MS/MS spectra assigned, for a total of 12,461 peptide-spectrum matches on average 
per sample (16% of total collected MS/MS spectra).  Although the total number of 
assigned MS/MS increased from NM < RFM < RFM_KG < RMPS, the number of 
unassigned, high-quality spectra decreased with database quality (NM > RFM > 
RFM_KG > RMPS).  
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Table 7.3: Database dependent distribution of acquired full MS and MS/MS and 
assigned MS/MS for samples 6a and 6b.  Unassigned MS/MS were parsed into either 
quality or poor spectra. 
 
The effects of two common filtering parameters (deltCN and high mass accuracy) 
on MS/MS peptide assignment were examined by determining the quantity of MS/MS 
spectra not assigned to the same peptide in multiple database searches (Supporting 
Text).  These results (Figure 7.2) suggest that filtering on high mass accuracy rather 
than deltCN can decrease ambiguous peptide-spectrum matches and provide more 
consistent and reproducible MS/MS identifications.  In order to maintain high specificity 
and accuracy with increasing metagenomic sequence data, a false discovery rate (FDR) 
was estimated at the peptide level using an established method of reverse database 
searching[96,126] for each metagenomic processing method for a total of 6 target-
decoy databases (RM, RFM, CAFM, KG, NM_KG, RMPS-6b).  Because we are using 
methods that directly measure peptides, not proteins, the FDR was estimated at the 
peptide level. In addition, we are primarily comparing the performance of all databases 
by peptide-spectrum matches, not proteins, given the nature of the metagenomic 
processing methods and their corresponding databases (i.e., not all databases contain 
assembled contigs, but only reads).  It has previously been noted[75] that false 
discovery rates can be difficult to accurately determine with metaproteome datasets due 
to problems associated with massive peptide degeneracy.  In this study, for example, of 
all the identified peptides for 6a (Run 2), only 7-30% were unique peptides from each 
database.  Consequently, if only unique peptides are used, the false discovery rate 
Sample Run # Database Total Spectra Collected
# MS1 
Collected
# MS/MS 
Collected
# 
Assigned 
MS/MS
% 
Assigned 
MS/MS
# Unassigned 
MS/MS
# of Quality MS/MS 
(ID'd + Qual Unass.)
# Poor Unass. 
MS/MS
# Quality 
Unass. MS/MS
NM 6,163 7.86 72,218 13,375 65,006 7,212
CAFM 8,872 11.32 69,509 15,681 62,703 6,809
RFM 8,854 11.30 69,527 15,622 62,759 6,768
RFM_KG 10,576 13.49 67,805 16,983 61,398 6,407
RMPS 13,426 17.13 64,955 19,139 59,242 5,713
NM 5,301 7.52 65,205 6,752 63,754 1,451
CAFM 7,918 11.23 62,588 9,215 61,291 1,297
RFM 8,305 11.78 62,201 9,522 60,984 1,217
RFM_KG 9,911 14.06 60,595 11,041 59,465 1,130
RMPS 12,413 17.60 58,096 13,390 57,119 977
NM 7,434 9.15 73,768 16,380 70,222 8,946
CAFM 8,391 10.33 72,811 16,921 64,281 8,530
RFM 8,234 10.14 72,968 16,802 64,400 8,568
RFM_KG 10,778 13.27 70,424 18,698 62,504 7,920
RMPS 12,077 14.87 69,125 19,543 61,659 7,466
NM 7,498 9.28 73,299 16,893 63,904 9,395
CAFM 8,517 10.54 72,280 17,594 63,203 9,077
RFM 8,327 10.31 72,470 17,447 63,350 9,120
RFM_KG 10,715 13.26 70,082 19,182 61,615 8,467
RMPS 11,927 14.76 68,870 20,124 60,673 8,197
78,38194,379
85,191Run 3
15,998Run 2
14,685 70,506
16,504 80,797
16,705 81,202
6a
6b
Run 1
Run 2
97,907
97,301
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would be overestimated; on the contrary, if all peptides are used the false discovery rate 
could be underestimated[75].  Therefore, to set a static FDR threshold and filter multiple 
databases (6 sequence databases in this study) of different sizes and internal levels of 
peptide redundancy to that threshold (i.e., 1%) becomes a challenge, in this case, for 
comparing and identifying the best metagenomic processing method for MS/MS 
database searching and peptide-spectrum matching.  As the level of redundancy affects 
the FDR, we have chosen a set of fixed scoring filters in order to accurately compare 
database assignments.  Thus, the same filter criteria to all database searches (i.e., 
Xcorr and ppm filtering) was applied to all database searches with a requirement that 
the FDR be less than or equal to, i.e., 2.0%.  The FDRs for the 1-peptide level, deltCN 
0.0, with and without HM filtering were 1.17%-2.03% and 16.09-31.47%, respectively for 
6b, Run 1 (Table 7.4).  The 2-peptide level and deltCN 0.08 filtered reverse database 
searches serve to represent the FDR of peptide identifications found in Table 1.  The 
FDRs for these PSMs, with and without HM filtering were within 0.09%-0.38% and 2.17-
4.15%, respectively for 6b, Run 1 (Table 7.5).  Following the application of a post-
database high precursor mass accuracy filter (± 10 ppm) to both, the 1- and 2-peptide 
filtered forward-reverse datasets, the number of identified reverse peptides decreased 
by, on average, 93% for each database which resulted in a reduction of the FDR to 
0.09%-0.38%.  
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Figure 7.2: Accuracy Assessment by DTASelect Filtering.  (A) For each DTASelect 
peptide prediction search, the number of identified spectra was calculated and 
compared using three different parameter combinations, deltCN filtered results at a 
deltCN of 0.08 only, both deltCN of 0.08 and HM (±10 ppm), and HM (±10 ppm) only, 
where identified peptide sequences were designated either ‘Consistent’ (solid gray) or 
‘Inconsistent’ (diagonal stripes).  (B) A VENN diagram with assignable spectra for RFM, 
RFM_KG, NM, and NM_KG databases, filtered by high mass accuracy, for both 
samples combined. 
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Table 7.4: False discovery rates for sample 6b (Run 1) against six different 
metagenomic-predicted sequence databases.  The database results were filtered at a 1-
peptide level with and without high mass accuracy. 
 
 
Table 7.5: False discovery rates for sample 6b (Run 1) against six different 
metagenomic-predicted sequence databases.  The database results were filtered at a 2-
peptide level with and without high mass accuracy. 
 
7.3.2: Tracking Missing Peptides 
By adding the unrelated KG metagenomic sequences to the RFM protein database, the 
number of additional predicted unique peptide sequences increased by 40%.  
Therefore, we wanted to determine how many additional peptide-spectrum matches 
were gained by adding these KG proteins sequences to the database.  The RFM_KG 
assigned MS/MS were distributed into three different categories: RFM only, KG only, 
and RFM plus KG (shared) for each sample (Table 7.6).  The majority of RFM_KG 
assigned spectra were “shared” between both RFM and KG protein sequences.  About 
26% of the total spectrum assignments were unique to the RFM protein sequences 
(zero overlap with KG sequences) and only ~8% of the spectra were unique to the KG 
protein sequences (no overlap with the RFM sequences) (Table 7.6).  
 
 
 <±10 ppm >±10 ppm <±10 ppm  >±10 ppm <±10 ppm >±10 ppm Total FP FP <±10 ppm
RM 19,589 8,747 69.13% 30.87% 321 4,551 29.34% 1.93%
RFM 18,229 8,375 68.52% 31.48% 320 4,648 31.47% 2.03%
CAFM 17,443 7,676 69.44% 30.56% 277 4,094 29.64% 1.88%
KG 20,059 7,672 72.33% 27.67% 256 3,419 23.40% 1.63%
NM+KG 23,881 8,709 73.28% 26.72% 256 3,603 21.17% 1.40%
RMPS 27,218 8,722 75.73% 24.27% 228 2,917 16.09% 1.17%
6b, Run1
False Discovery RateSample Database            (Forward/Reverse)
Total Identified Forward % of Forward Identified Total Identified Reverse 
 <±10 ppm >±10 ppm <±10 ppm  >±10 ppm <±10 ppm >±10 ppm Total FP FP <±10 ppm
RM 15,363 3,523 81.35% 18.65% 27 310 3.51% 0.28%
RFM 13,971 3,057 82.05% 17.95% 33 328 4.15% 0.38%
CAFM 13,783 2,902 82.61% 17.39% 16 291 3.61% 0.19%
KG 16,840 3,695 82.01% 17.99% 15 248 2.53% 0.14%
NM+KG 19,898 4,320 82.16% 17.84% 11 255 2.17% 0.09%
False Discovery RateSample
6b, Run1
Database 
(Forward/Reverse)
Total Identified Forward % of Forward Identified Total Identified Reverse
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Table 7.6: Distribution of RFM_KG assigned PSMs for 6a (Run 2 and 3) and 6b (Run1 
and 2).  The assigned PSMs were distributed into three different categories: RFM only, 
KG only, and RFM plus KG based on their sequence uniqueness to each set of 
sequences.  If a PSM was unique to protein sequences in RFM, but was not present in 
KG, the PSM was classified and categorized as RFM only and vice versa.  If a PSM 
was found to match a protein in both, RFM and KG, the PSM was categorized as a 
shared spectrum. 
 
There are two possible hypotheses for why the metagenomes from these 
samples (i.e., RFM) cannot be used to assign peptides to spectra which are assignable 
by the unrelated protein database KG: (1) because of low sequencing depth, peptides 
are not assigned because our protein database is incomplete or (2) because of a 
sequencing error or limitation for predicting ORFs, we are unable to predict the proteins 
that are present.  Therefore, we have aligned the RFM_KG (2-peptide, deltCN 0.08, HM 
filtered) identified peptides (Figure 7.3, y-axis) from 6a (left panel) or 6b (right panel) to 
predicted raw reads from the related/same sample (6b) and an unrelated sample (16b) 
(Fig. 7.3, x-axis) using TFASTS (Fig. 7.3, white, fine striped bars).  Those results were 
compared to alignments of the same identified peptides to the predicted protein 
database from the related/same sample (6b) and the unrelated sample (16b) using 
FASTS[193] (Fig. 7.3, gray, solid bars).  As expected, more peptides mapped to the 
related/same (matched metagenome-metaproteome) sample (15% for 6a: left panel, 
Fig. 7.3 and 6b: right panel, Fig. 7.3) than to the unrelated, 16b, predicted protein 
sequences (8% for 6a and 10% for 6b).  When these same peptides were compared 
using TFASTS (algorithm that compares peptides to DNA sequence) to the raw 
sequencing reads (Fig. 7.3, white, fine striped bars), the number of peptides matching to 
reads increased by two-fold for both 6a and 6b.   
Unique 
Spectra
% of RFM & KG 
Spectra
% of Total 
Spectra
Unique 
Spectra
% of RFM & 
KG Spectra
% of Total 
Spectra 
Shared 
Spectra
% of RFM & 
KG Spectra
% of Total 
Spectra
6a, Run 2 8,012 34.33% 30.35% 1,454 6.23% 5.51% 13,869 59.43% 52.53% 26,403
6a, Run 3 6,995 31.20% 27.73% 1,341 5.98% 5.32% 14,085 62.82% 55.84% 25,223
6b, Run 1 5,651 27.09% 23.64% 2,431 11.65% 10.17% 12,779 61.26% 53.46% 23,902
6b, Run 2 5,595 28.29% 23.93% 2,149 10.86% 9.19% 12,036 60.85% 51.48% 23,378
Runs Averaged 6,563 30.23% 26.41% 1,844 8.68% 7.55% 13,192 61.09% 53.33% 24,727
Sample
RFM_KG Database
Total Assigned 
Spectra
RFM Only Kurokawa & Gill (KG) Only RFM and KG
	   156	  
 
Figure 7.3: Comparison of identified peptides using sequence similarity techniques.  
Percentage of matches found when comparing identified peptides from sample 6a (left 
panel) or 6b (right panel) to predicted proteins using FASTS (gray bars) and raw 
sequencing reads using TFASTS (white striped bars). 
7.3.3: Targeting Peptide Discovery 
Throughout the course of our study, we were able to accumulate more metagenomic 
sequence data for the two healthy samples, 6a and 6b, by ~5 fold (Table 7.2, italicized 
text).  Although this increase in predicted ORFs resulted in an increase in the number of 
assigned MS/MS spectra, it can reduce the throughput of MS/MS sequence-database 
searching. Therefore, we investigated the impact of searching a metagenomic-based 
protein database derived from the exact same single sample to that of a concatenated 
sequence library of all available metagenomic data from this study.  The additional 
metagenomic sequences were used to construct a sequence database similar to that of 
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RM (non-assembled reads with 5.6 million predicted unique peptides), called RMPS 
(Figure 7.1) which has ~ 1.3 million predicted unique peptides, on average, per healthy 
sample 6a and 6b.  Searching the RMPS sequence databases with SEQUEST using 
standard 2-peptide, deltCN 0.08, and high mass accuracy filtering decreased the 
compute time to ~ 300-500 minutes per MS raw file.  By increasing the amount of 
metagenomic sequence data for a single sample, the total number of assigned spectra 
increased by 63% (from 34,666 to 56,782) and the number of total identified non-
redundant (NR) peptides increased by 67% (from 9,618 to 16,055) (Table 7.1, RM 
versus RMPS), resulting in a 54% increase in protein identifications (3,394 to 5,233) 
when mapping these peptides to a protein dataset generated from assembled reads for 
the exact same metagenomic sample.  
 Other than limitations associated with computational resources, there was also a 
concern that real peptides predicted from 454-reads would be filtered out given a 2-
peptide per protein minimum filter (Table 7.7, top panel).  Therefore, the filtering 
parameters were readjusted with a deltCN 0.0, 1-peptide minimum, and a high mass 
accuracy filter (±10 ppm) for the SEQUEST RMPS database searches for both 6a (Run 
2 and 3) and 6b (Run 1 and 2).  The identified peptides were then mapped back to the 
predicted protein sequences derived from the assembled metagenomic sequences with 
a 2-peptide filter, resulting in an increase of protein identifications, from 5,233 to 6,186 
(Table 2, RMPS top panel versus bottom panel).  The filtering parameters were also 
readjusted with a deltCN 0.0 and a high mass accuracy filter (±10 ppm) for the 
SEQUEST-RFM database searches for both 6a (Run 2 and 3) and 6b (Run 1 and 2).  
The protein identifications also increased, from 3,431 to 3,706 (Table 7.7, RFM top 
versus bottom panel).  While this increase might seem minimal, there is significantly 
less redundancy, less false positives, and no computational cost added to these filtering 
parameters.  The false discovery rate, using the same filtering parameters (deltCN 0.0, 
1-peptide minimum and HM) for the RMPS database was 1.17% for 6b (Table 7.4), 
however, these identified peptides (≥ 1 peptide/read) were mapped back to the 
predicted protein sequences derived from the assembled metagenomic sequences 
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using a post-database ≥2-peptide/protein filter.  Following application of this 2-
peptide/protein filter, the FDRs dropped to 0.1%-0.2% for 6b, Run 1 and 2 (Table 7.8). 
Table 7.7: Comparison of RFM and RMPS database results with different filtering 
metrics and a post-database mapping strategy. Comparison of SEQUEST/DTASelect 
database search results, non-redundant spectra and protein counts with different 
filtering parameters and HM, post-database mapping of identified peptides to a protein 
dataset generated from assembled reads for the same metagenomic sample. 
Protein Database RFM RMPS 
2-peptide, deltCN 0.08, HM Filter 
 Spectra Protein Spectra Protein 
6a Run 2 3,246 1,154 6,542 1,761 
6a Run 3 3,091 1,010 6,237 1,544 
6b Run 1 2,639 637 5,212 973 
6b Run 2 2,552 630 4,870 955 
Total 11,528 3,431 22,861 5,233 
1- or 2-peptide, deltCN 0.0, HM Filter 
 Spectra Protein Spectra Protein 
Peptide Criteria ≥ 2 peptide ≥ 1 peptide 
6a Run 2 3,541 1,252 7,497 2,069 
6a Run 3 3,346 1,088 7,048 1,808 
6b Run 1 2,879 686 5,881 1,182 
6b Run 2 2,786 680 5,502 1,127 
Total 12,552 3,706 25,928 6,186 
 
Table 7.8: False discovery rates for sample 6b (Run 1 and 2) against the RMPS 
database.  An initial ≥1-peptide, deltCN 0.0, and high mass accuracy (±10ppm) filter 
were applied to the read-based identifications followed by a ≥2-peptide/protein post-
database mapping filter. 
 
 
 
Sample Total Peptides
Non-redundant 
Peptides
Total Identified 
Forward Peptides
Non-redundant 
Forward Peptides
Total Identified 
Reverse Peptides
Non-redundant 
Reverse Peptides
Total 
FDR (%)
Non-redundant 
FDR (%)
6b, Run 1 5,500 3,765 5,498 3,763 2 2 0.07 0.11
6b, Run 2 5,325 3,538 5,316 3,535 9 3 0.34 0.17
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7.3.4: De novo Peptide Sequencing 
Two popular algorithms, PepNovo+[105] and PEAKS[109], were used to identify peptide 
sequences de novo from MS/MS spectra collected from both samples, independent of 
all protein sequence databases.  Initially, the two algorithms were run independently on 
the same raw MS data and samples as described.  The identified, high confidence 
consensus sequence tags (≥3 residues) were acquired from each de novo algorithm.  
The de novo consensus sequence tags (Supporting Text) for PEAKS and Pepnovo+ 
were compared for every MS/MS to identify the partial (≥3 residues) and exact 
consensus sequence tags that would represent the most confident PSMs identified by 
the two different de novo algorithms.  In this study, it was not our goal to compare the 
performance of the two programs; instead, we want to combine the best results from the 
two programs using their respective optimum parameters.  The final, representative de 
novo consensus tags were compared to the previously mentioned SEQUEST results 
from the RMPS sequence database searches that were filtered at a ≥1 peptide/read, 
deltCN 0.0, and high mass accuracy with a post-database ≥2 peptide/protein filters.    
On average, ~593-724 MS/MS spectra were assigned with a high confidence 
consensus peptide sequence between the two de novo algorithms, but were not 
assigned with the SEQUEST–RMPS database search (Figure 7.4).  These de novo 
peptide sequences were mapped to protein sequences predicted from assembled 
contigs with a 2-peptide minimum per protein and compared to the peptides that were 
identified from the SEQUEST-RMPS database searches.  A total of 421 new, non-
redundant proteins were identified with the de novo sequenced peptides for 
metagenome 6b, and 333 non-redundant proteins for metagenome 6a; these proteins 
were not identified using SEQUEST.  Approximately 450 de novo sequenced peptides 
(non-redundant) per sample could not be mapped to the matched metagenomic 
sequence data.  
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Figure 7.4: Performance and comparison of de novo peptide sequencing results. 
Distribution of assigned spectra per de novo algorithm with a predicted consensus 
sequence (partial and/or exact sequence match) among all three algorithms, PEAKS, 
PepNovo+, and SEQUEST.  Identified peptides from SEQUEST and RMPS sequence 
database were compared to the de novo predicted peptides for (A) 6a and (B) 6b. 
7.4: Discussion 
One of the major goals of MS-based proteomics is to comprehensively identify the 
protein complement of a given sample (isolate, mixture, or community).  The 
proteome(s) of microbial communities are highly complex and pose numerous 
challenges for MS experimentation and analysis.  These challenges include the 
dynamic range of peptide abundances and a number of informatics hurdles, such as 
differentiation between closely related species, identification of sequence 
polymorphisms, and global identification of post-translational modifications.  Many of the 
algorithms used in MS/MS database searching are based on the assumption that a 
protein is derived from a single organism with little sequence diversity.  However, these 
assumptions are no longer valid in the case of complex microbial communities.  This 
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study presents several strategies for improving metagenomic guided MS-based 
metaproteomic peptide-spectrum matching in complex samples.   
It has become very clear that the quality of metagenomic sequence data and 
resulting protein sequence database has a significant impact on community MS-based 
proteomics and the ability to achieve deep proteome coverage.  This study initially 
explored how assembly and gene finding methods for metagenomic sequences affects 
peptide-spectrum matching.  Our findings suggest that predicting ORFs from an ab-initio 
gene finder on metagenomic reads provides the best database for maximal MS/MS 
assignment.  While assembly of metagenomic data can greatly reduce the necessary 
compute time for gene finding and database searching, it essentially collapses 
sequence diversity; thus, it is sub-optimal for maximal spectral assignment. Yet, 
introducing a homology-based gene finding method (RFM) does not increase the 
number of assigned spectra.  Lastly, with an increase in sequence coverage for a 
biological sample, our results suggest that predicted protein sequence databases 
derived from matched metagenomic sequenced reads (RMPS), increases the number 
of MS/MS spectra, peptides, and protein identifications.  In conclusion, expanding the 
metagenomic sequence library for matched or related samples improved peptide-
spectrum matching.  However, improvements in gene finding are equally important to 
maximize protein identification and coverage. 
As the matched metagenomic predicted protein sequence database (RMPS) 
more accurately reflected the “true proteome”, previously unassigned high-quality 
spectra are now being identified and provided greater proteomic depth.  When these 
results were compared to a standard bacterial isolate (e.g., E. coli) with a well-curated 
genome, ~ 41,000 MS/MS spectra were assigned to peptides (37% of total collected 
MS/MS) (data not shown) using the same database searching filters (≥2 peptide and 
deltCN 0.08).  This would suggest that underlying challenges are still inhibiting the 
identification of a majority of spectra collected from the community samples compared 
to that of a standard bacterial isolate.  The classification of acquired and assigned 
MS/MS spectra and quantification of total identified peptides suggested that the RMPS 
processing method provided the most comprehensive assignment of MS/MS spectra.   
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When we examine why some peptides are assigned from the read-based ORFs 
(e.g., RMPS processing method) and not assigned from the contig-based ORFs (e.g., 
NM processing method), we find that these “lost peptides” fall into three categories: (i) 
some reads are not assembled and therefore their protein predictions are not in the 
contig-based ORF predictions, (ii) because of SNPs and frameshifts, the peptides are 
100% similar to a predicted contig-based ORF, but are not 100% identical, and (iii) 
some peptides were very different (<50% identical) or missing from the contig-predicted 
ORF.  A 6-frame translation protein database was generated for sample 6a to capture 
all possible candidate peptide sequences and searched against one MS experiment 
(Run 2).  However, routine use of this sequence database is impractical due to the 
increased quantity of sequences which directly correlates with an increased quantity of 
candidate peptides, therefore, more scoring and prohibitively large search times (~134 
hrs per MS experiment) (data not shown).  As sequencing data generation increases, 
even a read-based strategy could become unsustainable, which will only worsen as new 
larger ‘omic’ datasets become available.  The testing and comparison of new search 
algorithms that are faster, accurate, and developed for omic’ datasets may help 
researchers overcome these challenges. 
Identifying the most reliable set of peptides from a MS-based metaproteomic 
experiment can be complicated, as we have shown that MS/MS assignments can vary 
and be assigned to different peptide sequences with different protein databases.  While 
filtering on deltCN is a common practice for reducing false positives, this type of filtering 
may (i) continue to include many ambiguous peptides based on the different database 
predictions and (ii) remove many legitimate peptides as a result of a highly redundant 
database.  Although filtering on deltCN and peptide-protein matches has proven 
effective for single genome searching, these filters decrease both precision and 
sensitivity in metagenomic predicted sequence databases.  As common filtering 
strategies have proven to be less effective and practical for large-scale proteomics 
studies (e.g., post-translational studies), these and other challenges will surface as the 
MS field moves towards sampling more environmental communities.  Alternatively, we 
propose that when high mass accuracy is used in conjunction with other filtering 
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metrics, such as, cross correlation (XCorr) and enzyme cleavage specificity, one can 
confidently identify the most comprehensive and reproducible set of PSMs and control 
false positives adequately in a complex environmental community sample.  As shown, 
this strategy greatly reduces the rate of ambiguous peptide predictions thereby giving 
higher confidence to our final peptide-protein identifications.  Once peptides are 
identified and mapped to metagenomic sequences, which have been assembled, the 
subsequent use of a 2-peptide filter greatly reduces the number of false positives in 
protein discovery for complex microbial environments.  
Finally, de novo peptide sequencing can complement MS/MS database 
searching to identify peptides absent in the protein sequence database due to the 
limitations of the gene finding algorithms or low metagenomic sequence coverage. We 
believe that novel peptides were identified with high confidence in this study, because 
these peptides were independently identified by two de novo sequencing algorithms.  
However, there is no widely accepted method for us to use for rigorously evaluating the 
FDRs of novel peptides identified from our microbial community samples. Thus, de novo 
sequencing results should be used with the caveat of uncertain FDRs as supplement to 
database searching results[194]. 
7.5: Conclusions 
By using a variety of MS filtering metrics, we were able to assess the quality and 
accuracy of MS/MS peptide sequencing for each MS experiment against four predicted 
protein sequence databases derived from whole genome shotgun sequences.  Our 
findings suggest that: (i) proteomic data is twice as likely to match metagenomic data 
derived from the same sample, (ii) although unrelated metagenomic data may capture 
more sequence diversity, large protein databases can create unreasonable sequence 
redundancy, thereby hampering the ability to differentiate real peptide-protein 
identifications, (iii) the percentage of unassigned, high-quality MS/MS spectra 
decreases with increased quality of metagenomic sequences, (iv) metagenomic data 
processing, such as assembly and gene finding, affects the ability to assign peptides to 
spectra, (v) MS filtering metrics can affect the accuracy of peptide-spectrum matching, 
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(vi) deeper metagenomic sequencing coverage results in deeper coverage of matched 
metaproteomes and (vii) de novo peptide sequencing can overcome potential 
sequencing errors and provide evidence for novel sequences not yet sequenced or not 
identified by database searching methods.  The high-quality unassigned MS/MS from 
sequence-database searching would be ideal target spectra to submit for de novo 
peptide sequencing whereby these sequences could be mapped back to help refine the 
metagenome and identify potential sequencing errors.  Finally, this study illustrates how 
common metagenomic processing methods (assembly and ORF finding) and database 
construction can affect metaproteomics search results. 
	   165	  
Chapter 8 
Meta-omics reveals human host-microbiota signatures of Crohn’s disease 
The text is adapted from: 
Alison R. Erickson, Brandi L. Cantarel, Regina Lamendella, Youssef Darzi, 
Emmanuel F. Mongodin, Chongle Pan, Manesh Shah, Jonas Halfvarson, Curt 
Tysk, Bernard Henrissat, Jeroen Raes, Nathan C. Verberkmoes, Claire M. 
Fraser-Liggett, Robert L. Hettich, and Janet K. Jansson. “Meta-omics reveals 
human host-microbiota signatures of Crohn’s disease.” Draft will be submitted to 
the journal, Molecular Systems Biology (2012). 
Alison R. Erickson’s contributions include experimental preparation of all microbial 
samples for proteomics, experimental LC-MS/MS measurements, integrated matched 
MG-MP comparisons and analyses, biological inference of human proteins, and shared 
primary authorship with Brandi Cantarel and Regina Lamendella. 
8.1: Introduction 
Humans live in close association with communities of microorganisms (the human 
microbiota) that inhabit every exposed surface and cavity in the body[195]. The 
collective genetic information of the human microbiota represents a second genome, 
the human microbiome, currently the focus of intense international sequencing and 
research efforts[14],[196],[25]. Although most human host-microbe associations are 
beneficial, changes in the composition and function of the human microbiota are 
associated with a growing list of diseases, including inflammatory bowel disease 
(IBD)[197]. Several studies using both culture-dependent and molecular approaches 
have suggested that there is a dysbiosis in the gut microbiota of patients with Crohn’s 
disease (CD) compared to healthy subjects[158],[198],[199].  
 Recent advances in DNA sequencing and proteomics technologies have opened 
the door to explore the structure and function of the gut microbiota without the necessity 
for cultivation. However, there have been very few reports to date that have used a 
multi-“omics” approach to study the complex ecosystem in the human gut. The ability to 
combine information about the identities of microbial community members (obtained 
from 16S rRNA gene-based measurements), metabolic potential (obtained from 
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metagenome sequence data) and expressed proteins (obtained from metaproteome 
data) enables explorations of the gut microbiota at multiple molecular levels 
simultaneously[200].  
 In the previous chapter, we compared metagenomic data processing methods, 
such as assembly and gene finding, and their affects on the ability to assign peptides to 
MS/MS spectra.  Using the best performing informatics workflow, predicted protein 
sequence databases derived from matched metagenomic sequenced reads (RMPS), 
we can now apply this workflow to focus on biological inference and human disease as 
opposed to chapter 6, which focuses only on measurements of a healthy twin pair.  This 
study was focused on a subset of fecal samples collected from a large Swedish twin 
cohort with inflammatory bowel disease (IBD) that was previously characterized, with 
respect to their bacterial community composition by deep 16S rRNA pyrotag 
sequencing[158,198,201] and metabolite profiling[202]. Previous data indicated that 
healthy twin pairs had a similar gut microbiota, even when they had been living 
separately for decades. By contrast, twin pairs in which one or both subjects had CD 
harbored very dissimilar gut microbial compositions[158]. This disparity of the gut 
microbiota was particularly striking for subjects with inflammation in the ileum (ileal CD, 
ICD) compared to healthy subjects[158],[202],[201] and was primarily characterized by 
the reduced abundance of several key beneficial members of the community, such as 
Faecalibacterium prausnitzii. 
 Here our aim was to further explore a subset of the same Swedish twin cohort 
that had demonstrated microbial dysbiosis in fecal samples according to CD phenotype, 
for functions that were correlated to CD by applying non-targeted metagenomics12 and 
metaproteomics[26]. This eco-systems biology approach[200] allowed us to detect and 
directly correlate genes and expressed proteins for the first time in the same samples.  
It was particularly valuable to include discordant twin pairs in the sample set, where one 
twin was diseased and one was healthy, to mitigate the influence of host genetics on 
the microbiome[158],[112],[150]. The sample cohort included one healthy twin pair with 
existing metaproteome data[26], one colonic Crohn’s (CCD) twin pair, two ICD 
concordant twin pairs and two ICD discordant twin pairs (Table 2.1). All samples were 
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collected when the Crohn’s subjects were in endoscopic remission, or had minor 
inflammatory activity in the neo-terminal ileum only.  
8.2 Experimental Methods 
8.2.1: Sample collection 
Fecal samples were collected from 6 monozygotic twin pairs: 1 healthy twin pair with 
existing metaproteome data[26], 1 concordant pair with CCD, 2 concordant twins with 
ICD and 2 ICD discordant twin pairs (Table 2.1). DNA was extracted by the MoBio[158] 
and IGS-Zymo[203] protocols producing 3 – 5ug of purified metagenomic DNA from 
each sample. Proteins were extracted and processed for 2D-LC-MS/MS as previously 
described[26]. 
8.2.2: Metagenomics 
Sequences were generated and processed using the 454 Titanium Roche platform and 
assembled using Newbler (v2.0.01.14). Genes were predicted on contigs greater than 
500 bp using METAGENE[187] and for those less than 500 bp using a combination of 
METAGENE and FASTX[188] from alignments to homologous sequences in reference 
genomes.  Proteins were clustered using BLASTP[204], using e-value cutoffs of 10-5, 
and MCL[205], with an inflation value of 1.5. ORFs were searched against the 
eggnog[206], CAZY[129] and KEGG genes[207] using NCBI-BLAST[204] using e-value 
cutoff of 10-6 and bits per position cutoff of 1. 
8.2.3: Metaproteomics 
MS-based shotgun proteomics was performed as described[26] and acquired MS/MS 
searched against two databases: 1) matched metagenomic-predicted protein database 
(MM) and 2) human microbial reference genome database (HMRG); both including the 
human genome. The spectral count for a microbial protein cluster was calculated as the 
number of unique peptide identifications that can be attributed to proteins from that 
cluster only and not any other cluster. Spectral counts for human proteins were 
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calculated from both unique and non-unique peptide identifications. All spectral counts 
were normalized by the total numbers of MS/MS spectra per run. 
8.2.4: Statistics  
Non-metric multidimensional scaling was performed using normalized spectral 
abundances of identified proteins.   Protein lists were generated for proteins that 
correlated with a particular phenotype using Indicator Species Analysis and Wilcoxon’s 
rank sum tests.   
8.3: Results 
We generated whole genome shotgun metagenomic (Table 8.1) and shotgun mass 
spectrometry (MS)-based metaproteomic (Tables 8.2 and 8.3) datasets from the same 
samples for direct comparisons.  Metagenomic data were used to assess community 
gene content and predicted functional capability, while metaproteomics was used to 
identify the most abundant expressed microbial and human proteins.  The number of 
genes identified in each sample was two orders of magnitude greater than that of 
proteins (since proteins cannot be amplified like DNA), although both represent only the 
more abundant fraction of the total gene and protein reservoir in the human gut 
microbiome.   
Table 8.1: Metagenomic sequence data and statistics. 
 
  
Subject Mega base pairs  (Mbp)
Number of 
Reads 
(thousands)
Number of 
Singletons 
(thousands)
Number of 
Contigs
Mbp in 
Contigs 
Average Contig 
Length
Contigs > 
500 bp
Fraction 
Singleton
Fraction Contigs > 
500
6a 684 1,901 299 55,650 66 1195 39,318 0.157 0.7065
6b 409 1,183 372 55,463 43 776 33,375 0.3147 0.6018
9a 245 782 155 19,893 21 1053 13,439 0.1988 0.6756
9b 290 845 197 35,571 27 754 20,011 0.2328 0.5626
10a 502 1,211 82 36,328 49 1337 24,726 0.0681 0.6806
10b 541 1,327 140 30,642 39 1259 20,219 0.1053 0.6598
15a 504 1,358 256 38,046 42 1109 25,909 0.1887 0.681
15b 484 1,270 272 36,871 36 981 21,555 0.2146 0.5846
16a 229 585 207 22,764 18 798 15,545 0.3544 0.6829
16b 319 1,126 511 46,845 28 591 23,857 0.4541 0.5093
18a 425 1,341 215 26,803 27 1014 17,971 0.1604 0.6705
18b 258 955 372 28,631 19 671 13,862 0.3898 0.4842
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Table 8.2:  Normalized total spectra counts across all subjects and 24 MS runs for the 
matched metagenome (MM) database searches. 
 
 
  
Phenotype Sample Run Proteins Peptides Total Identified MS/MS Total Collected MS/MS #DB Entries
2 2,315 9,110 15,724 78,381
3 2,009 8,005 15,452 70,492
2 1,385 5,548 11,300 80,797
1 1,413 5,796 11,258 81,202
1 871 3,738 7,628 92,865
2 829 3,381 7,879 91,745
1 723 2,551 5,153 82,546
2 728 2,532 5,074 84,089
3 1,089 4,474 8,891 90,775
1 1,049 4,286 8,244 91,145
1 1,118 4,078 8,057 75,873
2 1,141 3,984 8,546 74,574
1 946 3,913 9,276 83,254
2 1,183 4,862 10,616 77,906
2 787 3,890 8,647 81,970
1 769 3,421 8,619 80,718
2 369 1,716 4,079 78,811
1 407 1,844 4,012 73,878
2 1,248 4,581 11,659 92,460
3 1,256 4,416 11,914 91,865
2 687 3,233 7,951 76,489
1 654 2,733 7,281 78,661
1 794 3,018 7,640 92,795
2 829 3,245 7,442 93,485
18a
18b
10b
15a
15b
16a
16b
6a
6b
9a
9b
10a
healthy
healthy
colonic CD
ileal CD
ileal CD
ileal CD
healthy
ileal CD
1,356,947
862,006
527,904
594,986
1,428,694
781,500
628,384
1,618,290
1,005,286
982,092
1,119,221
843,556
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Table 8.3: Normalized total spectra counts across all subjects and 24 MS runs for the 
human microbial isolate reference genome database (HMRG) searches. 
 
8.3.1: Taxonomic Community structural differences 
Taxonomic profiles of the metagenomic data were determined using nucleotide 
alignments and compared based on disease status (healthy, CCD, ICD). Greater than 
60% of the metagenomic sequence reads in the healthy samples could not be assigned 
at the phylum, family or genus level, as compared with ~40% of the reads in ICD or 
CCD subjects, potentially resulting from reduced diversity in CD. Of the metagenomic 
reads for which a taxonomic assignment could be made, 396 genera were represented 
in all of the samples, and nine of those were present at > 5%.  Eleven genera of the 
Firmicutes phylum (Faecalibacterium, Geobacillus, Desulfotomaculum, 
Desulfitobacterium, Holdemania, Thermoanaerobacter, Thermosinus, 
Carboxydothermus, Enterococcus, Alkaliphilus, Subdoligranulum and Anaerotruncus) 
Phenotype Sample Run Proteins Peptides Total Identified MS/MS Total Collected MS/MS
2 3,138 8,679 13,254 78,381
3 2,618 6,838 11,351 70,492
2 2,716 6,653 11,022 80,797
1 2,612 6,308 10,919 81,202
1 2,477 5,910 10,089 92,865
2 2,337 5,416 10,388 91,745
1 2,089 5,231 8,485 82,546
2 2,062 5,161 8,354 84,089
3 2,172 5,997 10,199 90,775
1 1,985 5,635 9,291 91,145
1 1,859 4,483 7,964 75,873
2 1,878 4,071 7,919 74,574
1 1,874 5,494 10,291 83,254
2 2,122 6,783 11,698 77,906
2 2,146 6,235 9,816 81,970
1 1,916 5,430 9,695 80,718
2 1,733 4,738 7,728 78,811
1 1,840 4,956 7,830 73,878
2 3,049 6,926 12,610 92,460
3 3,108 7,070 13,281 91,865
2 1,964 5,931 11,161 76,489
1 1,648 5,108 10,350 78,661
1 2,855 6,830 12,669 92,795
2 3,139 7,626 12,642 93,485
healthy
ileal CD
healthy
healthy
colonic CD
ileal CD
ileal CD
ileal CD
18b
6a
6b
9a
9b
10a
10b
15a
15b
16a
16b
18a
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and one genera of the Proteobacteria phylum (Pelobacter) were less abundant in the 
ICD compared to healthy subjects (Table 8.4).  The depletion of Faecalibacterium and 
Subdoligranulum was previously reported using 16S rRNA gene sequencing in these 
same samples[201]. Bacteria that were more abundant in the microbiota of ICD 
compared to healthy subjects included genera of Pasteurella.  These data are 
consistent with other reports of dysbiosis of the microbiota in subjects with CD[198], 
however, the list of differentially abundant genera are not entirely consistent between 
studies, which most likely reflects the different cohorts that have been studied to date. 
Table 8.4: Relative abundances of differentially abundant species. 
Taxonomy CCD 16S CCD WGS ICD 16S ICD WGS H 16S H WGS 
Desulfitobacterium 0.00E+00 0.00E+00 0.00E+00 1.67E-06 0.00E+00 1.50E-05 
Desulfotomaculum 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 5.00E-06 
Geobacillus 0.00E+00 1.00E-05 0.00E+00 0.00E+00 0.00E+00 7.50E-06 
Pasteurella 0.00E+00 2.00E-05 0.00E+00 8.33E-06 0.00E+00 2.50E-06 
Thermoanaerobacter 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1.50E-05 
Enterocytozoon 0.00E+00 5.00E-06 0.00E+00 0.00E+00 0.00E+00 7.50E-06 
Carboxydothermus 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 5.00E-06 
Thermosinus 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 2.50E-06 
Pelobacter 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 2.50E-06 
Holdemania 0.00E+00 1.65E-04 6.67E-05 1.25E-04 0.00E+00 5.08E-04 
Anaerotruncus 1.20E-03 1.85E-04 2.83E-04 2.00E-04 6.25E-04 1.18E-03 
Enterococcus 2.45E-03 1.77E-02 0.00E+00 1.19E-03 0.00E+00 7.87E-04 
Faecalibacterium 1.53E-02 2.69E-03 1.55E-03 1.65E-03 1.50E-02 1.25E-02 
Neorickettsia 0.00E+00 1.50E-05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Fibrobacter 0.00E+00 5.00E-06 0.00E+00 0.00E+00 0.00E+00 7.50E-06 
Alkaliphilus 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1.75E-05 
Subdoligranulum 8.50E-03 2.58E-03 7.75E-03 4.97E-04 3.25E-03 2.99E-03 
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8.3.2: Peptide-Spectrum Matching (PSM) and broad functional comparisons 
In addition to taxonomic information, metagenomic data provides information on gene 
content of the gut microbiome; however, it does not reveal the identities and relative 
abundances of expressed gene products (proteins) under the conditions studied. 
Therefore, to directly address gene function and expression, we performed database 
searches with tandem mass spectra (MS/MS) of peptides from the same samples.  
These extensive MS/MS datasets were searched both against their corresponding 
matched microbial metagenome (MM) (Table 8.1) or a representative set of 51 
sequenced human microbiome isolate reference genomes (HMRGs) (Table 8.5), each 
concatenated with the human genome. The HMRGs provide nearly complete DNA 
sequence coverage of a bacterial species, and the predicted genes are often full length, 
as compared to the MMs that are not sequenced to sufficient depth to contain complete 
genomes, and the predicted genes are often fragmented.  However, many sequences 
captured from a clinical sample do not map to HMRGs.  One challenge in using a 
HMRG database is gene redundancy between strains/species belonging to the same 
genera, which can make it difficult to uniquely assign a peptide to a mass spectrum. 
Therefore, we developed a novel method for clustering functionally similar proteins from 
the MMs to provide a more robust method of assigning peptide-spectrum counts for 
relative quantification.  This approach enabled us to take advantage of both MMs and 
HMRGs to identify both ‘core’ proteins and disease-specific proteins associated with the 
human gut microbiota, including those with unknown function.   
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Table 8.5: Human microbial isolate reference genome database (HMRG) database 
components. 51 bacterial isolates were downloaded from the JGI IMG human 
microbiome project (IMG-HMP) into a single FASTA-formatted protein sequence 
database. 
 
Database'Identifier Genome GID Total'#'of'Predicted'Proteins
Aero_hydr_hydr_ATCC_7966 Aeromonas2hydrophila2hydrophila2ATCC27966 639633004.faa 4,129
Cate_mits_DSM_15897 Catenibacterium2mitsuokai2DSM215897 643886110.faa 2,977
Dore_form_ATCC_27755 Dorea2formicigenerans2ATCC227755 641736133.faa 3,277
Ente_faec_PC4.1 Enterococcus2faecalis2PC4.1 647000238.faa 2,695
Shig_sp._D9 Shigella2sp.2D9 645058835.faa 4,463
Akke_muci_ATCC_BAAL835 Akkermansia2muciniphila2ATCC2BAAL835 642555104.faa 2,176
Alis_putr_DSM_17216 Alistipes2putredinis2DSM217216 641736205.faa 2,742
Anae_ster_DSM_17244 Anaerofustis2stercorihominis2DSM217244 641736193.faa 2,331
Bact_cacc_ATCC_43185 Bacteroides2caccae2ATCC243185 640963023.faa 3,855
Bact_dore_DSM_17855 Bacteroides2dorei2DSM217855 642979370.faa 4,966
Bact_frag_NCTC_9343 Bacteroides2fragilis2NCTC29343 637000024.faa 4,299
Bact_ovat_ATCC_8483 Bacteroides2ovatus2ATCC28483 641380449.faa 5,536
Bact_pect_ATCC_43243 Bacteroides2pectinophilus2ATCC243243 642979337.faa 3,246
Bact_sp._2_2_4 Bacteroides2sp.22_2_4 646206266.faa 5,959
Bact_sp._3_1_33FAA Bacteroides2sp.23_1_33FAA 647533113.faa 4,666
Bact_sp._3_2_5 Bacteroides2sp.23_2_5 646206273.faa 4,505
Bact_sp._4_3_47FAA Bacteroides2sp.24_3_47FAA 646206274.faa 4,613
Bact_sp._9_1_42FAA Bacteroides2sp.29_1_42FAA 646206263.faa 4,871
Bact_sp._D4 Bacteroides2sp.2D4 646206258.faa 4,431
Bact_thet_VPIL5482 Bacteroides2thetaiotaomicron2VPIL5482 637000026.faa 4,816
Bact_unif_ATCC_8492 Bacteroides2uniformis2ATCC28492 641380447.faa 4,663
Bact_vulg_ATCC_8482 Bacteroides2vulgatus2ATCC28482 640753008.faa 4,076
Bifi_adol_L2L32 Bifidobacterium2adolescentis2L2L32 640963015.faa 2,428
Bifi_long_infa_ATCC_15697 Bifidobacterium2longum2infantis2ATCC215697 643348516.faa 2,486
Blau_hans_DSM_20583 Blautia2hansenii2VPI2C7L242DSM220583 643886146.faa 3,218
Blau_hydr_S5a33_DSM_10507 Blautia2hydrogenotrophicus2S5a332DSM210507 643886199.faa 3,869
Citr_kose_ATCC_BAAL895 Citrobacter2koseri2ATCC2BAAL895 640753015.faa 5,031
Clos_bart_DSM_16795 Clostridium2bartlettii2DSM216795 641736113.faa 2,787
Clos_bolt_ATCC_BAAL613 Clostridium2bolteae2ATCC2BAAL613 641380428.faa 7,284
Clos_lept_DSM_753 Clostridium2leptum2DSM2753 641380427.faa 3,923
Clos_nexi_DSM_1787 Clostridium2nexile2DSM21787 642979369.faa 4,239
Clos_sp_M62L1 Clostridium2sp2M62L1 643886005.faa 4,266
Clos_sp._SS2L1 Clostridium2sp.2SS2L1 641736270.faa 3,167
Coll_aero_ATCC_25986 Collinsella2aerofaciens2ATCC225986 640612206.faa 2,367
Coll_inte_DSM_13280 Collinsella2intestinalis2DSM213280 642979320.faa 1,786
Copr_come Coprococcus2comes 643886116.faa 3,913
Dial_invi_DSM_15470 Dialister2invisus2DSM215470 645951833.faa 1,954
Esch_coli_KL12_MG1655 Escherichia2coli2str.2KL122substr.2MG1655 646311926.faa 4,148
Euba_rect_ATCC_33656 Eubacterium2rectale2ATCC233656 644736367.faa 3,621
Faec_prau_A2L165 Faecalibacterium2prausnitzii2A2L165 645951831.faa 3,475
Faec_prau_M21L2 Faecalibacterium2prausnitzii2M21L2 641380420.faa 3,493
Lact_reut_CF48L3A Lactobacillus2reuteri2CF48L3A 643886138.faa 2,164
Meth_smit_F1_DSM_2374 Methanobrevibacter2smithii2F12DSM22374 643886215.faa 1,710
Myco_tube_CDC1551 Mycobacterium2tuberculosis2CDC1551 637000172.faa 4,235
Para_dent_F0305 Parascardovia2denticolens2F0305 647533193.faa 1,481
Prev_copr_CB7_DSM_18205 Prevotella2copri2CB72DSM218205 643886200.faa 3,293
Rose_inte_L1L82 Roseburia2intestinalis2L1L82 642979356.faa 4,817
Rumi_gnav_ATCC_29149 Ruminococcus2gnavus2ATCC229149 640963057.faa 3,913
Rumi_lact_ATCC_29176 Ruminococcus2lactaris2ATCC229176 642791604.faa 2,750
Rumi_obeu_ATCC_29174 Ruminococcus2obeum2ATCC229174 640963024.faa 4,175
Rumi_sp._5_1_39BFAA Ruminococcus2sp.25_1_39BFAA 646206280.faa 3,525
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On average, a total of 1,250 (healthy), 850 (ICD), and 788 (CCD) proteins were 
identified with MM database searches and 2,904 (healthy), 1,928 (ICD), and 2,241 
(CCD) proteins using the HMRG database, thus represents the most extensive 
metaproteome characterization of the human gut to date (Tables 8.2 and 8.3).  Due to 
the redundancy of homologous proteins, microbial proteins with >80% sequence identity 
were clustered to generate a total of 5,692 and 3,101 orthologous clusters (OC) from 
the HMRGs and MMs, respectively, across all 24 MS runs. Of the OCs that were 
identified using the MM searches, 52 were identified across all subjects (core; Table 
8.6) and included primarily general housekeeping functions (such as ribosomal 
proteins); whereas 151, 3, and 88 OCs were unique to either the healthy, ICD, or CCD 
core metaproteomes, respectively (Figure 8.1). Post-cluster analysis revealed that 
1,017 proteins from the MM database searches were unique (i.e., they did not fall into a 
protein cluster), in contrast, all identified proteins from the HMRGs did cluster, 
suggesting that there is considerable diversity of genes within the human gut microbiota 
that is not captured in reference genome sequences.  
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Table 8.6: Common core microbial proteins identified in the metaproteomes of all 
subjects included in the study (healthy, ileal CD and colonic CD). 
 
 
Cluster Protein
CLST000006 Ribosomal/protein/L14
CLST000011 Ribosomal/protein/S11
CLST000208 Annotation/not/available
CLST000254 Phosphoenolpyruvate/carboxykinase/(ATP)
CLST000335 NifU/homolog/involved/in/FeLS/cluster/formation
CLST000603 GlyceraldehydeL3Lphosphate/dehydrogenase/erythroseL4Lphosphate/dehydrogenase
CLST000797 GTPases/L/translation/elongation/factors
CLST000998 Ribosomal/protein/L11
CLST001935 Rubrerythrin
CLST005531 Fructose/tagatose/bisphosphate/aldolase
CLST005618 KetolLacid/reductoisomerase
CLST005666 Chaperonin/GroEL/(HSP60/family)
CLST005804 Ribosomal/protein/L5
CLST005825 Ribosomal/protein/L7/L12
CLST005842 DNALdirected/RNA/polymerase,/beta/subunit/140/kD/subunit
CLST005865 Ribosomal/protein/S7
CLST005872 Ribosomal/protein/S2
CLST005915 Molecular/chaperone
CLST005929 Ribosomal/protein/S19
CLST005988 Ribosomal/protein/L20
CLST005996 Ribosomal/protein/S8
CLST006170 Ribosomal/protein/S9
CLST006191 Translation/elongation/factors/(GTPases)
CLST006298 Ribosomal/protein/L1
CLST006300 Phosphoenolpyruvate/synthase/pyruvate/phosphate/dikinase
CLST006373 ABCLtype/sugar/transport/systems,/ATPase/components
CLST006584 IMP/dehydrogenase/GMP/reductase
CLST006673 Ribosomal/protein/S10
CLST006805 Ribosomal/protein/L29
CLST006834 3Lphosphoglycerate/kinase
CLST006844 Ribosomal/protein/L13
CLST006883 F0F1Ltype/ATP/synthase,/beta/subunit
CLST006904 Ribosomal/protein/L23
CLST006921 Protein/involved/in/phosphoenolpyruvateLdependent/sugar/phosphotransferase/system
CLST007033 PyruvateLformate/lyase
CLST007119 DNALdirected/RNA/polymerase,/beta/subunit/160/kD/subunit
CLST007120 Transaldolase
CLST007226 Ribosomal/protein/S4/and/related/proteins
CLST007262 Ribosomal/protein/S3
CLST007269 Ribosomal/protein/S5
CLST007338 Pyruvate/oxaloacetate/carboxyltransferase
CLST007389 Ribosomal/protein/L6P/L9E
CLST007461 CoLchaperonin/GroES/(HSP10)
CLST007642 Ribosomal/protein/L17
CLST007797 Ribosomal/protein/S15P/S13E
CLST008351 Pyruvate:ferredox/in/oxidoreductase/and/related/2Loxoacid:ferredoxin/oxidoreductases,/beta/subunit
CLST008679 Triosephosphate/isomerase
CLST014282 Penicillin/tolerance/protein
CLST017476 AcetylLCoA/acetyltransferase
CLST018911 Formyltetrahydrofolate/synthetase
CLST020880 Carbon/dioxide/concentrating/mechanism/carboxysome/shell/protein
CLST022770 AcylLCoA/dehydrogenases
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Figure 8.1: Venn diagram showing the number of protein clusters common or unique to 
each disease category: H (healthy), ICD (ileal Crohn’s disease) and CCD (colonic 
Crohn’s disease). 
By broad comparison of the metagenomes and metaproteomes, two trends 
emerged:  (a) CD samples clustered separately from healthy (Figures 8.2a and 8.3) 
and (b) the percent of expressed genes compared to the total gene repertoire is lower in 
CD patients as compared to healthy subjects (Figure 8.2b), reflected by a significant 
decrease in protein family richness in ICD and CCD that was particularly pronounced for 
ICD (Figure 8.2c). The metaproteomes significantly differentiated by disease phenotype 
(p<0.004) based on spectra matching to HMRGs (Figure 8.3a).  This was also shown 
with i) clustering based on function to MMs (Figure 8.3b) and ii) functional assignments 
of genes from MMs by KEGG (Figure 8.3c), suggesting that disease phenotype was a 
stronger discriminator than zygosity, similar to our previous analyses of the same 
samples[201], [202].  Although healthy and CCD metaproteomes could be distinguished 
from another, they clustered more closely together compared to the ICD 
metaproteomes that were clearly distinct (Figure 8.2a).  Therefore, we primarily focused 
on functions that differentiated ICD from healthy, but included comparisons to the CCD 
twin pair when relevant.  
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Figure 8.2: (A) Non-metric multidimensional scaling (nMDS) of fecal metaproteomes.  A 
matrix of normalized spectral counts per protein from each duplicate gut metaproteome 
was imported into PCORD v5 software.  nMDS was performed using the Bray-Curtis 
distance measure A three-dimensional solution was found after 119 iterations. The final 
stress for the nMDS was 6.47458.  (B) Fraction of proteins expressed as measured by 
comparison to the metagenome (C) Functional richness as measured by the Chao1 
richness estimate of KEGG orthologous groups (KOs). 
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Figure 8.3: Clustering by Phenotype. (A) Non-metric multidimensional scaling (nMDS) 
of fecal metaproteomes.  A matrix of normalized spectral counts per protein from each 
duplicate gut metaproteome was imported into PCORD v5 software.  nMDS was 
performed using the Bray-Curtis distance measure A three-dimensional solution was 
found after 119 iterations. The final stress for the nMDS was 6.47458. (B) Heatmap of 
Metaproteomes prediced from matched metagenomes by protein clusters. (C) 
Hieractical Clustering of Metagenomes by KEGG KO relative abundances using 
Manhattan distance calculation and the ‘average’ clustering method with an arcsin 
square root transformation. 
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While there were core microbial functions that were identified across all samples 
in the metagenome (Figure 8.4a) and metaproteomes (Figure 8.4b), proteins involved 
in translation, defense, organic metabolism, post-translational modification and 
signaling, and genes involved in intracellular trafficking, translation and defense differed 
in abundance between healthy and ICD subjects.  To assess pathway abundance, 
KEGG module analysis was performed on metagenome and metaproteome datasets.  
Glycolysis, reductive pentose phosphate cycle and butyrate production were found to be 
under-represented in ICD compared with healthy microbiota, in both the metagenomic 
and metaproteomic datasets (data not shown).  In the metagenomic analysis, 
conjugated bile acid biosynthesis, urea cycle, phosphonate transport system and type 
IV secretion system were found to be over-represented in ICD compared with healthy 
microbiota.    
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Figure 8.4: (A) Relative abundance of metagenomic reads assigned to COG 
categories. (B) Relative abundance of metaproteomic spectra assigned to COG 
categories. (C, D) Sugar utilization in the metagenome (C) and metaproteome (D) by 
comparison to the CAZy database. 
Each dataset contained a subset of genes and proteins of unknown function.  For 
example, ~17% of predicted ORFs were conserved with no known function or were not 
homologous to any proteins.  Approximately 31% of identified HMRG proteins and 29% 
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of identified microbial OCs (including proteins that did not cluster in MMs) had no known 
function.  Interestingly, one OC comprising 11 unknown proteins was significantly 
correlated with ICD, where five OCs (10-100s of unknown proteins) were significantly 
correlated with healthy.  These findings support the need for better coupling of 
phenotypic assays with -omics strategies to aid in the characterization of important 
functional but unknown genes and proteins. 
8.3.3: Metabolic pathways differentiate CD and healthy phenotypes 
We identified several examples in both the metagenome and metaproteome datasets 
which suggested that functions related to carbohydrate transport and metabolism and 
energy production are depleted in the ICD microbiota (Figure 8.4b).  In addition to the 
differential pathways identified by KEGG analysis, the abundance of genes for sucrose 
and fructose degradation is higher in ICD, while genes and proteins involved in starch, 
glycogen, and complex carbohydrate degradation are lower in abundance (Figure 8.4c 
and d).  These results, along with pathway analysis, suggest that the microbiota of ICD 
subjects have a reduced capability to uptake complex carbohydrates and breakdown 
nutrients. 
Many proteins that were less abundant in ICD reflected a decreased abundance 
of bacteria that contain metabolic pathways with relevance to the physiology of the 
human gut (Figure 8.2a).  Butyrate, a major energy source for colonocytes, is involved 
in the maintenance of colonic mucosal health and can elicit anti-inflammatory 
effects[208], thus its depletion could be one reason for the inflammation in CD.  
Faecalibacterium prauznitzii is a major butyrate producer in the gut and the low 
abundance of this species (as revealed by 16S rRNA and metagenomic analyses) and 
proteins involved in the butyrate pathway (Figure 8.5) could contribute to the 
inflammation associated with ICD.  Reduced butyrate production correlates to the 
depletion of known butyrate producers (e.g., Roseburia, Faecalibacterium and 
Subdoligranulum) in our CD subjects (Figures 8.2a and 8.6).  The increased 
abundance of F. prausnitzii revealed abundant proteins central to butyrate production 
and other short-chain fatty acid production (e.g., acetate and proprionate) exclusively in 
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the healthy and CCD subjects but not in ICD (Figure 8.7a).  Several other genes 
associated with anti-inflammatory responses and properties, such as lactocepin 
(EC3.4.21.96) and aspartate dehydrogenase (EC3.4.21.96), were significantly more 
abundant in CD relative to healthy (Figure 8.5b).   
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Figure 8.5: (A) Metabolic pathways differentiating by disease phenotype, as resulting from the metabolic module analysis 
(p<0.05; 5% FDR). Highlighted areas discussed in the main text: (1) butyrate production; (2) membrane proteins (B) 
Enzymes that were significantly different across Healthy, ICD, and CCD fecal metagenomes. 
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Figure 8.6: Differences in Butyrate Production in ICD compared to Healthy.  Cumulative 
plots of fraction of total reads assigned to Faecalibacterium, Rosburia and 
Subdoligranulum genera per sample.  
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Figure 8.7: (A) Most significantly differential proteins from Healthy and CD subjects.  
Presence-absence heatmap shows which of the 51 bacterial strains the proteins 
matched to.  (B) Enzymes that were significantly different across Healthy, ICD, and 
CCD fecal metagenomes. 
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Protein abundance measurements, based on MM searches, indicate an over-
representation of bacterial TonB-dependent cell surface receptors, which are multi-
functional but are involved in inorganic ion transport and metabolism, in the ICD 
microbiota. These data are also consistent with metagenomic analysis which reveals a 
greater abundance of genes involved in inorganic ion metabolism in the CD microbiota 
(Figure 8.4a).  If the gut ecosystem is deficient in inorganic ions in CD, the gut 
microbiota may compensate by up-regulation of genes and proteins that are involved in 
ion acquisition and transport. 
8.3.4: Bacterial-host interactions and defense  
Several proteins involved in bacterial-host interactions and defense were more 
abundant in the ICD microbiota and included several bacterial outer membrane proteins 
(e.g., OmpA, RagB, and SusC/D) that were differentially present in both the 
metagenomes and metaproteomes (Figure 8.7a and b), supporting the current 
hypothesis that CD is manifested by an aberrant mucosal response to otherwise 
harmless bacterial antigens in genetically susceptible subjects[209,210,211].  OmpA, a 
pore-forming protein in the outer membrane of many Gram-negative bacteria, harbors 
diverse functions including maintenance of cell structure, binding various substances, 
adhesion, and resistance to antimicrobials[212], and is suggested to be involved in gut 
mucosal association[213]. One hypothesis is that because OmpA is highly represented 
and highly conserved in many enteric bacteria, the immune system has acquired the 
ability to recognize and to be activated by this class of protein[214]. Because these 
proteins are more abundant in ICD, this suggests that the immune system is functioning 
abnormally with respect to reduced levels of the corresponding bacteria expressing this 
protein, and supports the current hypothesis that CD is manifested by an aberrant 
mucosal response to otherwise harmless bacterial antigens in genetically susceptible 
individuals[209,210,211].   
Our study provides the first evidence of elevated abundance of other major 
OMPs, such as RagB, SusC/D associated with CD (Figure 8.5a).  An elevated IgG 
response to RagB was previously reported in subgingival samples of patients with 
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periodontitis[215] and virulence of the rag locus was demonstrated in Porphyromonas 
gingivalis strains[216].  While the role of RagB/Sus in the etiology of CD warrants further 
study, our data suggest that there is a shift from a healthy microbiota towards a 
microbial consortium that can elicit an inflammatory immune response. 
In addition, an integration host factor (IHF) protein, which is linked to virulence 
gene regulation[217,218], was identified as being statistically more abundant in ICD 
metaproteomes using MMs, but not HMRGs.  This finding highlights the importance of 
MMs to identify proteins that originate from bacteria not yet sequenced, or cultivated.   
8.3.5: Broad Functional Comparisons of the Human Proteome 
Because we are able to measure both bacterial and human proteins using 
metaproteomics, a total of 1,646 human proteins were experimentally identified.  Gene 
ontology (GO) analysis revealed that human proteins found in all 3 subject groups 
(core) are enriched in functions associated with the structural integrity of the mucosal 
epithelium.  Proteolysis, digestion, and carbohydrate catabolism were also among the 
most abundant ‘core’ functions, as would be expected in the GI-tract (Figure 8.8a).   For 
human proteins that varied in healthy compared to CD, the majority were involved in 
epithelial integrity and function, as detailed below.  To our knowledge, this is the first 
use of non-targeted shotgun proteomics to simultaneously assess both human and 
microbial proteins from the same fecal samples to assess a disease state.   
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Figure 8.8: Human proteins identified in the metaproteome data. (A) Human proteins’ 
“core” Gene Ontology terms across all subjects (healthy (H), ileal Crohn’s Disease 
(ICD), and colonic Crohn’s Disease (CCD)).  (B) Human proteins Gene Ontology terms 
that are enriched according to disease. 
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Figure 8.8 (A) 
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Figure 8.8 (B) 
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8.3.6: Impaired epithelial integrity in ICD 
The human proteins detected primarily in CD subjects support the hypothesis that 
subjects with ICD, even in remission, have a defective epithelial barrier.  A higher 
abundance of proteins in GO categories for inflammatory and host defense, wounding 
response, intracellular transport, and epithelial development and differentiation were 
enriched in ICD subjects (Figure 8.8b).  For example, mucin 2 (MUC-2), the most 
prominent mucin secreted by intestinal epithelial cells, was also more abundant in ICD 
subjects.  Similarly, thiosulfate sulfurtransferase, important in sulfate reduction and 
linked to mucin fermentation (PMID 3214155), was elevated in CD (p<0.001) based on 
metagenome analysis (Figure 8.5b).  
Other proteins that function in maintaining mucosal integrity were identified as 
being statistically under-represented in ICD, including protocadherin LKC, a calcium 
dependent mediator of cell-cell adhesion that associates with the mucosal actin 
cytoskeleton[219] and type 1 collagen (alpha-2), the major collagen in the intestinal 
extracellular matrix[220].  A depletion of these proteins might compromise host defense 
at the mucosal interface.  
A defective epithelial barrier is thought to result in an aberrant host response to 
luminal antigens leading to an exaggerated adaptive immune response and chronic 
inflammation[211]. Alpha defensin 5, a protein implicated in regulation of bacterial 
concentrations in the ileal intestinal crypt[221,222,223] was statistically more abundant 
in ICD, suggesting that the host may increase expression of defensins in response to 
aberrant microbiota in these subjects, or that the products are leaking from the intestinal 
site of action to feces.  
8.3.7: Impaired intestinal absorption in ICD 
The primary function of the small intestine is absorption and this appears to be impaired 
in subjects with ICD. For example, several pancreatic enzymes: chymotrypsinogen B1 
and B2, pancreatic carboxypeptidase A1 and B1 and pancreatic lipase were identified 
with higher abundance in ICD.  These enzymes are synthesized in the pancreas as 
	   194	  
inactive precursors that are activated in the intestine where they aid in digestion. 
Relatively high amounts of pancreatic enzymes in feces may be indicative of 
pancreatitis, which has been linked to CD[224], but remains to be confirmed since the 
subjects in this study have not had active pancreatitis.   
Several bile salts were previously found to be elevated in ICD fecal 
samples[202], supporting the hypothesis that there is malabsorption of secreted 
enzymes and metabolites by the gut epithelium in ICD. The reduced uptake of bile salts 
and pancreatic enzymes could also be due to surgery since all ICD patients had 
undergone resections of the ileum. Since uptake of bile salts occurs within the terminal 
part of the ileum, patients that have undergone resections, leaving them with a shorter 
ileum, might have a reduced uptake of bile salts. Bile salt malabsorption with secondary 
diarrhea is a common clinical feature in patients undergoing extensive ileal resections. 
8.4: Conclusions 
Here we have used a combination of extensive and complementary “-omics” datasets to 
provide a more comprehensive view of the role of the gut microbiota in CD than has 
been previously possible. The value of this approach comes from the ability not only to 
examine the structure and function of the microbiota from multiple perspectives, but also 
from the ability to integrate data from the gut microbiota and the host.  The validity of 
our methods is supported by data at the species, gene, and protein levels that confirm 
previous reports that ICD is associated with a loss of F. prauznitzii. New findings from 
this study suggest several other malfunctions in CD, both with respect to the intestinal 
microbiota and the host.  Dysbiosis of the bacterial community in ICD results in a higher 
abundance of bacterial surface proteins, many of which are antigenic and could 
contribute to an exaggerated immune response, and that could cause or aggravate 
inflammation associated with CD. This imbalance comes at the expense of loss of many 
beneficial members of the microbiota, including those that produce butyrate. At the 
same time, there are several indications that the host epithelial barrier is impaired, both 
with respect to structural integrity of the mucosal boundary and with respect to its ability 
to absorb secreted enzymes and metabolites. These functional changes may define the 
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CD phenotype, even when patients are in remission.  It will be of great value to extend 
these studies to larger cohorts of CD patients and to also carry out longitudinal studies 
to assess how the structure and function of the gut microbiota changes in a given 
patient over time.  We have also uncovered some interesting examples of where the 
meta-omics data does not completely overlap, indicating the need to further explore the 
fundamental differences and significance of genomic potential versus proteome 
abundances.   Together, these data point towards several new targets for further 
investigation in the hunt for diagnostic targets and therapeutic treatments for CD. 
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Chapter 9 
Conclusions from the Metaproteomics Characterization of the Human Gut-
Associated Microbiome 
 
9.1: Conclusions 
The human microbiome, the collective set of microbes inhabiting the human body, is a 
complex ecosystem that is poorly understood in both human health and disease.  
Although the HMP has focused tremendous efforts and funds to understand the human 
microbiota by sequencing the microbes present in and on the skin, oral and nasal 
cavity, vagina and gastrointestinal tract by metagenomics, this approach will only reveal 
the composition and ‘potential’ function.  While genomics and metagenomics have laid 
the groundwork for many microbial communities including the human microbiome, 
proteomics and metaproteomics have evolved to provide an additional level of 
information, ‘actual’ protein abundance that is not possible with metagenomics.   
The research presented in this dissertation represents a detailed characterization 
of the human gastrointestinal (gut) microbiome.  Although not completely 
comprehensive, a fairly deep level of detail regarding the identity and functional 
signature of the host and gut microbial metaproteomes has been revealed through an 
integrative approach consisting of both community genomics and proteomics.  The 
technology that enables high-throughput, unbiased, and highly reproducible community 
proteomics is high throughput, high performance mass spectrometry.  MS-based 
proteomics can identify hundreds to thousands of proteins from a microbial community 
sample.  As discussed previously, genomics and metagenomics (predicted protein 
database) is the foundation for MS-based proteomics.  Therefore, the quality of DNA 
sequencing (i.e., depth of coverage and sequencing errors), assembly, and gene-finding 
has a tremendous effect on the ability of MS-based proteomics to assign all tandem 
mass spectra using protein database searching.  For example, if the final genomes or 
metagenomes are not representative of the exact same samples used for proteomic 
measurements or are not sequenced to a sufficient depth, fewer quality MS/MS will be 
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assigned resulting in fewer peptide and protein identifications.  Due to the 
interdependence of both technologies and future of systems biology, it is the 
development and advancement of genomic and proteomic technologies that will enable 
and improve biological inference of the complex human microbiome. 
The objective of this dissertation research is a detailed and mechanistic 
understanding of the host and microbial functional signature in the human gut 
microbiome.  Initially, we used a less complex and defined human-derived microbial 
community in gnotobiotic mice as a model system to study the human gut microbiome.  
This model system is advantageous for several reasons, including the ability to control 
the microbial membership in present in the gut.  A defined human microbiota enables 
the functional study of each of microbial member, their interactions, cooperation, 
competition and adaptation in the gut.  From the lower complexity binary and 12-
member consortia, we progressed to a representative and higher complex human gut 
microbiome in human individuals.  A non-targeted MS-based approach is ideal for 
studying complex communities based on its ability to directly measure expressed 
proteins from complex environmental matrices.  This approach was applied to elucidate 
the functional ‘core’ and differences in the commensal microbiota of human twins with 
and without Crohn’s disease.  Although challenges are present in both approaches, 
both have provided different information that has contributed to a larger understanding 
of how the human gut, health and disease, functions with our microbial counterparts.   
9.2: Experimental optimization and biological inference in the human gut 
microbiome 
The experimental methodology and analytical technology originally developed on single 
bacterial isolates has been extended to low- (AMD) and high-complexity (soil, ocean, 
and the human microbiome) microbial communities, all of which with range in microbial 
composition and diversity.  Microbial communities have many challenges not 
characteristic of single bacterial isolates including: environmental sample biomass 
quantity, interfering matrices, species and protein dynamic range, and microbial 
sequence redundancy.  As revealed throughout this dissertation, experimental 
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challenges associated with human gut microbiome related samples include efficient, 
non-biased lysis and extraction of proteins from bacteria and host cells in complex 
sample matrices (feces and cece) and dynamic range (detection of lower abundant 
proteins and microbes).  Informatics challenges are based on traditional database 
filtering metrics and the ability to uniquely assign MS/MS to a protein and its’ 
corresponding microbial species within a large collection of closely related and diverse 
microbes.  Although these challenges initially had a significant impact on the ability to 
perform deep proteome characterizations, we have identified new strategies that have 
and will enhance community MS-based proteomic studies of the human microbiome.  
For the two approaches described in this dissertation, liquid chromatography coupled 
with tandem mass spectrometry has been successful to characterize the gut microbial 
community proteomes of gnotobiotic mice and human twins.   
9.2.1: Gnotobiotic mice 
A defined human representative consortium of microbes has provided insight into how i) 
distinct members of a larger consortium of microbes initially establish themselves 
through cooperation and competition, and subsequently ii) compose the collective 
functional community. Chapters 3-6 outlined experimental and computational 
procedures used for proteomic assays of a model gut microbiota, and also illustrated 
some of the benefits in obtaining this type of information.  Experimental methods that 
used a combination of pre-fractionation via ultracentrifugation and chemical 
solubilization and physical homogenization have significantly improved peptide-
spectrum matching and protein identification of in situ extracted proteomes.  
Computational methods that compare and use unique peptide (theoretical peptidome), 
spectra, and protein counts enable the differentiation and assignment of proteins with 
high sequence similarity to a distinct phylotype.  The binary community proteomic 
results revealed that the majority of identified proteins belonging to B. thetaiotaomicron 
and E. rectale are true unique identifications, and that these species can be easily 
differentiated by proteomics.   Although this was a simplified two component human gut 
microbiota of two evolutionary divergent species, the 12-member proteomic results 
revealed similar conclusions with unique peptides as a preferred method for the relative 
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estimation of species abundance with significant dynamic range.  These analyses 
suggested that the community structure is dictated by the host’s diet (i.e., diet is shaping 
overall community structure), with many conserved hypothetical and pure hypothetical 
proteins identified whose presence had not been predicted in the initial annotation of the 
finished genome.   
9.2.2: Human gut twin cohort 
With a successful method to study the proteomes of lower-complexity microbiota in 
gnotobiotic mice, we extended this methodology into higher complexity representative 
human gut microbiomes in human feces.  We have developed a novel non-targeted MS 
approach to measure the identities of thousands of microbial and host proteins in 
human feces using non-matched and/or matched metagenomes in addition to human-
derived reference genomes for protein identification.  Using this approach, we 
established the role of an integrated platform using MS-based proteomics and 
metagenomics in the human microbiome.  Although these results presented the largest 
coverage of the human gut metaproteome, to fully understand the functional role of the 
gut microbiota and its interaction with the human host would require extensive efforts to 
comprehensively define and characterize each microbial member in addition to the 
community as a single collective entity in health and disease.   
We have successfully demonstrated that whole community metaproteome 
measurements were achievable in the human gut microbiome and provided the first 
large-scale glimpse into the functional activities of the microbial community inhabiting a 
healthy gut.  These results also provided key insight into the challenges that we and 
future studies will encounter as the omics’ field progresses and accumulates thousands 
of metagenomic sequences, including extensive microbial sequence redundancy.  In 
order to advance and apply this methodology to higher complexity microbiota and 
human subjects with disease, the field has to establish methods for how to tackle 
microbial protein sequence redundancy in environmental samples.  Although non-
matched metagenomic data may capture more sequence diversity, large protein 
databases can create unreasonable sequence redundancy.  Therefore, we applied a 
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bioinformatics comparison and analysis of how to construct metagenomic sequence 
databases for optimum metaproteome measurements. These results suggested that 
proteomic data is twice as likely to match metagenomic data derived from the same 
sample and protein databases derived from matched metagenomic sequenced reads 
(RMPS), increased the number of MS/MS spectra, peptides, and protein identifications.  
Using this novel approach, we were able to increase PSM and coverage of 
metaproteomes collected from both healthy and individuals with Crohn’s disease and 
revealed examples of where reference genomes and meta-omics data does not 
correlate, indicating the need for future studies to explore the differences between 
genomic potential versus proteome abundances.     
9.3: Future directions 
As this dissertation has demonstrated, biological advancements go hand in hand with 
technological developments.  We cannot improve our understanding of the human 
microbiome unless the experimental and analytical tools are available and adapted for 
complex environmental samples with higher complexity in microbial composition and 
diversity (i.e., thousands of bacterial species with a wide range of abundances).  These 
analyses have and will advance the field of metaproteomics in the human gut 
microbiome by providing novel experimental and bioinformatic strategies to identify and 
characterize the metaproteomes of complex microbiomes extracted from feces and 
ceca.  Experimental comparisons and developments that lead to enhanced lysis and 
protein extraction methods will enable future studies to build upon these methods to 
increase protein identification and coverage of large-scale metaproteomes.  
The future of metaproteomics in the human microbiome will likely focus on 
several of the challenges discussed within this dissertation.  Because we are only 
sampling the surface with the identification of ~1-10% of the community proteome, 
technological advancements will enable deeper measurements and wider coverage of 
the entire community, but more importantly the lesser abundant microbes.  
Improvements in chromatographic peptide separation and/or fractionation and mass 
spectrometric measurements will provide better peptide separation and detection, 
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through-put, and higher resolution and mass accuracies to resolve single amino acid 
polymorphisms and post-translational modifications in the human microbiome which is 
currently not possible. 
The current bottleneck in microbial community metaproteomics hinges on the 
available informatics algorithms and filtering metrics that were designed for single 
microbial isolates and mixtures of proteins.  Contrary to single bacterial genomes, when 
faced with thousands of publically available metagenomes and reference genomes, 
computational resources will be stretched to their practical limits, and traditional 
database search algorithms will be ineffective and obsolete.  New cost-effective 
computational resources (i.e., to store and create substantial omic’ databases) and 
informatics algorithms that are designed for microbial communities will lead the future 
and enable the comprehensive and accurate assignment of all tandem mass spectra 
within microbial communities for which a large portion of the are closely-related 
microbes with high sequence similarity.   
The future of the human microbiome, both in metagenomics and 
metaproteomics, includes the development of tools to characterize large numbers of 
proteins with unknown function.  As evident throughout this dissertation in gnotobiotic 
mice and human individuals, a large percentage of the collective microbial community 
consists of proteins with unknown function that are not revealed by metagenomics.  It is 
obvious that these proteins are critical for microbial survival and carry out important 
functions in the human gut.  New experimental and biochemical assays focused on the 
profiling and characterization of proteins with unknown functions will likely unravel new 
microbial phylotypes and functions yet to be seen by traditional sequencing 
technologies. 
It is the field of systems biology and the combination of omic approaches, with 
advancement in all areas of MS-based proteomics including technology and informatics 
workflows that will serve as the future revolutionary tool to fully characterize microbial 
community metaproteomes in the human microbiome.  
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9.4: Perspective 
Over the last five years, the research presented here has helped establish the field of 
metaproteomics and its successfulness in the human gut microbiome, even though the 
majority of current research efforts and funds are focused on metagenomics.  We have 
identified an experimental and analytical platform that supports an unbiased and deep 
identification of the human gut metaproteome.  This platform can be effectively scaled 
from a less complex, controlled model microbiota to a highly complex gut microbiome 
derived from human subjects.  We have developed a novel bioinformatics workflow for 
integrated omic studies that incorporates metagenomic sequence data and MS to 
provide optimum identification and characterization of human host-gut metaproteomes.  
In addition to designing and developing experimental, analytical, and informatics 
workflows, we have provided a glimpse into whether a healthy ‘core’ gut metaproteome 
exists and the metabolic functional differences between individual microbial species 
(e.g., B. thetaiotaomicron and E. rectale) and communities as a whole (e.g., healthy 
versus disease).  These experiments and results represent substantial progress 
towards the ultimate goal of a complete identification of the human gut microbiome. 
The next 5 years will undoubtedly focus on implementing and continually 
developing the platforms described herein to characterize human microbiomes collected 
from higher complexity model communities (e.g., a 100-member microbial community in 
gnotobioic mice) and other human body sites (e.g., oral cavity and vagina).  The 
establishment of metaproteomics in the human microbiome should drive an increase in 
the funding and more extensive studies that focus on characterizing the actual 
functional metaproteome.  As a result, metagenomic-related research groups will 
engage metaproteomics to not only enhance our understanding of the microbiome, but 
also improve metagenomic sequencing with respect to its impact on metaproteomics.  
With regards to mass spectrometry, new informatics workflows that combine traditional 
protein database searching with novel de novo sequencing algorithms will be developed 
and benefit integrated omic’ studies with the identification of unknown proteins that are 
not sequenced and/or are missed in the assembly or gene-finding algorithms unique to 
metagenomics.  Finally, MS will be challenged to another level where efforts will likely 
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begin to focus on designing new techniques and technologies in all omic’ fields that 
permit the study of the ‘web of events’ rather than a static snapshot of the functional 
activities in a microbial community.   It is not apparent that there are any fundamental 
inpenetratable roadblocks to this progress towards a comprehensive systems-biology 
characterization of the human microbiome, but rather only experimental and informatics 
hurdles that need to continue to be navigated.  Since the ultimate goal is a gain in 
biological insight, a focus on mining biological inferences from integrated metagenomic-
metaproteomic datasets will advance mass spectrometry in the human microbiome. 
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